Annual Report 2017-18 | Monash Health
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Annual</strong><br />
<strong>Report</strong><br />
<strong>2017</strong>-<strong>18</strong>
Our vision<br />
& values<br />
Vision<br />
Exceptional care, outstanding outcomes.<br />
Purpose<br />
To deliver quality, patient-centred healthcare and services<br />
that meet the needs of our diverse community<br />
Our Values<br />
(iCARE)<br />
• Integrity<br />
• Compassion<br />
• Accountability<br />
• Respect<br />
• Excellence<br />
2 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Contents<br />
Our care at a glance 4<br />
<strong>Report</strong> of the Chair of the Board<br />
and Chief Executive 6<br />
The Year in review 9<br />
Innovation12<br />
Capital works 16<br />
Our people 22<br />
Our community 27<br />
The <strong>Monash</strong> <strong>Health</strong> Foundation 28<br />
A journey starts with one small step 31<br />
Our sites, services and staff 32<br />
Operational structure 34<br />
Jessie McPherson Private Hospital 36<br />
Clinical governance report 39<br />
Environmental sustainability report 40<br />
Our Board of Directors 42<br />
Members of the Board of Directors 45<br />
Statutory compliance 48<br />
Disclosure index 50<br />
Attestations 52<br />
Statement of Priorities - Part A 53<br />
Statement of Priorities - Part B 56<br />
Statement of Priorities - Part C 60<br />
Financial summary 62<br />
Financial statements and explanatory notes 66<br />
3
Our care<br />
at a glance<br />
In <strong>2017</strong>-<strong>18</strong><br />
3,915,202 40,987<br />
Total Episodes of care*<br />
Paediatric Admissions<br />
(3.6m in 2016-17) (40,293 in 2016-17)<br />
1,043,936<br />
Pathology Tests<br />
(1m in 2016-17)<br />
259,958<br />
Total Hospital Admissions<br />
(260,786 in 2016-17)<br />
1,453,333<br />
Outpatient Services<br />
(1.2m in 2016-17)<br />
226,315<br />
Emergency presentations<br />
(220,913 in 2016-17)<br />
10,027<br />
Births<br />
(10,162 in 2016-17)<br />
287,624<br />
Mental health<br />
(224,460 in 2016-17)<br />
58,858<br />
Ambulance Arrivals<br />
(54,495 in 2016-17)<br />
*Excludes: Surgical Operations,<br />
Total Hospital Admissions,<br />
Babies, Ambulance arrivals,<br />
and Paediatric Admissions.<br />
4 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
<strong>Monash</strong> <strong>Health</strong> is<br />
proud to provide<br />
healthcare to<br />
one quarter of<br />
Melbourne’s<br />
population, across<br />
the entire life-span<br />
from newborn and<br />
children, to adults,<br />
the elderly, their<br />
families and carers.<br />
We improve the health of<br />
our community through:<br />
• Prevention and early intervention<br />
• Community-based treatment and rehabilitation<br />
• Highly specialised surgical and medical diagnosis,<br />
treatment and monitoring services<br />
• Hospital and community-based mental health services<br />
• Sub-acute, aged care and palliative care programs<br />
• Research, education and teaching the next generation<br />
of healthcare professionals<br />
• Regional and state-wide specialist services.<br />
5
<strong>Report</strong> of the<br />
Chair of the<br />
Board and Chief<br />
Executive<br />
Welcome to the <strong>Monash</strong> <strong>Health</strong> <strong>2017</strong>-<strong>18</strong> <strong>Annual</strong> <strong>Report</strong><br />
Providing exceptional care<br />
<strong>Monash</strong> <strong>Health</strong> provides care to a<br />
quarter of all Victorians at every stage<br />
of their life. With the health and wellbeing<br />
of so many people in our hands,<br />
we strive to provide excellence in<br />
patient care. Our Transforming Care<br />
Program has this exact goal in mind,<br />
and we made significant progress this<br />
year. We are working to ensure our<br />
systems and our people align at<br />
every stage.<br />
<strong>Monash</strong> <strong>Health</strong> successfully achieved<br />
accreditation in <strong>2017</strong>, against the<br />
National Safety and Quality <strong>Health</strong><br />
Service Standards. Surveyors<br />
acknowledged our achievements and<br />
continued growth.<br />
We celebrated the one year anniversary<br />
of the opening of the <strong>Monash</strong><br />
Children’s Hospital school reflecting<br />
our commitment to patient care<br />
beyond the healthcare environment,<br />
and recognising the essential role that<br />
education plays in our young peoples’<br />
lives. We are immensely proud that this<br />
initiative will help to keep our young<br />
consumers connected to learning<br />
opportunities and the social aspects<br />
of attending school.<br />
Translating research into<br />
better patient outcomes<br />
<strong>Monash</strong> has achieved significant<br />
progress in research during FY 17-<strong>18</strong>,<br />
with widespread recognition of our<br />
people and our achievements. The<br />
work of our researchers and clinicians<br />
in pursuit of improved patient<br />
outcomes, is possible through the<br />
many partnerships we have in place.<br />
The <strong>Monash</strong> <strong>Health</strong> Translational<br />
Precinct (MHTP), an alliance between<br />
<strong>Monash</strong> <strong>Health</strong>, <strong>Monash</strong> University and<br />
Hudson Institute of Medical Research,<br />
had 1135 active research projects in FY<br />
<strong>2017</strong>-<strong>18</strong>, with $15.3 million new funds<br />
from the National <strong>Health</strong> and Medical<br />
Research Council to ensure lifechanging<br />
medical research is brought<br />
to the bedside. Innovative projects,<br />
such as home-based cancer treatments<br />
and use of virtual reality to alleviate<br />
anxiety in our youngest consumers are<br />
just two examples of the new thinking<br />
fuelling our work.<br />
Growing to meet Victoria’s<br />
healthcare needs<br />
In FY <strong>2017</strong>-<strong>18</strong>, <strong>Monash</strong> <strong>Health</strong> achieved<br />
many Australian and Victorian firsts,<br />
providing the latest equipment,<br />
procedures and services to consumers.<br />
We are now one of only two 24-hour<br />
endovascular clot retrieval services in<br />
Victoria; providing stroke victims with<br />
a better chance of survival. The use of<br />
3D modelling and a new generation<br />
scanner to assess musculoskeletal<br />
disease are just some of the amazing<br />
innovations we made available to<br />
consumers this year. The treatment of<br />
breast cancer through intraoperative<br />
radiotherapy has significantly improved<br />
our patients’ experience.<br />
We are well underway with the<br />
implementation of an Electronic<br />
Medical Record, which is <strong>Monash</strong><br />
<strong>Health</strong>’s biggest technology-based<br />
transformation and due to “go live”<br />
early 2019. It will provide clinicians<br />
with access to timely information about<br />
the people they are caring for, and<br />
assist them in making decisions with<br />
better evidence. For consumers, this<br />
means safer, higher quality care.<br />
We also progressed our capital works<br />
projects substantially, as we continue<br />
to plan for Victoria’s changing and<br />
expanding healthcare needs. Design<br />
consultants began work on our<br />
Victorian Heart Hospital - Victoria’s<br />
first standalone heart hospital that will<br />
bring together clinical practice and<br />
research and innovation.<br />
We continue to deliver our Casey<br />
Hospital expansion project to<br />
schedule, with the main inpatient<br />
tower construction works progressing<br />
well; new theatres and Central Sterile<br />
Services Department on track for<br />
completion by the end of September<br />
2019 and the site’s new front entrance<br />
building will open in late 20<strong>18</strong>. A<br />
key focus of 20<strong>18</strong>-19 will be detailed<br />
operational and budget planning.<br />
Likewise, service and capital planning<br />
for the expansion of Pakenham <strong>Health</strong><br />
Centre commenced in <strong>2017</strong>-<strong>18</strong> and will<br />
continue in 20<strong>18</strong>-19, to ensure it is well<br />
placed to meet growing demand for<br />
community-based services in the south<br />
eastern growth corridor of Melbourne.<br />
Planning for the expansion of<br />
<strong>Monash</strong> Medical Centre’s emergency<br />
department commenced in <strong>2017</strong>-<strong>18</strong>.<br />
This will enable the establishment of<br />
dedicated children’s emergency and<br />
mental health areas and improve traffic<br />
flows at the main entrance, thereby<br />
improving access to the hospital.<br />
Construction will commence in 20<strong>18</strong>-19.<br />
6 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Barbara Yeoh AM<br />
Chair of the Board of Directors<br />
(to 30 June 20<strong>18</strong>)<br />
Andrew Stripp<br />
Chief Executive<br />
Dipak Sanghvi<br />
Chair of the Board of Directors<br />
A fond farewell for our<br />
Chair of the Board<br />
This year marked the final chapter of a<br />
longstanding relationship with <strong>Monash</strong><br />
<strong>Health</strong> for our Board Chair, Ms Barbara<br />
Yeoh AM.<br />
Barbara has been an outstanding<br />
leader at <strong>Monash</strong> <strong>Health</strong> since 2009,<br />
guiding the organisation with calm<br />
determination through significant<br />
periods of change and growth.<br />
Barbara’s leadership has inspired our<br />
Board and Executive to commit to<br />
patient-focussed care and an ethos of<br />
continuous improvement. Barbara has<br />
remained dedicated to providing strong<br />
governance, with a focus on quality<br />
and safety. She is a leader who inspires<br />
by example and who is generous with<br />
her personal and professional support.<br />
<strong>Monash</strong> <strong>Health</strong> wishes her all the very<br />
best for the future.<br />
Mr Dipak Sanghvi has taken up the<br />
role of Chair of the Board as of 1 July,<br />
having served on the Board for three<br />
years already.<br />
Engaging with<br />
our community<br />
This year, our Community Advisory<br />
Committee members co-designed<br />
an improvement project to enhance<br />
emergency department patient<br />
experience. Other initiatives, such<br />
as the introduction of our integrated<br />
model for responding to elder abuse,<br />
reflect our belief in extending care<br />
beyond hospital walls and working<br />
together with consumers and their<br />
families to achieve the best<br />
possible outcomes.<br />
Our Primary Care and Population<br />
<strong>Health</strong> Advisory Committee is likewise<br />
progressing <strong>Monash</strong> <strong>Health</strong>’s Chronic<br />
Disease Strategy Implementation<br />
Plan. Once complete, this strategy<br />
will support community health and<br />
community healthcare providers to<br />
deliver diabetes, oral health, and<br />
management of advanced chronic<br />
non-malignant disease and palliative<br />
care in our community.<br />
The development of an Equity and<br />
Inclusion strategy was completed in<br />
<strong>2017</strong>-<strong>18</strong> and sets out the principles<br />
and a program to promote and ensure<br />
respect for all individuals irrespective<br />
of their personal beliefs, identity and<br />
choice of expression. The supporting<br />
action plan will be implemented in<br />
20<strong>18</strong>-19.<br />
Defining our strategic<br />
direction<br />
In <strong>2017</strong>, we began the process of<br />
developing <strong>Monash</strong> <strong>Health</strong>’s 2023<br />
strategic plan. This is a critical time for<br />
the organisation, as we define and focus<br />
our efforts over the next five years.<br />
Throughout the past 12 months,<br />
we listened to our community, our<br />
employees and our partners to<br />
understand what matters most to them,<br />
and what they believe we should aspire<br />
to achieve.<br />
Our 2023 strategic plan, describes our<br />
commitment to the relentless pursuit<br />
of excellence in our care, teaching and<br />
research, as well as the core principles<br />
and priorities to achieve our shared<br />
vision for the future. The plan will be<br />
published in FY 20<strong>18</strong>-19.<br />
Acknowledgements<br />
<strong>Monash</strong> <strong>Health</strong> works with many<br />
organisations and individuals to provide<br />
excellence in care. We acknowledge<br />
and thank the Victorian Government,<br />
Department of <strong>Health</strong> and Human<br />
Services and Federal Government for<br />
supporting us to serve our diverse<br />
and growing community.<br />
We extend grateful thanks to our<br />
Board Members and Executive<br />
for their leadership. To all <strong>Monash</strong><br />
<strong>Health</strong> employees and volunteers,<br />
thank you for your work and the<br />
wonderful contribution you make<br />
every day to the health and well-being<br />
of consumers. And to our community,<br />
we thank you for your feedback<br />
which provides us with rich insights<br />
into how we can improve.<br />
Andrew Stripp<br />
Chief Executive<br />
Dipak Sanghvi<br />
Chair of the Board of Directors<br />
7
Journeys of Inspiration<br />
and Hope book and<br />
exhibition launch<br />
The stories and experiences of people affected by an acquired<br />
brain injury were shared at the launch of a new book and art<br />
exhibition Journeys of Inspiration and Hope in October.<br />
The book is a collation of stories from clients of the <strong>Monash</strong><br />
<strong>Health</strong> Acquired Brain Injury: Slow to Recover (ABI: STR)<br />
program, which has been providing care to clients for 21 years.<br />
ABI: STR Program client Scott<br />
Harris and his mother Marissa<br />
The event was held in the Art Space at <strong>Monash</strong> Medical Centre,<br />
with around 70 consumers and families in attendance. The event<br />
was opened by Chief Executive Andrew Stripp, who reported that<br />
the program was launched in 1996 to provide for the very specific<br />
needs of those with severe to profound head injuries.<br />
Over that time, the program has helped more than 400 people<br />
to meet their rehabilitation goals.<br />
8 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
The year<br />
in review<br />
Delivering exceptional patient care<br />
<strong>Monash</strong> <strong>Health</strong> shines<br />
in National Standards<br />
accreditation<br />
<strong>Monash</strong> <strong>Health</strong> successfully achieved<br />
accreditation in October, against the<br />
National Safety and Quality <strong>Health</strong><br />
Service Standards.<br />
Twenty-two Australian Council on<br />
<strong>Health</strong>care Standards surveyors<br />
travelled across our health service<br />
speaking with staff, consumers and<br />
families. Many areas of <strong>Monash</strong><br />
<strong>Health</strong> performed strongly and<br />
received particular commendation<br />
from surveyors. <strong>Monash</strong> <strong>Health</strong> is now<br />
accredited to October 2020.<br />
Ruth welcomes a baby girl<br />
Ruth Staniscia gave birth to a healthy<br />
baby girl at <strong>Monash</strong> <strong>Health</strong> in<br />
December, after being told her<br />
heart condition could make<br />
pregnancy very risky.<br />
Ruth learned in late 2016 she had a<br />
congenital heart defect, bicuspid valve<br />
disease. Her heart has two leaflets on<br />
her aortic valve, instead of three like<br />
most people. This valve controls the<br />
one-way flow of oxygen-rich blood<br />
from the heart back into the body. Her<br />
condition means her heart was working<br />
overtime and some blood was flowing<br />
the wrong way.<br />
Becoming pregnant could have<br />
resulted in an enlarged artery in her<br />
heart rupturing, threatening her life<br />
and her baby’s.<br />
“In Ruth’s case the valve was also leaky<br />
and of most concern was that her aorta<br />
— the main pipe that attaches that<br />
valve to the body — was a lot bigger<br />
than it should be.” said <strong>Monash</strong> Heart<br />
cardiologist Dr Siobhan Lockwood.<br />
At thirty eight weeks pregnant her<br />
obstetrician Dr Annie Kroushev, from<br />
Jessie McPherson Private Hospital<br />
induced her and in September Ruth<br />
finally gave birth to healthy baby Aeva.<br />
“Seeing this gorgeous healthy looking<br />
girl was just amazing,” Mrs Staniscia<br />
said. “Even though it was a difficult<br />
pregnancy we felt so well looked after.”<br />
From patient to work<br />
experience<br />
In <strong>2017</strong>, Ashlene had surgery at <strong>Monash</strong><br />
<strong>Health</strong> to fix a valve in her heart, after it<br />
was discovered she was suffering from a<br />
congenital heart condition where blood<br />
was leaking and going the wrong way.<br />
She celebrated her 14th birthday in<br />
hospital and was so impressed with<br />
the care she received that she has now<br />
changed her career aspirations and<br />
wants to be a paediatric nurse.<br />
“The experience was lovely, even<br />
though I was stuck at the hospital. Now<br />
I’m really enjoying seeing the other side<br />
of hospital life,” she said.<br />
In 20<strong>18</strong> Ashlene spent a week of work<br />
experience with the <strong>Monash</strong> Heart<br />
team, chatting to consumers, seeing<br />
what happens in a catheter lab, and<br />
helping out nurses on ward tours.<br />
Delirium and dementia<br />
initiative launched<br />
After months of careful planning, the<br />
<strong>Monash</strong> <strong>Health</strong> Delirium and Dementia<br />
Initiative was launched in the general<br />
medicine wards at <strong>Monash</strong> Medical<br />
Centre in July.<br />
The initiative is being introduced<br />
across <strong>Monash</strong> <strong>Health</strong> to provide<br />
high-quality care for consumers with<br />
cognitive impairment, and improve<br />
staff experience in supporting<br />
these consumers. The approach<br />
uses a tailored framework, focusing<br />
on a number of principles of care<br />
throughout the patient journey.<br />
A key resource for the initiative is<br />
<strong>Monash</strong> <strong>Health</strong>’s new Cognition<br />
Clinical Lead, Bri Walpole. Bri will be<br />
based on the wards, helping staff to<br />
implement the principles of care and<br />
problem-solving with the team to<br />
provide safe and high quality care for<br />
consumers with cognitive impairment.<br />
Staff are being asked to be alert to<br />
the risk of delirium and the risk factors<br />
that can precipitate or predispose it;<br />
be aware that consumers with<br />
cognitive impairment are at increased<br />
risk of harm (e.g. falls, pressure injuries)<br />
in hospital; partner with consumers,<br />
families and carers to provide<br />
person-centred care and attend<br />
education sessions.<br />
9
<strong>Monash</strong> <strong>Health</strong> safely<br />
welcomes quadruplets<br />
In January <strong>Monash</strong> <strong>Health</strong> safely<br />
delivered a set of quadruplets,<br />
following a 30-week and one day<br />
gestation period.<br />
Mariam Hussaini and her husband<br />
Mohammed had always dreamed<br />
of having a family, after moving to<br />
Australia from Afghanistan in 2012.<br />
Mariam has been under the care of our<br />
Women’s & Newborn program since<br />
she was three months pregnant, with<br />
the wellbeing of Mariam and babies<br />
carefully monitored by a team of staff.<br />
“Each of the four babies had their own<br />
team, and everyone knew which team<br />
they belonged to,” said <strong>Monash</strong> <strong>Health</strong><br />
Director of Neonatology Dr Charles<br />
Barfield.<br />
All four boys were delivered safely by<br />
caesarean section.<br />
Named Elyas and Almaas (identical<br />
twins) and Rayan and Shayan (fraternal<br />
twins), all four were born healthy and<br />
progressed so well that they were able<br />
to go home in early April.<br />
Kidsafe Victoria opens<br />
Community Centre at<br />
<strong>Monash</strong> Children’s Hospital<br />
The Victorian Minister for Families<br />
and Children, the Hon Jenny Mikakos<br />
MP opened Kidsafe Victoria’s new<br />
Community Centre at <strong>Monash</strong><br />
Children’s Hospital in August.<br />
<strong>Monash</strong> <strong>Health</strong> Chief Operating<br />
Officer, Martin Keogh said <strong>Monash</strong><br />
Children’s Hospital is proud to work<br />
alongside Kidsafe Victoria to support<br />
them in education and advocacy that<br />
prevents injuries to children.<br />
“We treat over 30,000 children every<br />
year at this hospital, and many of them<br />
are here because of unintentional<br />
injuries and accidents,” he said.<br />
“The Kidsafe Children’s Injury<br />
Prevention Hub will be an asset for<br />
<strong>Monash</strong> Children’s Hospital, for our<br />
staff, parents, consumers and visitors.”<br />
Erica Edmands, President of Kidsafe<br />
Victoria said the opening of the new<br />
Child Injury Prevention Centre was<br />
made possible by many sponsors and is<br />
a major milestone for Kidsafe Victoria.<br />
“The location at the <strong>Monash</strong> Children’s<br />
Hospital will provide parents, carers,<br />
hospital staff and early childhood<br />
services with central access to<br />
lifesaving information,” she said.<br />
“The new Centre will increase<br />
opportunities to expand Kidsafe<br />
Victoria’s interaction with the<br />
community, as well as facilitate injury<br />
prevention initiatives in partnership<br />
with <strong>Monash</strong> Children’s Hospital.”<br />
Cassy and Hayley celebrate<br />
a very special school formal<br />
For many teenagers, the school<br />
Formal is the biggest event of the<br />
social calendar.<br />
School friends, Cassy and Hayley were<br />
both devastated that they couldn’t<br />
attend their formal last week.<br />
<strong>Monash</strong> Children’s Hospital<br />
Occupational Therapist, Larissa said<br />
she didn’t want the girls to miss out on<br />
the important occasion.<br />
“When the girls told me they were<br />
missing out on their Formal I thought<br />
– why can’t we bring the Formal to<br />
them?” she said.<br />
Larissa and her team worked to pull<br />
together a celebration the girls would<br />
never forget. Cassy and Hayley had<br />
grins from ear to ear and enjoyed party<br />
food, beautiful outfits, dancing, great<br />
music, and most importantly, lots<br />
of friends.<br />
In the lead up to the event, Hayley had<br />
been in bed for almost a week after<br />
undergoing surgery and that day was<br />
her first out of bed.<br />
Hayley’s mum Sharlene said she was<br />
absolutely blown away by the effort<br />
everyone had gone to for the girls.<br />
“It’s so wonderful to see all of their<br />
school friends here, the staff made<br />
cakes and the Starlight Captains<br />
painted their nails,” she said,<br />
“thank you.”<br />
Starlight Express Room<br />
opens at <strong>Monash</strong> Children’s<br />
Hospital<br />
In October, <strong>Monash</strong> <strong>Health</strong> officially<br />
opened the Starlight Express Room at<br />
<strong>Monash</strong> Children’s Hospital.<br />
The Starlight Express Room and<br />
Starlight Captains play a vital role in<br />
bringing fun, happiness and laughter to<br />
consumers and their families every day.<br />
<strong>Monash</strong> <strong>Health</strong> Chief Executive<br />
Andrew Stripp said <strong>Monash</strong> Children’s<br />
Hospital has been a proud partner<br />
with Starlight for many years. “This<br />
is a space for children to forget that<br />
they’re in hospital; to be children, not<br />
consumers,” he said.<br />
“The Starlight Captains help to<br />
support children when they are<br />
in hospital, providing a range<br />
of activities and distractions to<br />
improve their experience.”<br />
We are incredibly grateful to the<br />
Starlight Captains, staff, volunteers,<br />
supporters and ambassadors to have<br />
this amazing space in our hospital.”<br />
10 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Baby Harry<br />
goes home<br />
after 176 days<br />
For first time parents Belinda and Ivan Campbell,<br />
it was concerning when their baby needed to<br />
come into the world extremely early on 28 March<br />
<strong>2017</strong> at just 27 weeks, weighing just 730 grams.<br />
As a nurse, Belinda knew it was essential to have<br />
her baby delivered in a hospital with a Neonatal<br />
Intensive Care Unit (NICU) after she was<br />
diagnosed with preeclampsia.<br />
Baby Harry has gone through a lot to survive his<br />
first six months of life.<br />
With severe lung complications, he had to spend<br />
many weeks on a ventilator on life support and<br />
later underwent surgery.<br />
But he proved to be a fighter.<br />
At the time <strong>Monash</strong> <strong>Health</strong>’s neonatologist,<br />
Dr Atul Malhotra said, “as one of the first,<br />
sickest and most delicate consumers to be<br />
moved into the new <strong>Monash</strong> Newborn service<br />
on 19 April, it took ten specially trained staff to<br />
move him across.”<br />
“Harry has done great in the last few months,<br />
he is a little trooper.”<br />
Belinda and Ivan have a unique perspective<br />
of NICU life, having spent time in the old unit<br />
before being part of the move.<br />
“The new NICU is light, spacious and so<br />
comfortable. We are so grateful to the wonderful<br />
care we have received at <strong>Monash</strong> Children’s<br />
Hospital,” said Belinda.<br />
We can report little Harry was able to leave<br />
hospital and go home in September.<br />
<strong>Monash</strong> Medical Centre<br />
celebrates 30 years<br />
Current and past staff came together<br />
to celebrate the 30th anniversary of<br />
<strong>Monash</strong> Medical Centre in September.<br />
Memories and stories of the hospital’s<br />
past were shared between the 200<br />
guests during the celebratory event<br />
with an historical exhibition on display.<br />
Among many great memories, the<br />
event reunited Jessica Bailey and her<br />
parents Susan and Michael with the<br />
doctor who delivered the first baby -<br />
Jessica - at <strong>Monash</strong> Medical Centre,<br />
Dr Paul Shekleton. Professor Richard<br />
Harper, interim Director <strong>Monash</strong>Heart<br />
and Emeritus Professor of Cardiology<br />
took the audience through the journey<br />
of creating a cardiology service for<br />
the south east, which has resulted<br />
in <strong>Monash</strong>Heart being the largest<br />
cardiovascular service provider in<br />
Victoria. Jennine Harbrow, Acting<br />
Operations Director <strong>Monash</strong> <strong>Health</strong><br />
Community, shared her experience as a<br />
senior nurse over this period.<br />
Since its inception <strong>Monash</strong> Medical<br />
Centre has cared for more than two<br />
million people, helped to deliver close<br />
to 120,000 babies and supported<br />
hundreds of thousands of Victorian<br />
families through difficult times.<br />
11
Innovation<br />
Symptom and urgent<br />
review clinic<br />
A symptom and urgent review clinic<br />
for oncology patients began at<br />
Dandenong Hospital.<br />
Funded with a Department of <strong>Health</strong><br />
and Human Services competitive grant,<br />
the clinic runs four days a week and<br />
consists of advanced practice nurse<br />
in oncology, Gurpreet Grewal, and<br />
experienced oncology pharmacist,<br />
Chihao La, with oncologists support.<br />
Supportive care clinics are a pillar<br />
of modern oncology services. The<br />
objective of the clinic is to provide<br />
practical support to consumers<br />
receiving cancer treatment so that<br />
toxicities can be identified early and<br />
effectively managed.<br />
It is expected that pre-emptive<br />
management will reduce emergency<br />
department and hospital presentations<br />
and allow consumers to maintain<br />
their independence and quality of life.<br />
Appropriate consumers are identified<br />
by clinicians including doctors, nurses,<br />
and allied health staff.<br />
3D printing an education<br />
tool for surgical trainees<br />
and medical students<br />
In May, a team at <strong>Monash</strong> <strong>Health</strong> and<br />
<strong>Monash</strong> University created the first<br />
3D printed model of a three-year-old<br />
patient’s abnormal biliary tree and<br />
choledochal cyst, to improve the<br />
planning and outcome of her corrective<br />
surgery. The technology has also<br />
enhanced the educational experience<br />
for medical staff and students.<br />
The novel project, led by <strong>Monash</strong><br />
<strong>Health</strong> Consultant Paediatric and<br />
Neonatal Surgeon, Mr Ram Nataraja,<br />
who is also Director of Surgical<br />
Simulation and a Senior Lecturer<br />
at <strong>Monash</strong> University, was also<br />
published in the Journal of<br />
Paediatrics and Child <strong>Health</strong>.<br />
Mr Nataraja’s team constructed a<br />
3D model of the patient’s cyst, a rare<br />
congenital enlargement of the bile<br />
ducts. Mr Nataraja said the child had<br />
a straight forward uncomplicated<br />
post-operative recovery with no<br />
operative complications and has<br />
remained well since her surgery.<br />
Transforming care across<br />
<strong>Monash</strong> <strong>Health</strong><br />
<strong>Monash</strong> <strong>Health</strong> is undergoing a whole<br />
of hospital transformation, to provide<br />
the best possible care and experience<br />
for consumers.<br />
In the <strong>2017</strong>/<strong>18</strong> financial year the<br />
Transforming Care program has:<br />
• Encouraged and supported all<br />
employees to speak up regarding any<br />
safety concerns.<br />
• Allocated $<strong>18</strong>.1m towards<br />
replacement of medical equipment.<br />
• Continued to embed clinicians<br />
as managers and leaders in the<br />
health service.<br />
• Invested $2.6m in nursing leadership,<br />
to ensure nurse managers were able<br />
to allocate their time in accordance<br />
with clinical and management<br />
priorities, rather than working within<br />
nurse ratios.<br />
• Commenced the organisation-wide<br />
multi-day bed reconfiguration; to<br />
assist patient flow, and reduce the<br />
moving of people once admitted to<br />
an inpatient ward.<br />
• Improved the ability of clinical teams<br />
to communicate patient-related task<br />
requests and evenly distribute<br />
workload over night by implementing<br />
the electronic Smartpage system.<br />
• Attracted $172,379 in competitive<br />
funding for the <strong>2017</strong> Victorian<br />
Telehealth Specialist Clinic Funding<br />
Project, to improve access to adult<br />
specialist clinics for regional and<br />
rural consumers in collaboration with<br />
Gippsland <strong>Health</strong> Services.<br />
• This enabled, for example, the<br />
first adult telehealth conference<br />
between Casey Haematology Clinic,<br />
a Gippsland patient and a local GP<br />
clinic; saving the patient a 14+ hour<br />
round trip. See story below.<br />
• Commenced roll out of an electronic<br />
referral triage system to replace paper<br />
processes and eliminate the risk of<br />
lost referrals in specialist clinics.<br />
• Commenced relocation of paediatric<br />
and high safety risk adult clinics to<br />
fit-for-purpose specialist consulting<br />
clinic space.<br />
• Implemented a specialist consulting<br />
data dashboard, to enable<br />
transparency and allow staff<br />
to make data-driven decisions.<br />
• Introduced multidisciplinary inpatient<br />
ward based leadership teams, to<br />
support local areas to support ward<br />
performance and deliver patient<br />
centred care at the local level.<br />
• Implemented prioritised patient<br />
care pathways and investigations<br />
framework, to enable safe and<br />
direct patient admissions from<br />
our emergency departments to<br />
inpatient wards.<br />
• Improved ambulance offload<br />
processes in our emergency<br />
departments. This saved over 250<br />
hours in ‘Ambulance Victoria in<br />
corridors time’ from November to<br />
December <strong>2017</strong>, which significantly<br />
decreased the time ambulances<br />
were off the road.<br />
12 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Telehealth pilot program<br />
saves John 14 hour commute<br />
Gippsland-based John Bailey was<br />
delighted with <strong>Monash</strong> <strong>Health</strong>’s pilot<br />
adult telehealth service, after he was<br />
invited to participate in the program<br />
in June.<br />
John’s specialist appointments<br />
previously required a time commitment<br />
of more than 14 hours, including travel<br />
to Casey Hospital and back from<br />
Bruthen, a small town 20 minutes’<br />
drive east of Bairnsdale.<br />
In the past, appointments have meant<br />
a 4:30am wakeup and the hassle of car,<br />
train, and bus travel.<br />
“People don’t really understand the<br />
stress and anxiety that causes, because<br />
you don’t know the bus lines, or the<br />
train might be delayed or you end up<br />
on the wrong line. And there’s only so<br />
many magazines you can read!”<br />
Often, John would end up getting back<br />
home to Bruthen after 10pm at night.<br />
During the consultation, John spoke<br />
to his specialist via a phone and web<br />
connection at his local medical clinic,<br />
and was able to be home again in just<br />
90 minutes.<br />
“It was fantastic,” John said. “It felt<br />
like I was sitting in the room, sitting<br />
across the table with the doctor.<br />
You could see his face and speak to<br />
him as if he was there. It was all very<br />
personable and easy.”<br />
John was able to travel to his local<br />
clinic in Bairnsdale, the Macleod<br />
Street Medical Centre.<br />
Practise Manager at the centre, Mr<br />
Wayne Howlett, liaised with <strong>Monash</strong><br />
<strong>Health</strong> to ensure a private consultation<br />
room and the technology required.<br />
“Wayne had everything ready to go,<br />
and the Macleod Street Medical Centre<br />
were really helpful,” John said.<br />
John was ‘virtually’ checked in as a<br />
<strong>Monash</strong> <strong>Health</strong> patient at the Casey<br />
Specialist Consulting Clinic. After<br />
a private consultation, including<br />
immediate pathology requests and<br />
blood samples taken locally, John<br />
was able to make the short drive<br />
home again.<br />
“For people in the region, this will save<br />
us hours and hours of travel just to see<br />
a specialist that we otherwise may not<br />
have access to,” John said.<br />
“It was really excellent; a 20 minute<br />
drive that I’m used to, and I even had<br />
time to get my shopping done!”<br />
John’s GP also received a detailed<br />
letter after the appointment for any<br />
follow-up.<br />
Geriatric oncology clinic<br />
now open<br />
<strong>Monash</strong> <strong>Health</strong> Department of<br />
Oncology, in collaboration with<br />
Southern Metropolitan Integrated<br />
Cancer Service, announced the opening<br />
of our first Geriatric Oncology Clinic at<br />
Dandenong Hospital in February.<br />
The clinic places the focus on the whole<br />
patient, and includes collaborative<br />
patient management by a geriatrician,<br />
an oncologist, and allied health<br />
professionals.<br />
Every patient undergoes a<br />
comprehensive geriatric assessment,<br />
which identifies otherwise hidden<br />
problems including malnutrition,<br />
cognitive impairment, frailty, and<br />
social vulnerability. The information<br />
allows clinicians, consumers and<br />
families to tailor cancer treatment in a<br />
way that allows elderly consumers to<br />
benefit from modern therapies, while<br />
protecting them from risks.<br />
Establishing key community links to<br />
support function is a vital aspect of<br />
this clinic. The clinic is staffed by Dr<br />
Ranjana Srivastava, an oncologist who<br />
trained at the University of Chicago’s<br />
award-winning geriatric oncology clinic<br />
and Dr Irene Wagner, a geriatrician<br />
with extensive experience in managing<br />
dementia, behavioural issues, and<br />
the broader community needs of the<br />
elderly. They are supported by a range<br />
of hospital-based and community allied<br />
health services.<br />
<strong>Monash</strong> Children’s Hospital<br />
School officially opened<br />
The Victorian Premier, the Hon Daniel<br />
Andrews MP and Minister for Education<br />
the Hon James Merlino MP officially<br />
opened the <strong>Monash</strong> Children’s Hospital<br />
School in October.<br />
Welcomed to <strong>Monash</strong> Children’s<br />
Hospital by school Principal, Colin<br />
Dobson, the Premier and Minister visited<br />
young people as they worked alongside<br />
teaching staff.<br />
The school is run by the Department<br />
of Education, with teachers delivering<br />
classes throughout the hospital,<br />
including at students’ bedsides,<br />
in small activity rooms, and in central<br />
ward areas. There will soon also be four<br />
purpose-designed classrooms and a<br />
specialist art room.<br />
Classrooms feature hot desk areas and<br />
are equipped with cameras and the<br />
latest technology to enable students<br />
to virtually connect with teachers and<br />
classmates at their regular school, and<br />
with their families at home.<br />
13
24/7 Endovascular Clot<br />
Retrieval service saving<br />
stroke patients<br />
Victorian stroke victims now have a<br />
better chance of survival, with a new<br />
clot retrieval service improving stroke<br />
survival rates.<br />
<strong>Monash</strong> Medical Centre joined The<br />
Royal Melbourne Hospital as the<br />
state’s only 24/7 Endovascular Clot<br />
Retrieval hospitals. The service enables<br />
consumers to be transported for rapid<br />
treatment no matter where the patient<br />
is located.<br />
In <strong>2017</strong>/20<strong>18</strong>, 112 patients received<br />
endovascular clot retrieval compare<br />
to 70 patients in 2016/<strong>2017</strong>. In <strong>2017</strong> we<br />
performed 91 retrievals. In the first<br />
seven months of 20<strong>18</strong> we had already<br />
performed 83 cases and we estimate<br />
about 130-150 cases will be performed<br />
in 20<strong>18</strong>.<br />
First published by Nine News,<br />
17 September <strong>2017</strong>.<br />
A 30-minute heart disease<br />
test is being trialled by<br />
<strong>Monash</strong>Heart doctors<br />
A 30-minute test for coronary<br />
artery disease aims to cut the<br />
number of invasive investigations<br />
consumers have to undergo to get<br />
their diagnosis confirmed.<br />
The single test, which uses a patient’s<br />
CT scan to make a 3D model of the<br />
heart arteries and simulate blood<br />
flow, is designed to be faster with<br />
less potential side effects than<br />
current techniques.<br />
<strong>Monash</strong>Heart Interventional Cardiology<br />
Fellow, Dr Abdul Rahman Ihdayhid<br />
said when a patient was suspected of<br />
having clogged arteries, they usually<br />
had a CT scan. While it could highlight<br />
narrowing in these small tubes, he said<br />
that without further invasive tests, the<br />
cardiac CT could not say how blood<br />
flow to the heart was affected.<br />
Not all clogged arteries require a stent<br />
or bypass surgery and in some cases<br />
medication is sufficient.<br />
“The current gold standard for<br />
measuring blood flow is an angiogram,”<br />
Dr Ihdayhid said.<br />
“It’s done in the catheter lab where<br />
we put a specialised pressure wire<br />
down someone’s coronary artery<br />
and measure the blood flow. It’s an<br />
invasive procedure associated with<br />
potential side effects, discomfort to<br />
the patient, and considerable cost<br />
to the health system.”<br />
New generation bone<br />
scanner first in Australia<br />
A new generation scanner to assess<br />
musculoskeletal disease was made<br />
available to <strong>Monash</strong> <strong>Health</strong> consumers<br />
in March.<br />
The XtremeCT-II measures bone<br />
density and quantifies the threedimensional<br />
microarchitecture<br />
of bones (including 3D bone<br />
microstructure, tendons, cartilage,<br />
joints, muscle, fat and vascular<br />
calcification) at the highest resolution<br />
and precision currently available.<br />
“The XtremeCT-II is the only one of its<br />
kind in Australia and will allow cutting<br />
edge musculoskeletal research both<br />
domestically and internationally,”<br />
Research Fellow, Dr Ayse Zengin said.<br />
There are only two of these scanners<br />
in the world—the other is in China.<br />
The XtremeCT-II will be available as<br />
a research platform for researchers,<br />
clinicians and surgeons, ensuring<br />
collaboration between health<br />
care professionals.<br />
Head, Department of Medicine, School<br />
of Clinical Sciences at <strong>Monash</strong> <strong>Health</strong>,<br />
Professor Peter Ebeling, AO, heads up<br />
the Bone and Muscle Research Group<br />
at <strong>Monash</strong> University. Prof Ebeling<br />
anticipates using a low-radiation<br />
method for high-resolution imaging of<br />
bone, muscle and joints will enhance<br />
understanding of musculoskeletal<br />
conditions, enabling effective<br />
preventative and treatment strategies.<br />
Virtual reality to distract<br />
children during medical<br />
procedures<br />
Clinicians at <strong>Monash</strong> Children’s Hospital<br />
and <strong>Monash</strong> University are conducting<br />
a research study using virtual reality<br />
— an interactive computer system that<br />
can be ‘seen’ when wearing a headset<br />
and smartphone — to help distract<br />
consumers from procedures in our<br />
pathology and emergency departments.<br />
Current pain management techniques,<br />
such as local anaesthetic cream or<br />
distraction is inadequate for some<br />
children and may result in the need for<br />
restraints and/or sedation.<br />
Young consumers can now explore a<br />
virtual ocean and interact with friendly<br />
sea life, all while a doctor is performing<br />
medical procedures, including<br />
venepuncture or the inserting an<br />
intravenous cannula. These procedures<br />
can often be upsetting for children and<br />
family members.<br />
14 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Trial provides<br />
treatment at home<br />
for cancer patients<br />
The Hospital in the Home program was involved in a trial of a new way<br />
of treating cancer patients deemed at low risk of febrile neutropenia, a<br />
complication of chemotherapy usually treated with antibiotics.<br />
Until recently, consumers were treated as inpatients with IV antibiotics.<br />
Consumers now have the option of being safely treated in their own<br />
environment; shown to have great benefits for consumers and carers,<br />
and efficiencies for healthcare providers.<br />
The project was first trialled at the Peter MacCallum Cancer Centre,<br />
where it found inpatient length of stay was reduced from four days to<br />
less than one day.<br />
The program brings together several departments at <strong>Monash</strong> <strong>Health</strong><br />
and collaboration and education among staff and departments is<br />
expected to provide great benefits to consumers.<br />
L-R: Andre Levak, Low Risk Febrile<br />
Neutropenia Coordinator, Rhonda and<br />
Vicki McLeod, Oncology Nurse Practitioner.<br />
15
Pet therapy puppy Abby visits a young<br />
patient at <strong>Monash</strong> Children’s Hospital.<br />
Capital works<br />
Moorabbin Hospital –<br />
refurbished imaging and<br />
outpatient areas<br />
We were delighted to welcome The<br />
Hon Jill Hennessy MP, Victorian<br />
Minister for <strong>Health</strong> and Ambulance<br />
Services, and Mr Nick Staikos MP,<br />
Member for Bentleigh, to Moorabbin<br />
Hospital in November, to visit newlyrefurbished<br />
diagnostic imaging and<br />
outpatient areas.<br />
The $16.2 million capital project has<br />
already made a significant difference<br />
to the way Moorabbin Hospital cares<br />
for consumers.<br />
A new MRI machine and PET CT<br />
scanning technology have begun<br />
to operate at the site, with enhanced<br />
facilities for the imaging team.<br />
The outpatients’ area has also been<br />
improved, with additional consultation<br />
suites and a naturally-lit, more<br />
open environment.<br />
Casey Hospital expansion<br />
progresses on schedule<br />
Casey Hospital is poised to deliver<br />
even more services to one of the<br />
fastest growing areas in Melbourne’s<br />
south-east. Funded by the Victorian<br />
Government, construction began<br />
in <strong>2017</strong>, in conjunction with the<br />
Department of <strong>Health</strong> and Human<br />
Services and Plenary Group, and<br />
the project has reached a number of<br />
milestones in FY <strong>2017</strong>-<strong>18</strong>.<br />
The main inpatient tower construction<br />
works are progressing well and will<br />
be handed over in stages. The new<br />
theatres and Central Sterilising<br />
Supply Department is a major project<br />
milestone and is on track for completion<br />
by the end of September 2019.<br />
A number of internal refurbishment<br />
works will commence over coming<br />
months to create a new pharmacy<br />
and expand pathology services. The<br />
site’s new front entrance building is<br />
due to open in September 20<strong>18</strong>. The<br />
front entrance building will provide<br />
new retail areas for the site and also<br />
accommodate <strong>Monash</strong> University.<br />
Expansion is needed to ensure that<br />
Casey Hospital has the capacity<br />
and services needed to provide the<br />
residents of Casey and Cardinia with<br />
quality care at their local facility, given<br />
the unprecedented growth in this area<br />
and the need for increased specialised<br />
services. Construction is expected to<br />
be completed in 2019.<br />
16 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Happy 1st birthday <strong>Monash</strong><br />
Children’s Hospital!<br />
On 19 April <strong>Monash</strong> <strong>Health</strong> celebrated the first birthday of <strong>Monash</strong> Children’s Hospital<br />
(MCH). Staff and consumers came together to join in activities and entertainment,<br />
including an animal farm, face painting and a teddy bear hospital.<br />
Channel 9 was there to capture all the fun, as <strong>Monash</strong> celebrated its first year of<br />
operations. The MCH is only the second dedicated paediatric tertiary hospital in<br />
Victoria, and focusses on providing state-of-the-art facilities and care in a childfriendly<br />
environment.<br />
Victorian Heart Hospital<br />
development $320m funding<br />
boost<br />
The Victorian Government announced<br />
in December it will invest an additional<br />
$320 million to build the Victorian<br />
Heart Hospital, Victoria’s first<br />
standalone heart hospital that will bring<br />
together clinical practice and research.<br />
In FY <strong>2017</strong>-<strong>18</strong> design consultants were<br />
appointed and design has commenced,<br />
with construction scheduled to<br />
commence later in 20<strong>18</strong>.<br />
The newest hospital for <strong>Monash</strong> <strong>Health</strong><br />
is due for completion in 2022. Project<br />
partners <strong>Monash</strong> University will have<br />
embedded researchers within the<br />
facility, allowing cutting-edge research<br />
to directly benefit consumers.<br />
The total project is projected to cost<br />
$543 million, and the new hospital will<br />
have 195 beds, with the capacity to<br />
provide 2000 cardiac surgeries each<br />
year, 13,500 cardiac catheterisation<br />
laboratory procedures and 108,000<br />
consultations and outpatient<br />
appointments.<br />
<strong>Monash</strong> Medical Centre<br />
opens new state-of-the-art<br />
angiography facility<br />
<strong>Monash</strong> Medical Centre now offers<br />
more consumer emergency treatment,<br />
after opening our new innovative,<br />
state-of-the-art treatment facility<br />
in June.<br />
Professor Timothy Buckenham,<br />
Interventional Radiologist said that<br />
in <strong>2017</strong>, <strong>Monash</strong> <strong>Health</strong> treated 2400<br />
consumers with a comprehensive<br />
range of procedures to diagnose or<br />
treat consumers with cerebrovascular<br />
disease, kidney disease, sepsis,<br />
bleeding, aneurysms, and cancer.<br />
The new Biplane Angiography Suite<br />
is equipped with a new-generation<br />
image-guided therapy platform,<br />
capable of performing a wide range<br />
of routine and minimally-invasive<br />
catheter-based procedures in the<br />
interventional lab.<br />
Neuro-Interventional Radiologist and<br />
Head of Endovascular Clot Retrieval,<br />
Professor Ronil Chandra said the new<br />
facility is a major improvement for<br />
patient care at <strong>Monash</strong> <strong>Health</strong> and will<br />
increase capacity to provide lifesaving<br />
treatment to consumers across the<br />
south east of Victoria.<br />
The new Azurion Biplane<br />
Angiography imaging platform is<br />
one of the first of its kind installed<br />
in Australia, featuring substantial<br />
hardware and software upgrades.<br />
17
Research and<br />
partnerships<br />
Our research vision<br />
To be a health service that integrates excellence in clinical<br />
services, education and research. <strong>Monash</strong> <strong>Health</strong> provides<br />
a supportive and dynamic environment for health care<br />
professionals to conduct world-class clinical and translational<br />
research that drives improved clinical practice.<br />
<strong>Monash</strong> <strong>Health</strong><br />
Translation Precinct<br />
The <strong>Monash</strong> <strong>Health</strong> Translation<br />
Precinct (MHTP) partnership aims to be<br />
a world leader in translational research,<br />
generating innovative scientific<br />
discoveries and revolutionising clinical<br />
care in a dynamic and collaborative<br />
environment.<br />
The MHTP is a partnership between<br />
<strong>Monash</strong> <strong>Health</strong>, Hudson Research<br />
Institute and <strong>Monash</strong> University. MHTP<br />
is also a critical component of <strong>Monash</strong><br />
Partners Academic <strong>Health</strong> Science<br />
Centre. Through these partnerships,<br />
leading researchers have direct access<br />
to clinicians and consumers, enabling<br />
scientific breakthroughs to reach<br />
the bedside more effectively than<br />
ever before.<br />
Areas of focus within the MHTP<br />
include:<br />
• Cancer<br />
• Neurosciences<br />
• Endocrinology<br />
• Inflammation<br />
• Women’s, Children’s, and<br />
Reproductive <strong>Health</strong>.<br />
Breast cancer: Single<br />
dose of radiation replaces<br />
daily treatment<br />
A single nine-minute dose of radiation<br />
therapy delivered during breast cancer<br />
surgery has replaced three to five<br />
weeks of daily treatment at <strong>Monash</strong><br />
<strong>Health</strong>. Intra-operative radiotherapy<br />
was trialled in <strong>2017</strong>-<strong>18</strong> at Moorabbin<br />
Hospital, together with Peter<br />
MacCallum Cancer Centre. The trial<br />
found if radiation was delivered at<br />
the time of surgery to remove the<br />
tumour, it was as effective as standard<br />
external radiation.<br />
The trial and introduction of the therapy<br />
into standard care practices, means<br />
Victorian women with early, low-risk<br />
breast cancer are among the first in<br />
the world to have access to intraoperative<br />
radiation therapy, which<br />
could revolutionise cancer treatment by<br />
allowing it to be completed in one day.<br />
Consumers previously required<br />
up to 25 hospital visits to complete<br />
their treatment.<br />
Intra-operative radiotherapy offers<br />
women with early stage breast cancers<br />
another therapeutic option, a better<br />
patient experience and a more rapid<br />
return to normal activity. The technique<br />
delivers radiation to a more targeted<br />
area through a balloon in the resection<br />
cavity, which spares organs and tissue<br />
from radiation.<br />
Aspirin and the mysteries of<br />
preeclampsia<br />
A <strong>Monash</strong> <strong>Health</strong> researcher involved<br />
in world-first research is spreading<br />
the word about a simple solution to a<br />
potentially-deadly condition.<br />
Dr Daniel Rolnik was part of a team of<br />
researchers whose ground-breaking<br />
research was published in June’s edition<br />
of the prestigious New England Journal<br />
of Medicine. The large study screened<br />
almost 27,000 women in six countries,<br />
revealing aspirin is an effective<br />
treatment for preventing preeclampsia.<br />
Preeclampsia is a major cause of<br />
maternal and infant death around the<br />
world. It is often unclear what causes<br />
preeclampsia, with treatment options<br />
often limited once the condition<br />
has developed.<br />
Dr Rolnik found improved screening<br />
and a simple daily dose of inexpensive<br />
aspirin could dramatically reduce the<br />
incidence and mortality numbers.<br />
He observed a 60 per cent reduction<br />
in the development of preterm<br />
preeclampsia in women taking a low<br />
dose of aspirin during pregnancy,<br />
compared to the placebo group, and<br />
more than 80 per cent reduction in<br />
preeclampsia requiring delivery before<br />
34 weeks.<br />
<strong>Monash</strong> <strong>Health</strong> doctors<br />
invent bidirectional cannula<br />
to save limbs and lives<br />
<strong>Monash</strong> <strong>Health</strong> clinicians led a<br />
collaboration of Australian organisations<br />
to solve a global medical problem that<br />
will save lives around the world.<br />
A ‘bidirectional cannula’ device was<br />
developed by three <strong>Monash</strong> <strong>Health</strong> and<br />
<strong>Monash</strong> University clinicians. It is likely<br />
to significantly reduce complication<br />
rates around the world during certain<br />
types of heart surgery procedures.<br />
<strong>18</strong> <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
In FY <strong>2017</strong>-<strong>18</strong>:<br />
470<br />
New research projects<br />
approved by <strong>Monash</strong><br />
<strong>Health</strong> Human Research<br />
Ethics Committee<br />
1,135<br />
Active research<br />
projects.<br />
In <strong>2017</strong>/<strong>18</strong>:<br />
$15.3+<br />
million<br />
In National <strong>Health</strong><br />
and Medical Research<br />
Council (NHMRC)<br />
funding awarded<br />
to <strong>Monash</strong> <strong>Health</strong><br />
and <strong>Monash</strong> <strong>Health</strong><br />
Translation Precinct<br />
partners.<br />
374<br />
Clinical drug<br />
or device trials<br />
implemented<br />
229<br />
Quality improvement<br />
and service activities<br />
registered<br />
In <strong>2017</strong>:<br />
$20+<br />
million<br />
In funding for<br />
commercially sponsored<br />
clinical trials by<br />
leading pharmaceutical<br />
and biotechnology<br />
companies for national<br />
and international<br />
clinical research.<br />
19
The device has been designed,<br />
engineered, and tested in Australia.<br />
The clinical trials of the device was<br />
made possible by a generous grant<br />
from the Victorian Government.<br />
The device is used to connect<br />
consumers to a heart-lung machine<br />
through a large artery at the top of<br />
the leg. Clinical trials of the device at<br />
the Alfred Hospital, led by Associate<br />
Professor Silvana Marasco, have<br />
yielded very favourable results.<br />
The new device has shown tremendous<br />
promise in reducing the risk of leg<br />
ischaemia (lack of oxygen supply), a<br />
potentially serious complication that<br />
can occur during heart surgery and in<br />
consumers requiring artificial cardiac<br />
support in intensive care units.<br />
A world-first treatment for<br />
pelvic organ prolapse<br />
<strong>Monash</strong> <strong>Health</strong> has collaborated with<br />
Hudson Institute of Medical Research<br />
on a world-first approach to treating<br />
pelvic organ prolapse.<br />
With lab research underway, clinical<br />
trials are expected to begin in the next<br />
three to five years.<br />
A new bio-construct created by<br />
combining stem cells from the lining<br />
of a woman’s own uterus will be used<br />
to restore quality of life to women with<br />
pelvic organ prolapse, and to prevent<br />
the condition from occurring<br />
in younger women.<br />
Pelvic organ prolapse is a lifelong,<br />
potentially debilitating condition,<br />
predominantly caused by the impact of<br />
childbirth. It affects an estimated one<br />
in four women, and around one in two<br />
women aged over 50.<br />
Associate Professor Anna Rosamilia,<br />
head of the Pelvic Floor Unit at<br />
<strong>Monash</strong> <strong>Health</strong> says “It’s exciting to<br />
be part of a research team looking<br />
at new treatment options for pelvic<br />
organ prolapse which use degradable<br />
scaffolds and the woman’s own<br />
mesenchymal endometrial stem cells.<br />
Theoretically this should translate into<br />
better healing than currently available<br />
options but the technology needs<br />
further vigorous testing to establish<br />
its place.”<br />
World’s largest clinical<br />
trial in follicular lymphoma<br />
providing hope<br />
An international collaborative study,<br />
including researchers at <strong>Monash</strong><br />
<strong>Health</strong> and <strong>Monash</strong> University, has<br />
shown that follicular lymphoma<br />
patients treated with a therapy known<br />
as obinutuzumab, in combination with<br />
chemotherapy, leads to significant<br />
improvements in how the disease<br />
is controlled.<br />
Published in the prestigious New<br />
England Journal of Medicine in<br />
October, the results from the largest<br />
ever follicular lymphoma clinical trial<br />
revealed that consumers treated with<br />
a combination of chemotherapy and<br />
obinutuzumab had their disease under<br />
control for one and a half times longer<br />
than the standard treatment with<br />
chemotherapy and rituximab.<br />
The Gallium study was the largest<br />
clinical trial ever conducted in<br />
follicular lymphoma, comparing<br />
the safety and effectiveness of two<br />
different anti-lymphoma antibodies<br />
(rituximab and obinutuzumab), in<br />
combination with chemotherapy for<br />
consumers with previously untreated<br />
follicular lymphoma.<br />
1202 consumers — including 30 at<br />
<strong>Monash</strong> <strong>Health</strong>, the largest recruitment<br />
site in Australia—were randomly<br />
selected to receive chemotherapy with<br />
rituximab or chemotherapy<br />
with obinutuzumab.<br />
It’s hoped this new technique will<br />
trick the body or modify its immune<br />
response to promote healing rather<br />
than scarring, which will help to repair<br />
the damage.<br />
20 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
<strong>Monash</strong>Heart and <strong>Monash</strong> University<br />
research wins trifecta of prizes<br />
<strong>Monash</strong>Heart interventional cardiology fellow and <strong>Monash</strong> University PhD candidate Dr Abdul Ihdayhid<br />
was recognised for his ground-breaking research into coronary artery disease, receiving two highly<br />
prestigious awards in Perth in August. The two awards follow on from Dr Ihdayhid’s Young Investigator<br />
Award in July, at the Society of Cardiovascular Computed Tomography in Washington D.C.<br />
Dr Ihdayhid was awarded the highly regarded Ralph Reader Prize at the annual scientific<br />
meeting of the Cardiac Society of Australia & New Zealand as well as the prestigious<br />
Geoff Mews Memorial Fellows’ Prize at the Australia & New Zealand Endovascular Therapies<br />
Meeting for his research into assessing the functional significance of coronary artery disease.<br />
21
Our people<br />
<strong>Monash</strong> <strong>Health</strong> farewells<br />
Board Chair Barbara Yeoh AM<br />
On 27 June, more than one hundred<br />
people from <strong>Monash</strong> <strong>Health</strong><br />
community came together to farewell<br />
our Board Chair, Barbara Yeoh AM.<br />
<strong>Monash</strong> <strong>Health</strong> Chief Executive<br />
Andrew Stripp said how extremely<br />
fortunate <strong>Monash</strong> <strong>Health</strong> has been to<br />
have Barbara guiding the organisation<br />
through so many changes over the<br />
past nine years.<br />
The event included a video, with<br />
special words from Chief Executive<br />
Andrew Stripp, Board Member Charles<br />
Gillies, Wurundjeri Elder Margaret<br />
Gardiner, Professor Euan Wallace AM,<br />
Moorabbin Hospital Ladies Auxiliary<br />
President Pat Huggins OAM, Director<br />
of Nursing Hospital in the Community,<br />
<strong>Monash</strong> <strong>Health</strong> Community and<br />
Allied <strong>Health</strong> Jennine Harbrow, and<br />
the Minister for <strong>Health</strong> the Hon. Jill<br />
Hennessy MP.<br />
Ms Hennessy said, “Barbara has done<br />
extraordinary things for <strong>Monash</strong> <strong>Health</strong><br />
and for the entire community. She’s a<br />
champion for patients, she’s a champion<br />
for diversity, and she’s a champion for<br />
the workforce. We have been so lucky<br />
to have had her service.”<br />
Andrew Stripp said, “Barbara has<br />
made an extraordinary commitment to<br />
health care, but I think one of her other<br />
achievements is her humanity and<br />
commitment to patient care<br />
and experience.”<br />
Concluding the event, Barbara took the<br />
time to say thank you and farewell. She<br />
shared a quote from Winnie the Pooh,<br />
“How lucky am I to have something that<br />
makes saying goodbye so hard.”<br />
Staff recognised at <strong>Monash</strong><br />
<strong>Health</strong> awards<br />
The <strong>Monash</strong> <strong>Health</strong> Awards is a<br />
chance to celebrate, recognise, and<br />
congratulate staff for outstanding<br />
work. Each year, nominations are<br />
received from across the organisation,<br />
in 12 award categories. Submissions<br />
exemplify excellence, innovation,<br />
quality, safety, and leadership.<br />
In FY <strong>2017</strong>-<strong>18</strong>, <strong>Monash</strong> <strong>Health</strong> hosted<br />
two separate award ceremonies; in<br />
August <strong>2017</strong> and June 20<strong>18</strong>.<br />
Aboriginal Graduate and<br />
Cadetship Program wins<br />
national awards<br />
Aboriginal Graduate and Cadetship<br />
Program Coordinator, Judy Clayton,<br />
and Aboriginal <strong>Health</strong> Midwife and<br />
Aboriginal Graduate and Cadet<br />
Congratulations to the winners<br />
of the <strong>2017</strong> and the 20<strong>18</strong> <strong>Monash</strong><br />
<strong>Health</strong> Awards:<br />
In <strong>2017</strong>: Associate Professor Peter Poon,<br />
Jeff Chen, Janelle Finn, Dr Ramini Shankumar,<br />
Michelle Ravesi, Jacquie McBride, Alyce Cuman,<br />
Katrina Clarke, Annette Bezzant, Associate<br />
Professor Ronil Chandra, Dr Hashrul Rashid,<br />
General Medicine Unit, Accountable Care team,<br />
Dandenong Hospital, Fiona McAlinden, and<br />
Helen Stubbs.<br />
In 20<strong>18</strong>: Jeff Chen, Dr Michael Gordon and<br />
the Early in Life Mental <strong>Health</strong> Service, Dr Atul<br />
Malhotra and The Stem Cell BPD Team, Associate<br />
Professor Peter Poon and The Supportive Chronic<br />
Conditions Care Team, Jacquie McBride, Kate<br />
Plowright, Dr Ramini Shankumar and The Dental<br />
<strong>Health</strong> Services team, Dr Christina Johnson and<br />
The <strong>Monash</strong> Doctors Education team, Dr Jacquie<br />
Taylor and The <strong>Monash</strong> Newborn Team, Anne<br />
Marie Hadley and the Patient eXperience Team,<br />
and Associate Professor Michelle Giles.<br />
22 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Support Officer, Tracey Stephens,<br />
recently attended the Congress of<br />
Aboriginal and Torres Strait Islander<br />
Nurses and Midwives (CATSINaM)<br />
conference on the Gold Coast to<br />
receive a partnership award and Sally<br />
Goold Award for individual excellence<br />
in nursing.<br />
The CATSINaM Partnership Award<br />
is presented to organisations<br />
that actively establish culturally<br />
respectful, committed, and successful<br />
partnerships between their members<br />
and other organisations. This was<br />
awarded to the <strong>Monash</strong> <strong>Health</strong><br />
Aboriginal Graduate and Cadetship<br />
program for its organisation-wide<br />
commitment to increasing the number<br />
of Aboriginal nurses and midwives<br />
employed within our service and for<br />
ensuring Aboriginal staff have access<br />
to a range of career development and<br />
employment opportunities.<br />
Tracey Stephens was also presented<br />
with the Sally Goold Award for<br />
individual nursing and/or midwifery<br />
excellence that recognises her<br />
achievements as an Aboriginal<br />
midwife who has made substantial<br />
contributions to the nursing and<br />
midwifery profession, and the health<br />
of Aboriginal and Torres Strait Islander<br />
Australians.<br />
Length of Service awards<br />
celebrate our staff and<br />
volunteers<br />
In November, <strong>Monash</strong> thanked our<br />
many staff and volunteers at the annual<br />
Length of Service Awards. Over 540<br />
certificates were presented throughout<br />
the day, a testament to our dedicated<br />
and passionate people.<br />
Staff completing 10, 15, 20, 25, 30,<br />
35, and 40 years of service were<br />
acknowledged, together with<br />
volunteers completing five years or<br />
more of service. One volunteer, Carlene<br />
Powell, was honoured for achieving<br />
an amazing 50 years of service with<br />
<strong>Monash</strong> <strong>Health</strong>.<br />
People Matter Survey results<br />
In <strong>2017</strong>, almost 3400 staff, or 31 per<br />
cent of our total employees, took the<br />
time to share their views as part of<br />
the People Matter Survey. In 20<strong>18</strong>, the<br />
response rate more than doubled to<br />
4 per cent.<br />
Release of the full 20<strong>18</strong> results is<br />
pending, however the <strong>2017</strong> results<br />
presented excellent feedback,<br />
including: most staff believe the<br />
work they do is important, more staff<br />
observed managers driving a safetycentred<br />
culture, where patient care<br />
errors are handled appropriately, and<br />
more people report that they work in<br />
a fair and inclusive workplace.<br />
Full results for <strong>2017</strong> were rolled<br />
out during the year at our People<br />
Matter Forums.<br />
Using creative strategies to<br />
enhance patient wellbeing<br />
As part of the <strong>Monash</strong> <strong>Health</strong> Delirium<br />
and Dementia Initiative, a dedicated<br />
group of medical, allied health and<br />
nursing staff found creative ways to<br />
support patient care in the acute general<br />
medical units at <strong>Monash</strong> Medical Centre.<br />
From left, Board member and in-coming<br />
Board Chair, Dipak Sanghvi, Board<br />
Member, Dandenong and District<br />
Aborigines Co-operative Ltd., Margaret<br />
Gardiner and Chief Executive Officer,<br />
Dandenong and District Aborigines<br />
Co-operative Ltd., Andrew Gardiner.<br />
23
People with dementia and delirium are<br />
more vulnerable to falls and pressure<br />
injuries. Hospitals are unfamiliar<br />
environments, which often disrupt usual<br />
routines and can be disorientating.<br />
To meet the challenge of providing<br />
meaningful activities and engagement<br />
for people with a cognitive impairment<br />
in hospital, the general medical teams<br />
developed a dementia and delirium<br />
resource library.<br />
A bake sale raised approximately<br />
$1300 to support patient wellbeing<br />
and engagement and helped to fund<br />
‘dementia-safe’ sensory and tactile<br />
resources such as gel mats, a ‘plumber’s<br />
mate’ and magnetic building blocks.<br />
Other resources include reminiscence<br />
cards and a toss-and-talk ball activity<br />
to build on person-centred care, which<br />
can foster social and physical skills and<br />
collaboration between consumers, their<br />
family and the multidisciplinary team.<br />
A range of ‘fidget blankets’ has also<br />
been created; used to provide sensory<br />
and tactile stimulation. People with<br />
dementia and other forms of cognitive<br />
impairment often find comfort in having<br />
something to keep their hands busy,<br />
especially those staying in an unfamiliar<br />
environment like a hospital. Fidget<br />
blankets can help people feel calm<br />
while keeping them occupied.<br />
<strong>Monash</strong> <strong>Health</strong> hosted first<br />
Schwartz Round (19 Oct)<br />
<strong>Monash</strong> <strong>Health</strong> hosted its first Schwartz<br />
Round in November. The Schwartz<br />
Rounds are a multidisciplinary forum,<br />
where clinical and non-clinical staff can<br />
discuss social and emotional issues that<br />
arise in caring for consumers.<br />
The program comes from The<br />
Schwartz Center for Compassionate<br />
<strong>Health</strong>care, an independent, nonprofit<br />
organisation with more than<br />
425 healthcare members in the US,<br />
Canada, Australia and New Zealand.<br />
The Centre was founded by Ken<br />
Schwartz, days before his death from<br />
cancer in 1995. His experience as a<br />
patient drove him to establish the<br />
organisation with the mission to promote<br />
compassionate care so that consumers<br />
and their caregivers relate to one<br />
another in a way that provides hope to<br />
the patient, support to caregivers and<br />
sustenance to the healing process.<br />
In <strong>2017</strong>, <strong>Monash</strong> <strong>Health</strong> became a<br />
member of the Schwartz Centre. A<br />
Schwartz Rounds Planning Committee,<br />
chaired by Associate Professor Andrew<br />
Block was then created to oversee all<br />
future rounds.<br />
Dr Anjali Dhulia, Director Medical<br />
Services, said the program provided an<br />
important opportunity for staff to reflect<br />
on their experiences as caregivers.<br />
“The Schwartz Rounds bring doctors,<br />
nurses and allied health caregivers as<br />
well as non-clinical staff together to<br />
discuss the human side of healthcare,” Dr<br />
Dhulia said.<br />
“The purpose of Rounds is to understand<br />
the challenges and rewards that are<br />
central to providing care, not to solve<br />
problems or to focus on the clinical<br />
aspects of patient care.”<br />
<strong>Monash</strong> <strong>Health</strong> recognised<br />
in the <strong>2017</strong> Victorian Public<br />
<strong>Health</strong>care Awards<br />
The Victorian Public <strong>Health</strong>care Awards<br />
recognise and celebrate excellence,<br />
dedication and innovation in public<br />
health, health services and service<br />
initiatives that deliver informed and<br />
effective health care. Areas that received<br />
acknowledgement included:<br />
Category: Excellence in CALD health<br />
The GP Engagement Initiative: Building<br />
capacity in primary healthcare to<br />
respond to refugee health needs –<br />
Highly Commended<br />
Category: Excellence in public sector<br />
aged care<br />
Residential in Reach: Thinking outside<br />
the box - Highly Commended<br />
Category: Secretary’s Award for<br />
improving integration of care for<br />
consumers with chronic and complex<br />
conditions<br />
Oncopain Clinic: Provision of<br />
multidisciplinary rapid access<br />
cancer pain assessment and<br />
management - Finalist .<br />
A new world for nursing<br />
recruitment at <strong>Monash</strong> <strong>Health</strong><br />
<strong>Monash</strong> <strong>Health</strong> began a six-month trial of<br />
a Centralised Recruitment Model (CRM)<br />
for all nursing and midwifery roles. With<br />
well over 7000 nursing and midwifery<br />
staff working at <strong>Monash</strong> <strong>Health</strong>, the<br />
CRM represents a collaborative new<br />
way of managing the recruitment of<br />
permanent and fixed-term nursing and<br />
midwifery roles. Clinical hiring managers<br />
have partnered with a dedicated<br />
recruitment specialist to support them in<br />
the end-to-end recruitment process.<br />
The CRM partnership has helped to<br />
ensure only the best talent is recruited;<br />
more quickly and at a lower cost. The<br />
model also gives back valuable time<br />
to our clinical nursing hiring managers<br />
to provide exceptional care and an<br />
enhanced patient experience<br />
Professors David Kissane, AC<br />
and Barbara Workman, AC<br />
recognised in Australia<br />
Day honours<br />
Professor David Kissane, Head of<br />
Department of Psychiatry, School of<br />
Clinical Sciences at <strong>Monash</strong> <strong>Health</strong> and<br />
Professor Barbara Workman Service<br />
Director for Rehabilitation and Aged<br />
Care at <strong>Monash</strong> <strong>Health</strong> were made<br />
Companions of the Order of Australia in<br />
the 20<strong>18</strong> Australia Day Awards.<br />
24 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Professor Barbara Workman received<br />
this award for her significant service<br />
to geriatric and rehabilitation medicine,<br />
as a clinician, academic and educator,<br />
and as a leader in the provision of aged<br />
care services.<br />
Professor Kissane received his honour<br />
in recognition for his contribution to<br />
psycho-oncology and palliative medicine,<br />
as an educator, researcher, author and<br />
clinician, and through executive roles<br />
with a range of national and international<br />
professional medical bodies.<br />
Diana Egerton-Warbuton<br />
inducted into Victorian<br />
Honour Roll of Women<br />
Associate Professor Diana Egerton-<br />
Warburton was inducted into the<br />
Victorian Honour Roll of Women in 20<strong>18</strong>.<br />
Currently the Director of Emergency<br />
Research and Innovation at <strong>Monash</strong><br />
<strong>Health</strong>, Diana has worked for almost<br />
three decades in Victorian emergency<br />
departments. She has trained and<br />
mentored a new generation of<br />
emergency medicine specialists and is<br />
passionate about developing women<br />
in leadership roles. She is Associate<br />
Professor with the School of Clinical<br />
Sciences at <strong>Monash</strong> University and<br />
the National Drug Research Institute<br />
at Curtin University. She has also<br />
advised Victorian and Commonwealth<br />
governments on alcohol and drug policy.<br />
Diana’s research has always focussed on<br />
patient needs, with a particular interest<br />
in reducing alcohol harm. Diana served<br />
as President of the Australasian Society<br />
for Emergency Medicine from 1997 to<br />
2000, where she was an advocate for the<br />
non-specialist workforce and recognised<br />
for her teaching, training, research, and<br />
public health achievements.<br />
25
26 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Our community<br />
Refugee Week 20<strong>18</strong><br />
In June we celebrated Refugee Week,<br />
which raises awareness about issues<br />
affecting refugees and recognises the<br />
valuable contribution refugees make to<br />
Australian society.<br />
The theme of this year’s Refugee Week<br />
is #WithRefugees.<br />
<strong>Monash</strong> <strong>Health</strong> has a long-standing<br />
commitment to improving the health<br />
of asylum seekers and refugees across<br />
Melbourne’s south-east. This is most<br />
strongly reflected in <strong>Monash</strong> <strong>Health</strong>’s<br />
multidisciplinary refugee service,<br />
Refugee <strong>Health</strong> and Wellbeing, located<br />
in Dandenong.<br />
After years of working closely with<br />
local refugee communities, Refugee<br />
<strong>Health</strong> and Wellbeing has become<br />
familiar with stories of the tragic<br />
circumstances that bring asylum<br />
seekers and refugees to Australia.<br />
However, we have also experienced the<br />
many ways that refugee communities<br />
embrace new opportunities with<br />
strength, resilience, and determination<br />
through countless stories of success.<br />
Refugee Week was a way for the<br />
organisation to reflect on the diverse<br />
journeys of others, consider our<br />
personal roles in creating a fair, just,<br />
and inclusive society, and celebrate the<br />
diversity that makes Australia a vibrant<br />
and culturally-rich nation.<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong><br />
General Meeting<br />
More than 100 people attended the<br />
<strong>2017</strong> <strong>Annual</strong> Meeting in November.<br />
<strong>Monash</strong> <strong>Health</strong> Board Chair Barbara<br />
Yeoh delivered the opening address,<br />
followed by a detailed account of<br />
the achievements and successes of<br />
the organisation presented by Chief<br />
Executive Andrew Stripp.<br />
Mr Stripp reported on the<br />
organisation’s clinical, operational,<br />
safety, capital and financial results,<br />
including <strong>Monash</strong> <strong>Health</strong> meeting all<br />
of its service delivery targets within its<br />
2016-17 operating budget of $1.7 billion.<br />
Mr Stripp also shared patient<br />
stories and our progress on<br />
organisational-wide priorities, such<br />
as patient experience, response to<br />
family violence, aboriginal health,<br />
sustainability initiatives, research<br />
and innovation. He also spoke about<br />
opportunities and guiding principles<br />
as <strong>Monash</strong> <strong>Health</strong> develops its new<br />
strategic plan.<br />
Keynote speaker was Dr Beth Wilson<br />
AM. A lawyer by training, Dr Wilson<br />
is an expert in mental health and a<br />
passionate consumer rights advocate.<br />
Dr Wilson spoke about <strong>Monash</strong><br />
<strong>Health</strong>’s duties to its consumers,<br />
including the recently produced<br />
‘Statutory duty of candour’, which<br />
recommends legislation which would<br />
ensure consumers and their families<br />
are told when and why things go wrong<br />
with their care.<br />
Committed volunteer goes<br />
above and beyond<br />
Dayawati Lal has been volunteering<br />
at Dandenong Hospital since 2013.<br />
Originally from Fiji, it is part of<br />
Dayawati’s culture and Hindu beliefs<br />
to give back to the community in<br />
which she lives.<br />
Dayawati is one of the first friendly<br />
faces you see when entering<br />
Dandenong Hospital, she provides<br />
important directions and guidance to<br />
consumers and their visitors. She also<br />
spreads hope and happiness with the<br />
delivery of flowers to the wards on<br />
Tuesday mornings.<br />
But Dayawati wanted to do even more<br />
for <strong>Monash</strong> <strong>Health</strong> consumers. She<br />
came to her shift one afternoon with<br />
the funds to purchase a wheelchair.<br />
“I wanted to give something useful<br />
to the people who need help moving<br />
around the hospital,” she said.<br />
We thank Dayawati and all of our<br />
committed volunteers who generously<br />
give their time to help consumers and<br />
their families.<br />
Integrated Model for<br />
Responding to Elder Abuse<br />
at <strong>Monash</strong> <strong>Health</strong><br />
In December, <strong>Monash</strong> <strong>Health</strong> launched<br />
a project to deliver an Integrated<br />
Model for Responding to Elder Abuse.<br />
The new model focusses on identifying<br />
and responding as part of a whole of<br />
health approach to elder abuse using<br />
a family centred approach, which<br />
engages both the person being abused<br />
and the person responsible.<br />
This new initiative is a 12-month project<br />
funded by the Department of <strong>Health</strong><br />
and Human Services through the Elder<br />
Abuse Prevention and Response Unit.<br />
The department has funded five trial<br />
sites throughout Victoria.<br />
The integrated model of care includes<br />
four key components: workforce<br />
training, an Elder Abuse Prevention<br />
Response liaison officer, counselling<br />
and mediation (including financial<br />
counselling), and an elder abuse<br />
prevention network. <strong>Monash</strong> <strong>Health</strong><br />
has partnered with like-minded<br />
organisations to help us achieve this,<br />
including St Vincent’s Hospital, the<br />
Bouverie Centre and FMC Mediation,<br />
and Counselling Victoria.<br />
27
The <strong>Monash</strong><br />
<strong>Health</strong> Foundation<br />
The <strong>Monash</strong> <strong>Health</strong> Foundation partners with the<br />
community through philanthropy to support the<br />
incredible work of <strong>Monash</strong> <strong>Health</strong>.<br />
Generous giving from individuals,<br />
organisations, and passionate fundraisers<br />
has enabled the purchase of state-of-theart<br />
equipment, investment in research<br />
and provided additional comfort and<br />
wellbeing programs for consumers and<br />
their families.<br />
Thank you to every person, family and<br />
organisation that has helped make a<br />
difference to our consumers through<br />
generous donations.<br />
20<strong>18</strong> has been a great year as we<br />
have built on the successful events<br />
of the past, forged new partnerships<br />
and strengthened our community of<br />
philanthropy. Through the launch of the<br />
Imagination Appeal we have reached new<br />
donors and inspired many to continue<br />
their support.<br />
We are particularly grateful to the people,<br />
groups and organisations who have<br />
supported <strong>Monash</strong> <strong>Health</strong> through direct<br />
gifts or by dedicating their time and<br />
energy to organising extraordinary events<br />
that have lasting impact:<br />
• The inaugural Premier’s Golf Day<br />
was held in support of the <strong>Monash</strong><br />
Children’s Hospital NICU. Over<br />
$400,000 was raised to purchase<br />
new equipment including a state-ofthe-art<br />
transportation cot. The event<br />
was supported by Victoria’s property<br />
development community and was<br />
attended by the Honourable Daniel<br />
Andrews MP, Premier of Victoria along<br />
with cricket legends Ian Botham and<br />
Dean Jones.<br />
• Bailey’s Golf Day has raised over $3<br />
million to fund paediatric oncology<br />
fellows at the <strong>Monash</strong> Children’s<br />
Hospital Cancer Centre.<br />
• The 2nd annual My Room Footy<br />
Show Telethon was held in August.<br />
Funds raised by My Room have<br />
been committed to support a<br />
Clinical Research Training program,<br />
Dietetics, Physiotherapy, a 3D<br />
pain distraction system, and<br />
patient families undergoing long<br />
term treatment.<br />
• Lincoln and Veronique Wulff and the<br />
Dandelion Wishes Gala Committee<br />
for their ongoing dedication and<br />
commitment to paediatric health,<br />
now in its third year, the annual gala<br />
has raised over $1.2 million for the<br />
<strong>Monash</strong> Children’s Hospital. Funds<br />
from this year’s event purchasing an<br />
echocardiograph for the Paediatric<br />
Intensive Care Unit.<br />
• The Friends of the Children Foundation<br />
who continue to support the <strong>Monash</strong><br />
Children’s Hospital through their<br />
fundraising and involvement in The<br />
Walk for <strong>Monash</strong> Children’s Hospital<br />
which raised nearly $200,000 this year.<br />
• Richard Lim and the Cambodian<br />
community came together to celebrate<br />
the inaugural Lim’s Pharmacy Charity<br />
Dinner Dance raising over $100,000<br />
for <strong>Monash</strong> <strong>Health</strong> and <strong>Monash</strong><br />
Children’s Hospital.<br />
• The annual <strong>Monash</strong> CF Foundation<br />
Charity Golf held at Cheltenham<br />
Golf Club, led by Felicity Stretch and<br />
her dedicated volunteers raised over<br />
$12,600. The funds support the Cystic<br />
Fibrosis service at <strong>Monash</strong> Children’s<br />
Hospital and <strong>Monash</strong> <strong>Health</strong> which<br />
treats over 230 kids & adults with<br />
Cystic Fibrosis.<br />
• Jennifer Herbert who is currently<br />
undergoing treatment for cancer,<br />
wanted consumers in the public health<br />
system to have the same options for<br />
treatment as those in private hospitals.<br />
Jennifer has inspired generosity<br />
from others and raised an amazing<br />
$81,000 to purchase two scalp cooling<br />
machines that preserve a patient’s hair<br />
during chemotherapy.<br />
28 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
29
Acknowledgment<br />
65km for Cystic Fibrosis Committee<br />
ALH Group Pty Ltd<br />
Amgen Australia Pty Ltd<br />
Anna Marsenovic<br />
Anna Wang<br />
Anthony Bellgrove<br />
Anthony Caligiuri Director –<br />
Mt Atkinson Holdings<br />
ANZAPP Vic<br />
ASL Real Estate<br />
Bailey’s Day<br />
BankVic<br />
Beletti Restaurant Cafe Bar<br />
Berwick Opportunity Shop<br />
Blueways Group<br />
BMF Construction<br />
Boston Scientific<br />
Brent and Jessica Cameron on behalf<br />
of Brooke Cameron<br />
Cambodian Community MCH<br />
Fundraising Event<br />
Camp Quality<br />
Cancer Council Victoria<br />
CEPIA – Cardiac Electrophysiology<br />
Institute of Australasia<br />
Chain Reaction<br />
Channel 9<br />
Children’s Cancer Foundation<br />
Chobani<br />
City of Casey<br />
Collier Charitable Fund<br />
Cystic Fibrosis Community Care<br />
Dandelion Wishes Gala Committee<br />
Effie Atkins’ Dr Hope<br />
Estate of Doris and Rupert Joseph<br />
Estate of EC Blackwood<br />
Estate of Ernest Finlay Burns<br />
Estate of John Frederick Wright<br />
Estate of John Lambrick<br />
Estate of Lindsay James Baldy<br />
Estate of Martin and Isobel McLoughlin<br />
Estate of Maxwell John Bradford<br />
Estate of Muriel Bradley<br />
Estate of Eva Tidswell<br />
Estate of William and Mary Levers &<br />
Sons Maintenance Fund<br />
Estate of William Macrow<br />
Exclusive Networks<br />
First State Super<br />
Freemasons Foundation Victoria<br />
Friends of the Children Foundation<br />
Giac Hoang Pagoda<br />
HESTA Superfund<br />
Indimax Productions<br />
INKA Surgical Instruments<br />
Jennifer Herbert<br />
John Kilpatrick<br />
John Plumridge – MAW Civil Pty Ltd<br />
Julie Biggar<br />
K Henzen<br />
KARL STORZ Endoscopy Australia<br />
Kaspersky Lab<br />
Kids with Cancer Foundation<br />
Australia<br />
Lady Marigold Southey AC<br />
Lim’s Parmacy<br />
Lincoln & Veronique Wulff<br />
Lions Club of Clarinda<br />
Lions Club of Dandenong Supper –<br />
District 201V5<br />
Lions Club of Waverley<br />
Lotus Oaks Development<br />
Louis and Lesley Nelken Trust Fund<br />
Mary MacKillop Foundation<br />
Maxxia<br />
Mazda Foundation<br />
McGrath Foundation<br />
Medical Indemnity Protection<br />
Society (MIPS)<br />
Medtronic Australasia Pty Ltd<br />
Melbourne Racing Club Foundation<br />
Mercedes-Benz Berwick<br />
Miei Fiori<br />
Moller Family Foundation<br />
<strong>Monash</strong> Cystic Fibrosis Foundation<br />
<strong>Monash</strong> Plastic &<br />
Reconstructive Surgery<br />
<strong>Monash</strong> University<br />
Moorabbin Hospital Ladies Auxiliary<br />
Moose Toys<br />
Mr Rolf Burggraaff<br />
My Room<br />
Paragon Financial Group<br />
Patterson Cheney<br />
Pellicano Property & Constructions<br />
Premier’s Golf Day<br />
Redkite<br />
Rombotis Event Trust<br />
Rotary Club of Endeavour Hills<br />
Rubbermaid (Newell Brands)<br />
Sam Polimeni<br />
Scleroderma Victoria Inc.<br />
Scottish Pacific<br />
Sparkling Car Wash<br />
Spicer Thoroughbreds<br />
Stihl Shop Ferntree Gully<br />
Stockwood Building Group<br />
Thai Hoa Long<br />
The Appu Family<br />
The Flinders Group (Tass & Tina Arhon<br />
and Steve Panopoulos)<br />
The Foundation for Aids Research (amfAR)<br />
The Garry White Foundation<br />
The Honda Foundation<br />
The Miranda Foundation<br />
The <strong>Monash</strong> Kids Support Group<br />
The Ricky Taylor Foundation Inc.<br />
The Teo Chew Chinese Assoc. of Vic.<br />
The Walt Disney Company<br />
The Wood Family<br />
Thi Ly<br />
Tom and Margo Hartley<br />
Unicharm Australasia<br />
Watsons<br />
Yan Wo Tong Chinese Medicine Centre<br />
Zagame Automotive Group.<br />
Thank you<br />
The <strong>Monash</strong> <strong>Health</strong> Foundation<br />
acknowledges the generosity of all<br />
the people who have supported the<br />
work of <strong>Monash</strong> <strong>Health</strong> throughout<br />
the year.<br />
In particular, we extend our gratitude<br />
to those who have raised funds in<br />
celebration of a special occasion<br />
or have given a gift in memory of<br />
a loved one.<br />
Our auxiliary members have, as<br />
always, worked tirelessly to raise<br />
funds for <strong>Monash</strong> <strong>Health</strong>. The<br />
extraordinary commitment from this<br />
wonderful group of people to support<br />
our <strong>Monash</strong> <strong>Health</strong> consumers<br />
continues to inspire generosity from<br />
our community.<br />
30 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
A journey starts<br />
with one small step<br />
Seven years ago, three mums decided to make a difference and<br />
raise funds to support vital research into cystic fibrosis (CF).<br />
After significant planning and<br />
organisation, Susan Biggar, Julie<br />
Noorman and Kathy Ryan, (all CF<br />
Mums) launched ‘65km for Cystic<br />
Fibrosis’ (www.65kmforcf.com.au),<br />
a 65km endurance walk to raise funds<br />
for research. The event exceeded their<br />
own expectations both in terms of<br />
participation and fundraising.<br />
As parents of children living with CF,<br />
these extraordinary mums know the<br />
value of research to improve the quality<br />
It is truly<br />
inspirational<br />
to witness and<br />
support such<br />
dedicated<br />
fundraisers.<br />
Matthew Hannan,<br />
<strong>Monash</strong> <strong>Health</strong> Foundation<br />
of life for their children. This was the<br />
driving factor and the motivation<br />
to work tirelessly to raise money to<br />
support research into CF.<br />
Cystic fibrosis is a complicated disease,<br />
it primarily effects the lungs and<br />
digestive system and there is currently<br />
no cure.<br />
<strong>Monash</strong> <strong>Health</strong> provides lifetime care<br />
for over 200 adults and children with<br />
cystic fibrosis. Every year, an average<br />
of eight newly diagnosed babies are<br />
referred to <strong>Monash</strong> <strong>Health</strong>’s Cystic<br />
Fibrosis clinic.<br />
Funds raised from the <strong>2017</strong> event have<br />
funded three research projects we<br />
hope will have a lasting impact on the<br />
lives of these consumers.<br />
• Studying the impact of DNase<br />
with early stage lung disease<br />
to decrease inflammation and<br />
infection. This project has the<br />
potential to improve the long-term<br />
outcome in children with CF<br />
• Investigating the effect of an<br />
innovative treatment to improve<br />
sinus symptoms, quality of life,<br />
and the amount of infections<br />
for people living with CF and<br />
sinus disease<br />
• Develop the optimal, patient-centred<br />
model of care for people with cystic<br />
fibrosis Related Diabetes.<br />
The small but amazing team continue<br />
their unwavering commitment to the<br />
cause, raising over $600k since 2013<br />
and funding more than 10 research<br />
projects.<br />
The team has now been joined by Sue<br />
Emery and Phil Ryan which has seen<br />
the event grow in its participation rates<br />
and success, remarkably raising over<br />
$147,000 in 20<strong>18</strong>. The Committee will<br />
work with health care professionals,<br />
researchers, and the CF community<br />
to determine priority projects for<br />
consideration with funding from this<br />
year’s event.<br />
In 2016, the team was awarded the<br />
Premier’s Volunteer of the Year, Dame<br />
Elisabeth Murdoch Award for Teamwork,<br />
for their inspiring contribution.<br />
‘65km for Cystic Fibrosis’ Committee<br />
members, from left, Julie Noorman,<br />
Susan Biggar, Kathy Ryan and Sue Emery.<br />
31
Our sites, services<br />
and staff<br />
Our sites<br />
<strong>Monash</strong> <strong>Health</strong> provides services to almost a quarter of metropolitan<br />
Melbourne’s population. We also play a significant role in providing<br />
regional and state-wide specialist services in Victoria.<br />
Casey Hospital<br />
Casey Hospital is a 273-bed hospital<br />
serving one of the fastest growing<br />
areas in Melbourne’s south-east.<br />
Services include an emergency<br />
department, general medical, mental<br />
health, rehabilitation, surgical and<br />
ambulatory care services, maternity,<br />
and a special care nursery. The hospital<br />
is a provider of paediatric services for<br />
<strong>Monash</strong> Children’s Hospital and gives<br />
access to the leading cardiac services<br />
of <strong>Monash</strong>Heart.<br />
Cranbourne Centre<br />
Cranbourne Centre provides a range<br />
of same-day acute and subacute<br />
services including surgery, renal<br />
dialysis, specialist consulting services,<br />
regional ophthalmology services and<br />
mental health services. It also provides<br />
the local community with access to<br />
community health services and a<br />
community rehabilitation centre.<br />
Dandenong Hospital<br />
Dandenong Hospital is a 573-bed<br />
acute hospital providing a wide range<br />
of health services to the people<br />
living and working in Dandenong and<br />
its surrounding areas. The hospital<br />
provides a number of general and<br />
specialist services. These services<br />
include general medical and surgical,<br />
an intensive care unit, <strong>Monash</strong>Heart<br />
cardiac care centre, rehabilitation<br />
and aged care services, pathology,<br />
radiology, maternity unit, special<br />
care nursery, children’s services,<br />
outpatients, day chemotherapy,<br />
home haemodialysis, mental health<br />
services, and allied health services.<br />
Dandenong Hospital also provides<br />
specialist services including<br />
orthopaedic, plastics, vascular,<br />
facio-maxillary, gynaecology,<br />
respiratory, and infectious diseases.<br />
Kingston Centre<br />
Kingston Centre is a 213-bed<br />
subacute facility specialising in<br />
high-quality rehabilitation, functional<br />
restoration, transitional care and aged<br />
mental health. The highly regarded<br />
rehabilitation program focuses on<br />
restoring function after illness or injury<br />
with the full range of allied health<br />
services provided to adults of all ages.<br />
The centre provides specialist services<br />
for older people including aged care<br />
assessment, cognitive dementia and<br />
memory services. It also offers a Falls<br />
and Balance Clinic, Pain Clinic, clinical<br />
gait analysis, and continence service.<br />
It is at the forefront of research into<br />
movement and gait disorders, aged<br />
mental health and geriatric medicine.<br />
<strong>Monash</strong> Medical Centre<br />
Clayton<br />
<strong>Monash</strong> Medical Centre Clayton is<br />
a 640-bed teaching and research<br />
hospital, providing a comprehensive<br />
range of specialist surgical, medical,<br />
allied health and mental health services<br />
to the community.<br />
Specialist units include coronary<br />
care, intensive care and neonatal<br />
intensive care.<br />
The hospital is designated a national<br />
provider of renal and pancreatic<br />
transplants, and statewide provider<br />
of Thalassemia and children’s<br />
cancer services.<br />
It is the base for <strong>Monash</strong>HEART,<br />
a centre of excellence in cardiac<br />
assessment, treatment and research;<br />
and <strong>Monash</strong> Children’s, Hospital.<br />
Uniquely offering maternity and<br />
newborn services integrated on the one<br />
site, <strong>Monash</strong> Medical Centre provides<br />
one of Victoria’s largest women’s health<br />
services. It is also renowned for men’s<br />
health services.<br />
Moorabbin Hospital<br />
Moorabbin Hospital is a 147-bed<br />
hospital incorporating <strong>Monash</strong> Cancer<br />
Centre, one of Victoria’s leading cancer<br />
treatment centres, and operating in<br />
partnership with Peter MacCallum<br />
Cancer Centre. The hospital also offers<br />
elective surgery, short-stay care and<br />
dialysis. Home to Victoria’s first Patient<br />
Simulation Centre, the hospital plays a<br />
major role in the education and training<br />
of undergraduate and postgraduate<br />
medical students, nurses, and allied<br />
health professionals. The hospital hosts<br />
the Southern Melbourne Integrated<br />
Cancer Services and is a centre for<br />
research, and in particular, a major<br />
contributor to cancer-related research.<br />
<strong>Monash</strong> Children’s Hospital<br />
<strong>Monash</strong> Children’s Hospital (MCH)<br />
is a network of paediatric healthcare<br />
services across three sites – the main<br />
Clayton campus (co-located with<br />
<strong>Monash</strong> Medical Centre), together<br />
with satellite sites at Dandenong<br />
and Casey Hospitals.<br />
MCH has Victoria’s largest Neonatal<br />
Intensive Care Unit and provides<br />
leading paediatric services in<br />
rehabilitation, oncology, paediatric<br />
intensive care unit, and palliative care.<br />
32 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Our services<br />
<strong>Monash</strong> <strong>Health</strong> provides more than 250 uniquely integrated<br />
community and hospital-based services focusing on improving<br />
the health of our community through:<br />
• Prevention<br />
• Early intervention<br />
• Community-based treatment and<br />
rehabilitation<br />
• Highly specialised surgical and<br />
medical diagnosis, treatment and<br />
monitoring services<br />
• Hospital and community based<br />
mental health services<br />
• Comprehensive aged care programs<br />
• Aged residential services<br />
• Palliative care.<br />
Aged residential care and<br />
targetted programs<br />
Aged residential care is provided<br />
at: Allambee Nursing Home; AG<br />
Eastwood Hostel; the Kingston Centre<br />
(Cheltenham); Chestnut Gardens Aged<br />
Care (Doveton); Yarraman Nursing<br />
Home (Noble Park); and Mooraleigh<br />
Hostel (East Bentleigh), collectively<br />
providing 249 aged and aged mental<br />
health residential beds. Comprehensive<br />
aged care programs are provided<br />
across our acute and community based<br />
services, including aged mental health,<br />
and our aged and community care<br />
program (Dandenong).<br />
Community-based<br />
rehabilitation services<br />
Community rehabilitation services<br />
are provided from centres at Kingston,<br />
Clayton, Doveton, Springvale,<br />
Dandenong, Cranbourne and<br />
Pakenham and in clients’ homes<br />
through the Rehabilitation in the<br />
Home services.<br />
Community services<br />
Community services are provided<br />
across the catchment. Our staff<br />
are located across 11 major sites<br />
(Cranbourne Centre and Mundaring<br />
Drive, Cockatoo, Doveton, Kingston,<br />
Berwick, Clayton, Pakenham, Parkdale,<br />
Springvale, and Thomas Street,<br />
Dandenong). A range of services<br />
are provided at each site by multidisciplinary<br />
teams of allied health<br />
workers including physiotherapists,<br />
podiatrists, occupational therapists,<br />
dieticians, our services counsellors,<br />
speech pathologists, nurses, health<br />
promotion practitioners, and exercise<br />
physiologists. Co-located services<br />
include dialysis, dental, pregnancy<br />
care clinics, and adult mental health.<br />
We also facilitate group programs to<br />
support respite, social inclusion, and<br />
improved health. Some of our services<br />
are targeted at specific populations<br />
in our community and are led by<br />
experienced staff in these fields. This<br />
includes aged care, Aboriginal health,<br />
refugee health, youth and other<br />
vulnerable groups. Self-management<br />
is central to our care - we aim to<br />
empower and prepare clients to<br />
manage their health and healthcare<br />
across all levels of the care continuum.<br />
Community Support Options provide<br />
personalised services to assist people<br />
who are aged or have a disability<br />
to remain in their own homes.<br />
Respite services are also provided<br />
to support carers.<br />
Hospital and<br />
community-based<br />
mental health services<br />
Mental health services are provided<br />
through hospital and community-based<br />
facilities. Our services for children,<br />
youth and adults experiencing mental<br />
health issues include: the <strong>Monash</strong><br />
<strong>Health</strong> Drug and Alcohol Service; a<br />
telephone psychiatric triage service;<br />
community and inpatient perinatal,<br />
child and youth services; crisis<br />
assessment and treatment teams<br />
and enhanced crisis assessment and<br />
treatment teams; consultation liaison<br />
psychiatry; psychological medicine;<br />
mental health Hospital in the Home,<br />
community care teams; mobile<br />
support and treatment services; acute<br />
inpatient care; secure extended care<br />
services; perinatal infant service<br />
including an inpatient unit; eating<br />
disorders services; gender dysphoria<br />
services, prevention and recovery care<br />
services; and community residential<br />
and rehabilitation services.<br />
Hospital in the Home<br />
Hospital in the Home operates a<br />
‘140-bed’ virtual acute ward from<br />
consumers’ homes or residential care<br />
facilities. In-home care is provided<br />
by medical and nurse practitioners<br />
to people who require acute care,<br />
but can safely receive it in their<br />
home environment.<br />
33
Operational<br />
structure<br />
Chief Executive<br />
Andrew Stripp<br />
Chief<br />
Operating<br />
Officer<br />
Martin Keogh<br />
Clinical Programs<br />
• Acute Medicine,<br />
Subacute &<br />
Community<br />
• Children’s<br />
• Mental <strong>Health</strong><br />
• Specialty<br />
Medicine, Cancer<br />
& Intensive Care<br />
• Surgery &<br />
Interventional<br />
Services<br />
• Women’s &<br />
Newborn<br />
Campuses<br />
• Casey Hospital<br />
• Community Sites<br />
• Cranbourne<br />
Centre<br />
• Dandenong<br />
Hospital<br />
• Kingston Centre<br />
• <strong>Monash</strong> Medical<br />
Centre & <strong>Monash</strong><br />
Children’s<br />
Hospital<br />
• Moorabbin<br />
Hospital<br />
Other<br />
• Emergency<br />
Management<br />
& Business<br />
Continuity<br />
• <strong>Health</strong><br />
Information<br />
Services<br />
• Patient Flow Unit<br />
Executive<br />
Director<br />
Innovation,<br />
Patient Safety<br />
& Experience /<br />
Chief Medical<br />
Officer<br />
Erwin Loh<br />
Clinical Programs<br />
• Pathology<br />
• Pharmacy<br />
• Radiology<br />
Other<br />
• Medical<br />
Workforce<br />
• Appointment<br />
• Credentialing<br />
• Medical<br />
Education<br />
• Library<br />
• Simulation<br />
Centre<br />
• Patient<br />
Experience Office<br />
• Patient Safety,<br />
Innovation &<br />
Strategy<br />
• Business<br />
Intelligence<br />
• Centre for<br />
Clinical<br />
Effectiveness<br />
• Clinical<br />
Analytics<br />
• Clinical<br />
Governance<br />
• Innovation &<br />
Redesign<br />
• Strategy &<br />
Planning<br />
Executive<br />
Director<br />
Residential<br />
Care &<br />
Support<br />
Services/<br />
Chief Nursing<br />
& Midwifery<br />
Officer<br />
Cheyne Chalmers<br />
Clinical Programs<br />
• Residential Care<br />
• Campuses<br />
• Hostels & Nursing<br />
Homes<br />
Other<br />
• <strong>Monash</strong> Bureau<br />
• Nursing &<br />
Midwifery<br />
• Education &<br />
Workforce<br />
• Security<br />
• Support Services<br />
Executive<br />
Director<br />
Research<br />
Strategy<br />
Erwin Loh<br />
(interim)<br />
Clinical Trials<br />
• <strong>Monash</strong> <strong>Health</strong><br />
• Translation<br />
Precinct (MHTP)<br />
• Research<br />
Governance<br />
• Research<br />
Strategy<br />
Executive<br />
Director<br />
Financial<br />
Services /<br />
Chief Financial<br />
Officer<br />
Stuart Donaldson<br />
• Budget<br />
• Clinical Costing<br />
• Finance<br />
• Payroll<br />
• Revenue<br />
34 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Office of the Chief Executive<br />
Stuart Cavill (Acting) – Chief Allied <strong>Health</strong> Officer<br />
Amanda Nolan – Executive Advisor Business<br />
Sara Golubenko – to June 20<strong>18</strong> – Reform: Executive Advisor Chief Executive<br />
Executive<br />
Director<br />
Information<br />
Development<br />
Emilio Pozo<br />
• Information<br />
Technology<br />
Services<br />
• Electronic<br />
Medical Record<br />
Executive<br />
Director<br />
People &<br />
Culture<br />
Karen Lowe<br />
• Diversity &<br />
Inclusion<br />
• Employee<br />
Development<br />
• Employee <strong>Health</strong><br />
& Wellbeing<br />
• Employee<br />
Relations<br />
• People & Culture<br />
• Recruitment &<br />
Retention<br />
• Occupational<br />
<strong>Health</strong> & Safety<br />
Executive<br />
Director<br />
Capital &<br />
Infrastructure<br />
Geoff McDonald<br />
• Biomedical<br />
Engineering<br />
• Capital<br />
• Engineering<br />
• Infrastructure<br />
• Property<br />
Executive<br />
Director<br />
Communications<br />
& Engagement<br />
Louise Kanis<br />
• Public Relations<br />
• Communications<br />
• Government<br />
& community<br />
relations<br />
• Media relations<br />
• Internal and<br />
corporate<br />
communications<br />
• Brand & marketing<br />
• Web and digital<br />
communication<br />
• Project<br />
communication<br />
Executive<br />
Director<br />
Corporate<br />
Services &<br />
Governance<br />
/ Chief Legal<br />
Officer<br />
Katherine Lorenz<br />
• Audit<br />
• Compliance<br />
• Corporate<br />
Governance<br />
• Fraud Control<br />
• Freedom of<br />
Information<br />
• Insurance<br />
• Legal Services<br />
• Medicolegal<br />
• Commercial<br />
• Employment<br />
• Procurement<br />
• Retail<br />
• Risk<br />
• <strong>Monash</strong> <strong>Health</strong><br />
Foundation<br />
35
Jessie McPherson<br />
Private Hospital<br />
Jessie McPherson Private Hospital is a 103-bed<br />
tertiary level private hospital and a subsidiary<br />
of <strong>Monash</strong> <strong>Health</strong>. The hospital is proud to have<br />
a team of highly skilled and dedicated staff<br />
and is equipped with some of the best medical<br />
facilities in Victoria.<br />
Jessie McPherson Private Hospital<br />
offers specialist services including<br />
cardiology, cardiothoracic surgery,<br />
neurosurgery, vascular, gastro-sciences,<br />
general medicine and respiratory, high<br />
acuity maternity and neonatal services.<br />
The co-location of the hospital<br />
with <strong>Monash</strong> Medical Centre provides<br />
consumers with access to a wide<br />
range of additional services and<br />
facilities such as pharmacy, pathology<br />
and diagnostic imaging.<br />
This affiliation also provides Jessie<br />
McPherson Private Hospital consumers<br />
access to world-renowned research<br />
and teaching facilities.<br />
Jessie McPherson Private Hospital<br />
provides quality healthcare for people<br />
in Melbourne, regional Victoria,<br />
interstate, and overseas. As one of<br />
only a few private hospitals to provide<br />
tertiary level services in Victoria,<br />
Jessie McPherson Private Hospital has<br />
preferred provider agreement status<br />
with all major health funds.<br />
Safe patient care is the number one<br />
priority at Jessie McPherson Private<br />
Hospital and processes are in place<br />
to provide the best patient outcomes.<br />
The hospital’s ‘Point of Care Goals’<br />
were developed following input from<br />
Jessie McPherson Private Hospital staff<br />
and consumers about what constitutes<br />
safe and quality care. These goals<br />
reflect what consumers’ value about<br />
healthcare access and delivery, and<br />
how this translates into exceptional<br />
care, for every patient, every time.<br />
Jessie McPherson<br />
Private Hospital is<br />
one of a select few<br />
private hospitals<br />
accredited as a TAVI<br />
Hospital, this means<br />
that we are able to offer<br />
an alternative to open<br />
heart surgery for aortic<br />
stenosis patients.<br />
36 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
After developing symptoms, Brendan’s<br />
doctor picked up on a problem<br />
with his heart and he was referred<br />
to <strong>Monash</strong>Heart Interventional<br />
Cardiologist, Dr Ben Dundon.<br />
A rapid recovery for Brendan<br />
Dr Dundon’s assessment confirmed<br />
Brendan required coronary angioplasty,<br />
and he then had a stent inserted at the<br />
<strong>Monash</strong>Heart Cath Lab followed by<br />
a stay on the Cardiac Ward at Jessie<br />
McPherson Private.<br />
Whilst the stent improved his<br />
symptoms, Dr Dundon informed<br />
Brendan his aortic valve was not<br />
functioning as it should and may<br />
require treatment in the near future.<br />
Over the course of <strong>2017</strong>, Brendan<br />
noticed his condition worsening, he<br />
was struggling to remain active,<br />
finding himself out of breath doing<br />
everyday tasks like walking up a hill.<br />
It became increasingly worse.<br />
Brendan was then considered for<br />
a TAVI procedure and admitted to<br />
Jessie McPherson Private Hospital in<br />
November <strong>2017</strong>. The procedure was<br />
carried out the following day in the<br />
<strong>Monash</strong>Heart Cath Lab and Brendan<br />
was home by Friday and back at work<br />
the following week.<br />
Brendan has since returned to all the<br />
activities he enjoys.<br />
37
Our staff<br />
Our staff continue to provide quality health care to our community.<br />
As an equal opportunity employer, <strong>Monash</strong> <strong>Health</strong> is<br />
committed to a fair and non-discriminatory workplace<br />
that maximises the talent, potential and contribution of all<br />
employees. We act with fairness, dignity and empathy for<br />
each other and for consumers.<br />
We value honesty, openness and taking responsibility for our<br />
performance. We aim for and recognise innovation, quality<br />
and professionalism. All our staff remain firmly committed<br />
to our iCare values: integrity, compassion, accountability,<br />
respect, and excellence.<br />
We are continuing our commitment to conducting safety<br />
inspections with participation from <strong>Health</strong> and Safety<br />
Representatives and management. We are working to ensure<br />
ongoing consultation and engagement at all levels of <strong>Monash</strong><br />
<strong>Health</strong> to continuously improve our occupational health and<br />
safety performance.<br />
Staff numbers<br />
Labour category<br />
June<br />
YTD**<br />
FTE*<br />
June<br />
Current month<br />
FTE*<br />
<strong>2017</strong> 20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong><br />
Nursing Services 4,799 4,968 4,970 5,111<br />
Admin. & Clerical 1,624 1,698 1,681 1,771<br />
Medical Support Services 1,102 1,179 1,145 1,233<br />
Hotel & Allied Services 958 1,029 990 1,050<br />
Medical Officers <strong>18</strong>6 <strong>18</strong>8 191 192<br />
Hospital Medical Officer 978 1,054 1,015 1,079<br />
Sessional Med. Officers 324 348 330 373<br />
Ancilliary Support Serv. 948 1,016 987 1,042<br />
Grand Total 10,919 11,480 11,309 11,852<br />
*Full-time equivalent (FTE) staff at <strong>Monash</strong> <strong>Health</strong> and Jessie<br />
McPherson Private Hospital as at 30 June 20<strong>18</strong>.<br />
**Average monthly FTE for financial year.<br />
Occupational health and safety statement<br />
<strong>Monash</strong> <strong>Health</strong> is committed to providing a safe and healthy<br />
working environment for our employees, contractors,<br />
volunteers and the public and we take all reasonable steps<br />
to control hazards and minimise risk of injury.<br />
This year we have focused on the strategic approach of<br />
managing health and safety in the workplace with the<br />
development of our OHS Strategy 20<strong>18</strong> – 2023 and the<br />
Action Plan for 20<strong>18</strong>/2019. For the first time lead and lag<br />
OHS targets have been established for <strong>Monash</strong> <strong>Health</strong> and<br />
will be reported monthly to all levels of the organisation.<br />
<strong>Monash</strong> <strong>Health</strong> has continued with a proactive and<br />
supportive approach to occupational health and safety with<br />
a focus on support in the workplace. A series of eLearning<br />
modules have been developed for all staff and managers<br />
to increase awareness and provide guidance in completing<br />
tasks safely.<br />
We are continuing our commitment to conducting safety<br />
inspections with participation from HSRs and management<br />
to ensure consultation and engagement at all levels of<br />
<strong>Monash</strong> <strong>Health</strong>. All new initiatives seek to ensure <strong>Monash</strong><br />
<strong>Health</strong> continuously improves occupational health and<br />
safety performance.<br />
Occupational violence statistics<br />
WorkCover accepted claims with an<br />
occupational violence cause per 100<br />
FTE<br />
Number of accepted WorkCover<br />
claims with lost time injury with an<br />
occupational violence cause per<br />
1,000,000 hours worked<br />
Number of occupational violence<br />
incidents reported<br />
Number of occupational violence<br />
incidents reported per 100 FTE<br />
Percentage of occupational violence<br />
incidents resulting in a staff injury,<br />
illness or condition<br />
2016-17 <strong>2017</strong>-<strong>18</strong><br />
0.37 0.35<br />
2.17 1.71<br />
850 1327<br />
7.83 11.47<br />
4.71 38.43*<br />
*In previous years the percentage of occupational violence<br />
lost time injuries (LTIs) resulting in a staff injury, illness or<br />
condition were reported. This year the value includes all<br />
incidents not just LTIs.<br />
WorkCover claims<br />
Number of standard claims by year<br />
17<br />
-<strong>18</strong><br />
16<br />
-17<br />
15<br />
-16<br />
14<br />
-15<br />
13<br />
-14<br />
12<br />
-13<br />
11<br />
-12<br />
10<br />
-11<br />
09<br />
-10<br />
08<br />
-09<br />
07<br />
-08<br />
171 177 148 176 130 166 166 151 152 165 174<br />
Definitions<br />
For the purposes of the statistics the following<br />
definitions apply:<br />
Occupational violence – any incident where an employee is<br />
abused, threatened or assaulted in circumstances arising out<br />
of, or in the course of their employment;<br />
Incident – an event or circumstance that could have resulted<br />
in, or did result in, harm to staff;<br />
Accepted WorkCover claims – accepted WorkCover claims<br />
that were lodged in <strong>2017</strong>-<strong>18</strong>;<br />
Lost time – at least one shift lost due to a work related injury<br />
or illness;<br />
Injury, illness or condition – this includes all reported<br />
harm as a result of an incident, regardless of whether the<br />
employee required time off work or submitted a claim.<br />
38 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Clinical<br />
governance<br />
report<br />
<strong>Monash</strong> <strong>Health</strong> is a public health service; a body corporate<br />
established under Section 65P of the <strong>Health</strong> Services Act 1988,<br />
as amended in 2005 and listed in Schedule 5 of that Act.<br />
Excellence is our standard<br />
Our Clinical Governance Framework<br />
outlines the structure and processes,<br />
leadership, and culture that are in<br />
place and the outcomes monitored to<br />
ensure we provide accountable, safe,<br />
effective, efficient patient-centred care<br />
underpinned by continuous improvement.<br />
It is based on the Victorian Clinical<br />
Governance Framework (June <strong>2017</strong>)<br />
and the Australian Safety and<br />
Quality Framework for <strong>Health</strong>care<br />
(December 2010).<br />
Key quality indicators are available<br />
on dashboards customised for<br />
each ward, unit and program and<br />
prominently displayed on quality<br />
boards in all wards.<br />
The health service performance<br />
against pre-determined quality<br />
indicators are tracked and reported<br />
monthly to Clinical Council, <strong>Monash</strong><br />
<strong>Health</strong> Executive, and the <strong>Monash</strong><br />
<strong>Health</strong> Board.<br />
39
Environmental<br />
sustainability report<br />
<strong>Monash</strong> <strong>Health</strong> is committed to reducing our ecological<br />
footprint. Sustainability is one of the priorities of our<br />
20<strong>18</strong>-23 Strategic Plan.<br />
We recognise the compelling link<br />
between greenhouse gas emissions,<br />
climate change, and the resultant<br />
impact on our environment.<br />
<strong>Monash</strong> <strong>Health</strong> has committed<br />
to actively contribute to the<br />
implementation of the Victorian<br />
Government’s policy to be net zero<br />
carbon emissions by 2050 and improve<br />
environmental sustainability.<br />
Eco Champions Committee<br />
The <strong>Monash</strong> <strong>Health</strong> Eco Champions<br />
Committee has represented <strong>Monash</strong><br />
<strong>Health</strong> at the Victorian Green<br />
<strong>Health</strong> Round Table and Australian<br />
Nursing and Midwifery Federation<br />
Sustainability Conference.<br />
The Committee meets bimonthly<br />
with a comprehensive and growing<br />
representation inclusive of clinical and<br />
non-clinical staff.<br />
Their outcomes this year include:<br />
• Highlighting sustainability<br />
initiatives to encourage staff<br />
participation as well as to support<br />
sustainability messaging<br />
• Regular contributions to the<br />
internal staff newsletter, keeping<br />
communications contemporary<br />
and relevant<br />
• Development of training materials<br />
and displays to support staff<br />
education and promotion of<br />
environmental sustainability<br />
• Running Keep a Cup drives to<br />
further encourage staff to reduce the<br />
amount of disposable cups used in<br />
our facilities<br />
• Our retail providers continue to offer<br />
a discount to those staff who bring<br />
their own mug<br />
• Engineering continues to roll out our<br />
LED lighting program<br />
• Implementation of a building<br />
analytics program for <strong>Monash</strong><br />
Children’s Hospital to ensure early<br />
detection of any Heating, Ventilation<br />
and Air Conditioning faults<br />
• Employment of an energy<br />
performance management consultant<br />
to conduct a level 2 energy audit<br />
for <strong>Monash</strong> Medical Centre and<br />
Dandenong Hospital. This audit<br />
will identify any opportunities to<br />
improve our energy consumption<br />
for these facilities.<br />
The Minister<br />
for <strong>Health</strong> and<br />
Ambulance<br />
Services,<br />
The Hon Jill<br />
Hennessy<br />
MP, is the<br />
responsible<br />
Minister.<br />
40 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Bicycle Facilities<br />
<strong>Monash</strong> <strong>Health</strong> has invested to<br />
encourage our staff to ride to work by<br />
installing /maintaining a number of bike<br />
parking facilities and changing facilities.<br />
These include but are not limited to:<br />
• Undercover and secure bike<br />
parking for 78 bikes at <strong>Monash</strong><br />
Medical Centre<br />
• Curved hoops at Casey Hospital near<br />
the Emergency Department. These<br />
are also available for the public<br />
• Bike racks at Moorabbin and<br />
Dandenong Hospitals.<br />
Cleaning without chemicals<br />
Our Infection Control and Support<br />
Services team presented our ‘cleaning<br />
without chemicals’ approach to the New<br />
South Wales branch of the Australian<br />
Nursing and Midwifery Federation. The<br />
session provided nurses and midwifes<br />
with information on the program, how<br />
to make the change, and the benefits to<br />
using this system. The session received<br />
great feedback.<br />
Recycling initiatives<br />
<strong>Monash</strong> <strong>Health</strong> continues to explore<br />
opportunities to increase our recycling<br />
rate. Despite changes to the recycling<br />
waste industry <strong>Monash</strong> <strong>Health</strong> still<br />
managed to recycle 1,104 tonnes of<br />
waste. This is equates to around<br />
25% of all waste generated across<br />
<strong>Monash</strong> <strong>Health</strong>.<br />
In addition <strong>Monash</strong> <strong>Health</strong> utilizes<br />
reusable sharps containers which saves<br />
between 10-15 tonnes of plastic going<br />
into landfill per year.<br />
Our Dandenong and Clayton sites<br />
diverted 1.4 tonnes of single use<br />
instruments from our clinical waste<br />
stream. These are removed free of<br />
charge by a local metal recycler.<br />
Grass roots initiatives<br />
Passionate staff drive local sustainability<br />
efforts in their areas or sites to raise<br />
awareness and contribute to the<br />
reduction of our environmental impact.<br />
Some of the staff-led activities this<br />
year included:<br />
• Staff continuing to self-nominate to<br />
become sustainability champions in<br />
their own areas<br />
• Our theatres continue to review the<br />
content of their prepacked theatre<br />
packs to eliminate any unnecessary<br />
items and reduce waste. They have<br />
been successful in reducing the<br />
number of hand towels in each pack<br />
that were otherwise thrown out<br />
• Our Central Production Kitchen<br />
which produces over 7,500 meals per<br />
day, five days per week continued to<br />
work with their suppliers to reduce<br />
the amount of packaging coming into<br />
the facility switching from recyclable<br />
cardboard boxes to reusable plastic<br />
food crates for meat deliveries<br />
• Dandenong Theatre is now recycling<br />
their PVC – oxygen masks and<br />
plastic tubing<br />
• Paper reduction is supported by an<br />
ever expanding electronic access<br />
system to information/forms<br />
and learning materials. We have<br />
continued to roll QR readers for<br />
attendance records for training<br />
and meetings<br />
• The Asset Sales Program is now in its<br />
5th year. The program has recycled<br />
thousands of items, including<br />
kitchen, cleaning, workshop, audio<br />
visual, IT, medical and laboratory<br />
equipment that would otherwise have<br />
been waste disposed of in landfill.<br />
Installation of hand dryers<br />
An initiative to install hand dryers into<br />
high use public and staff toilets has<br />
commenced. These hand dryers are<br />
very energy efficient and result in a<br />
number of benefits including reducing<br />
the amount of paper hand towels<br />
used. This initiative also improves the<br />
presentation of our bathrooms with no<br />
hand towels being left on the floors,<br />
reducing slip hazards.<br />
Garden Maintenance<br />
The gardens at <strong>Monash</strong> <strong>Health</strong> are<br />
maintained by our engineering<br />
department to ensure consumers,<br />
visitors and staff are able to enjoy the<br />
beautiful and relaxing garden spaces.<br />
This year our engineering department<br />
has engaged an arborist to ensure our<br />
trees are well maintained.<br />
41
Our Board<br />
of Directors<br />
The Board of Directors of <strong>Monash</strong> <strong>Health</strong> is appointed by the Governor-<br />
In-Council on the recommendation of the Minister for <strong>Health</strong> and<br />
Ambulance Services in accordance with the <strong>Health</strong> Services Act 1988.<br />
Functions of the Board<br />
of Directors<br />
The functions of the Board are:<br />
• To monitor the performance of<br />
<strong>Monash</strong> <strong>Health</strong><br />
• To recommend the appointment<br />
of and determine the employment<br />
terms (including remuneration)<br />
of a Chief Executive<br />
• To oversee the management of<br />
<strong>Monash</strong> <strong>Health</strong> and monitor the<br />
performance of the Chief Executive<br />
• To develop statements of priorities<br />
and strategic plans for the operation<br />
of <strong>Monash</strong> <strong>Health</strong> and monitor<br />
their compliance<br />
• To develop financial and business<br />
plans, strategies and budgets to<br />
ensure accountable and efficient<br />
provision of health services by<br />
<strong>Monash</strong> <strong>Health</strong> and its long-term<br />
financial viability, as well as to<br />
ensure they are adhered to<br />
• To establish and maintain effective<br />
systems to ensure that health<br />
services meet the needs of the<br />
community served by <strong>Monash</strong><br />
<strong>Health</strong> and that the views of<br />
users and providers of health<br />
services are taken into account<br />
• To ensure that <strong>Monash</strong> <strong>Health</strong><br />
operates within its budget and that<br />
its systems accurately reflect its<br />
financial position and viability<br />
• To ensure effective and accountable<br />
systems are in place to monitor<br />
and improve the quality and<br />
effectiveness of health services<br />
provided by <strong>Monash</strong> <strong>Health</strong><br />
• To ensure any problems identified<br />
with the quality or effectiveness<br />
of the health services provided are<br />
addressed in a timely manner and<br />
that <strong>Monash</strong> <strong>Health</strong> continuously<br />
strives to improve the quality of the<br />
health services it provides and to<br />
foster innovation<br />
• To develop arrangements with<br />
other agencies and health service<br />
providers to enable effective and<br />
efficient service delivery and<br />
continuity of care<br />
• To establish the organisational<br />
structure, including the management<br />
structure, of <strong>Monash</strong> <strong>Health</strong><br />
• To establish and ensure the<br />
effectiveness of a Finance<br />
Committee, an Audit Committee,<br />
a Quality Committee, and other<br />
committees considered appropriate<br />
• To facilitate health research and<br />
education and any other functions<br />
conferred on the Board by or<br />
under the Act.<br />
Board committees<br />
The following committees support<br />
the functions of the Board of<br />
Directors:<br />
Quality Committee<br />
The purpose of the Quality Committee<br />
is to support the Board’s function<br />
of providing strategic leadership in<br />
relation to the clinical governance of<br />
quality and safety at <strong>Monash</strong> <strong>Health</strong>.<br />
It serves to ensure, on behalf of<br />
the Board, that the following broad<br />
objectives are fulfilled:<br />
• Effective and accountable systems<br />
are in place to monitor and improve<br />
the quality and effectiveness<br />
of health services provided by<br />
<strong>Monash</strong> <strong>Health</strong><br />
• Any problems identified with the<br />
quality or effectiveness of the health<br />
services provided are addressed in<br />
a timely manner<br />
• Ensure <strong>Monash</strong> <strong>Health</strong> continuously<br />
strives to improve the quality of the<br />
health services it provides and to<br />
foster innovation.<br />
Audit Committee<br />
The role of the Audit Committee is to<br />
advise the Board of Directors on audit<br />
matters and matters relating to the<br />
financial, accounting and legislative<br />
compliance, and the operational<br />
effectiveness and efficiency of<br />
<strong>Monash</strong> <strong>Health</strong>.<br />
The committee also advises the<br />
Board on the level of business risk or<br />
exposure to which <strong>Monash</strong> <strong>Health</strong><br />
might be subject and oversight of<br />
internal and external audit activities.<br />
Membership of the committee<br />
includes:<br />
• John Thomson Member 1 July 2016<br />
to 30 June 20<strong>18</strong><br />
• Charles Gillies Member 1 July 2016<br />
to 30 June 20<strong>18</strong><br />
• Sarah Ralph Member 2 March 2016<br />
to 30 June 20<strong>18</strong><br />
• Jorden Lam Member 2 March 2016<br />
to 30 June 20<strong>18</strong>.<br />
Remuneration Committee<br />
The principal role of the Remuneration<br />
Committee is to advise the Board<br />
of Directors on matters relating to<br />
the organisation’s remuneration<br />
policies and practices. In addition,<br />
the Remuneration Committee provides<br />
oversight with respect to succession<br />
planning for the Chief Executive and<br />
senior executive positions.<br />
42 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
43
Aboriginal <strong>Health</strong> Strategic<br />
Partnership Committee<br />
The Aboriginal <strong>Health</strong> Strategic<br />
Partnership Committee operates<br />
under the authority of the <strong>Monash</strong><br />
<strong>Health</strong> Board of Directors and the<br />
Dandenong and District Aborigines<br />
Co-operative Limited Board of<br />
Directors. The Aboriginal <strong>Health</strong><br />
Strategic Partnership Committee<br />
commenced in 2012 and was followed<br />
by a signing of the Statement of Intent<br />
and a Memorandum of Understanding<br />
between the two organisations.<br />
The purpose of the Aboriginal <strong>Health</strong><br />
Strategic Partnership Committee is<br />
to ensure a collaborative partnership<br />
between the Dandenong and District<br />
Aborigines Co-operative Limited and<br />
<strong>Monash</strong> <strong>Health</strong>.<br />
The intent is to ensure that by working<br />
closely together we are able to better<br />
meet the health and wellbeing needs<br />
of our local Aboriginal and Torres Strait<br />
Islander communities.<br />
The Aboriginal <strong>Health</strong> Strategic<br />
Partnership Committee shall:<br />
• Ensure accountability and leadership<br />
in relation to all Aboriginal and<br />
Torres Strait Islander health matters<br />
• Ensure a respectful and collaborative<br />
relationship between <strong>Monash</strong> <strong>Health</strong><br />
and the Aboriginal and Torres Strait<br />
Islander community<br />
• Oversee the implementation of<br />
the <strong>Monash</strong> <strong>Health</strong> Reconciliation<br />
Action Plan and Employment Plan<br />
• Identify shared strategic opportunities<br />
and projects<br />
• Monitor the <strong>Monash</strong> <strong>Health</strong> Aboriginal<br />
<strong>Health</strong> Data <strong>Report</strong> and relevant data<br />
from the Dandenong and District<br />
Aborigines Co-operative Limited<br />
• Support the Aboriginal <strong>Health</strong><br />
Working Group to achieve their goals.<br />
During FY <strong>2017</strong>-<strong>18</strong>, the committee<br />
has focussed on a few key priorities:<br />
Improving maternity and emergency<br />
care for Aboriginal and Torres Strait<br />
Islander people. Increasing Aboriginal<br />
employment at <strong>Monash</strong> <strong>Health</strong> has also<br />
been another key priority as we have a<br />
2 per cent Aboriginal and Torres Strait<br />
Islander employment target.<br />
Finance Committee<br />
The role of the Finance Committee<br />
is to advise the Board of Directors on<br />
financial matters and to assist in the<br />
oversight of financial performance.<br />
The Finance Committee reviews and<br />
makes recommendations to the Board<br />
regarding financial strategy, financial<br />
policies, annual operating and capital<br />
budgets, cash flow and business plans<br />
to ensure alignment with key strategic<br />
priorities and performance objectives.<br />
Community Advisory Committee<br />
The role of the Community Advisory<br />
Committee (CAC) is to provide<br />
direction and leadership to integrate<br />
consumer, carer, and community views<br />
into health services operations and<br />
strategic policy development; and<br />
to identify and advise the Board of<br />
Directors on priority areas and issues<br />
requiring a consumer, carer and/or<br />
community perspective.<br />
The last 12 months have been a period<br />
of change for the committee saying<br />
goodbye to a number of committee<br />
members including Peter McDonald,<br />
Halina Gwizdzil, Catherine Rampant,<br />
Reg Shelly, Judy Little, Peter Vant Hooft<br />
and Debbie Williams (Board member).<br />
We also welcomed a new chair<br />
Lynda Condon and new committee<br />
members Zuben Rustomjee, Julie<br />
Noorman, Shabnam Safa, and Emma<br />
Burt. Continuing on the committee<br />
are Sharon Harris, Pauline Hopkins and<br />
Betty Wilderman (Vice Chair). The<br />
CAC has appreciated the enormous<br />
support from the Board Chair Barbara<br />
Yeoh and her commitment to consumer<br />
engagement at <strong>Monash</strong> <strong>Health</strong>.<br />
Key Achievements<br />
• Successfully supported <strong>Monash</strong><br />
<strong>Health</strong> through the National<br />
Standards Accreditation process.<br />
Members were integral in National<br />
Standards planning, preparation<br />
and survey meeting with auditors<br />
to discuss the role and extent<br />
of consumer engagement and<br />
contributions to the many<br />
committees and working parties<br />
across the organisation<br />
• Engaged in the development of<br />
equity and inclusion definition for<br />
<strong>Monash</strong> <strong>Health</strong><br />
• Commenced work around the<br />
review of the consumer participation<br />
framework following engagement<br />
from Safer Care Victoria who<br />
is developing a new state-wide<br />
framework<br />
• Contributed to the strategic plan<br />
consultation process giving valuable<br />
feedback during key milestone<br />
points that have been incorporated<br />
into the plan<br />
• Providing feedback into the<br />
proposed <strong>Monash</strong> <strong>Health</strong> Volunteer<br />
Ward Ambassador program<br />
• Realignment of consumer<br />
representation on all of the<br />
organisations Clinical Governance<br />
Committees following the<br />
introduction of a new<br />
program structure.<br />
• Currently co designing an<br />
improvement project to enhance<br />
the experience of consumers in the<br />
Emergency Department<br />
• Completed CAC governance training<br />
• Drove the development of a new<br />
Consumer Advisor Orientation /<br />
On boarding program.<br />
Primary Care and Population<br />
<strong>Health</strong> Advisory Committee<br />
The Primary Care and Population<br />
<strong>Health</strong> Advisory Committee provides<br />
strategic advice to the Board of<br />
Directors on matters specific to the<br />
primary care and population health<br />
of our local community. Membership<br />
comprises primary care and academic<br />
partners in our region and members<br />
of the <strong>Monash</strong> <strong>Health</strong> Board and<br />
management.<br />
The committee has a particular focus<br />
on improving the health status of<br />
our community across focus areas<br />
such as the hospital primary care<br />
interface, models of care for high<br />
risk community members, health<br />
promotion, and, primary care research<br />
and education. In addition, there is a<br />
focus on the health and wellbeing of<br />
vulnerable groups such as refugees,<br />
Aboriginal and Torres Strait Islanders<br />
and culturally and linguistically diverse<br />
communities.<br />
The Primary Care and Population<br />
<strong>Health</strong> Advisory Committee<br />
has continued to provide strong<br />
leadership to the development<br />
and implementation of <strong>Monash</strong><br />
<strong>Health</strong>’s Chronic Disease Strategy<br />
Implementation Plan. This work builds<br />
on a foundation set in initial action<br />
areas of diabetes; chronic respiratory<br />
disease; management of advanced<br />
stage chronic disease; and oral health.<br />
Implementation of the strategy involves<br />
small collaborative cross-sector pilots<br />
in each area, bringing back key themes<br />
and learnings to inform initiatives to<br />
scale, and ultimately our healthcare<br />
system as a whole.<br />
44 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Members of the<br />
Board of Directors<br />
Ms Barbara Yeoh AM<br />
BSc (Hons), FAICD<br />
• Chair, <strong>Monash</strong> <strong>Health</strong> Board<br />
• Chair, Remuneration Committee<br />
• Member, Finance Committee<br />
• Chair, Board Quality Committee,<br />
June <strong>2017</strong><br />
• Member, Aboriginal <strong>Health</strong> Strategic<br />
Partnership Committee<br />
Term of appointment:<br />
July 2009 - 30 June 20<strong>18</strong>.<br />
Ms Barbara Yeoh has more than 30<br />
years experience as a director in both<br />
the public and private sectors across<br />
a broad range of industries. She is<br />
currently a Member of the AHPRA<br />
Agency Management Committee,<br />
Deputy Chair of the Victoria State<br />
Emergency Service and Deputy Chair of<br />
the Civil Aviation Safety Authority Audit<br />
Committee. Ms Yeoh is also a Principal<br />
Associate of Phillips KPA, specialist<br />
advisers to the education sector.<br />
In 2015, Ms Yeoh was inducted into<br />
the Victorian Honour Roll of Women<br />
and received the CEO Magazine<br />
Chairperson of the year award which<br />
encompasses the public, private and<br />
not for profit sectors.<br />
Mr Charles Gillies<br />
BSc/BA, MBA, SF Fin, GAICD<br />
• Chair, Finance Committee<br />
• Chair, Audit Committee<br />
• Member, Kitaya Holdings Board<br />
Pty Ltd*<br />
Term of appointment:<br />
July 2011 - current.<br />
Mr Charles Gillies is co-founder of<br />
Jolimont Global Mining Systems which<br />
specialises in investing in mining<br />
technology companies.<br />
These companies compete in fastmoving,<br />
highly competitive global<br />
technology markets. As an active<br />
investor himself his approach has been<br />
to work closely with management to<br />
develop a plan to create economic<br />
value. He has been Director and<br />
Chairman of a number of technology<br />
and investment companies and<br />
has worked closely with CEOs and<br />
management teams, developing<br />
strategies and setting objectives and<br />
performance targets.<br />
*Kitaya Holdings Pty Ltd operates Jessie<br />
McPherson Private Hospital.<br />
Ms Debbie Williams<br />
FAICD, MBA, ME, BCom, GradDip<br />
in <strong>Health</strong> Services Management<br />
• Chair, Primary Care and Population<br />
<strong>Health</strong> Advisory Committee<br />
• Member, Community Advisory<br />
Committee<br />
Term of appointment:<br />
July 2009 - June 20<strong>18</strong>.<br />
Ms Debbie Williams is a strategy<br />
consultant who brings extensive<br />
experience in healthcare management,<br />
corporate governance, business<br />
strategy development, mental<br />
health management and financial<br />
management. Ms Williams is President<br />
of Toy Libraries Australia.<br />
45
Mr Dipak Sanghvi<br />
• Member, Primary Care and<br />
Population <strong>Health</strong> Advisory<br />
Committee<br />
• Member, Finance Committee<br />
• Member, Kitaya Holdings Board Pty<br />
Ltd, March 20<strong>18</strong> to June 20<strong>18</strong><br />
Term of appointment:<br />
June 2016 - current.<br />
Mr Dipak Sanghvi is a pharmacist<br />
who owns five pharmacies in Victoria.<br />
He is currently Chair of Member<br />
Benefits Australia Pty Ltd. Previous<br />
positions held include: President of<br />
the Pharmacy Guild Victoria Branch<br />
during 2006-2011, Chair of Gold Cross<br />
Products and Services Pty Ltd, Chair of<br />
Return of Unwanted Medicines, being<br />
a Board member of Guild Insurance<br />
and Superannuation, and Meridian<br />
Lawyers; as well as several other board<br />
positions in the community<br />
and pharmaceutical industry.<br />
Ms Heather Cleland<br />
MBBS, FRACS (Plas)<br />
• Member, Quality Committee<br />
Term of appointment:<br />
July 2016 - current.<br />
Ms Heather Cleland is a Plastic<br />
Surgeon who is currently head of<br />
the state-wide Victorian Adult Burns<br />
Service at the Alfred Hospital. In<br />
addition to clinical practice and service<br />
development, she is actively involved<br />
in clinical education, training, and<br />
research. She has been instrumental in<br />
establishing the clinical quality Burns<br />
Registry of Australia and New Zealand,<br />
and chairs its steering committee. She<br />
is a Board member of the Australian<br />
and New Zealand Burns Association<br />
and Past President. She has served on<br />
various departmental and professional<br />
committees, and is a member of the<br />
Donor Tissue Bank Committee of<br />
the Victorian Institute of Forensic<br />
Medicine, member of the Court of<br />
Examiners of the Royal Australasian<br />
College of Surgeons and an Adjunct<br />
Senior Lecturer at <strong>Monash</strong> University.<br />
Ms Jorden Lam<br />
LLM, LLB, BCom, GradDipLP,<br />
GAICD, SA Fin.<br />
• Member, Audit Committee<br />
• Member, Community Advisory<br />
Committee<br />
Term of appointment:<br />
October 2016 - current.<br />
Ms Jorden Lam is the Company<br />
Secretary & General Counsel at HESTA<br />
Super Fund, and also serves on the<br />
Board of BreastScreen Victoria and<br />
the Policy Committee of Women<br />
in Super. She has also previously<br />
served on the Community Advisory<br />
Committee for Ambulance Victoria.<br />
She is experienced in the development<br />
and implementation of corporate<br />
governance frameworks, regularly<br />
advises on director and trustee duties<br />
and is passionate about achieving high<br />
standards of governance practice in<br />
organisations. Ms Lam has previously<br />
practiced as a commercial lawyer<br />
with several leading firms, advising<br />
corporations across a range of complex<br />
matters. In 2015 she was a recipient<br />
of the Australian Financial Review’s<br />
“Young Executive of the Year Award”.<br />
46 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Dr Misty Jenkins<br />
BSc (Hons), PhD, MAICD<br />
• Member, Quality Committee<br />
• Member, Aboriginal <strong>Health</strong> Strategic<br />
Partnership Committee<br />
Term of appointment:<br />
November 2016 - current.<br />
Dr Misty Jenkins is a NHMRC fellow,<br />
biomedical scientist and laboratory<br />
head at Walter and Eliza Hall Institute<br />
for Medical Research, where she<br />
researches cellular immunology<br />
and new immunotherapies for<br />
cancer. Dr Jenkins has previously<br />
held postdoctoral positions at The<br />
Universities of Cambridge and Oxford,<br />
and The Peter MacCallum Cancer<br />
Centre in Melbourne. Dr Jenkins was<br />
awarded the L’Oreal for Women in<br />
Science Fellowship (2013), was Tall<br />
Poppy of the year (2015) and won the<br />
Westpac/Australian Financial Review<br />
Top100 Women of Influence award<br />
(2016). In addition to her research<br />
career, Dr Jenkins brings experience in<br />
governance as a Director and Deputy<br />
Chair of The National Centre for<br />
Indigenous Genomics at ANU, previous<br />
Director of the Aurora Education<br />
Foundation, Ambassador for the<br />
Poche Centre for Indigenous <strong>Health</strong><br />
and Chair of NHMRC Project Grant<br />
Review Panels.<br />
Ms Sarah Ralph<br />
BA, LLB, LLM<br />
• Member, Audit Committee<br />
• Member, Primary Care and<br />
Population <strong>Health</strong> Advisory<br />
Committee<br />
Term of appointment:<br />
November 2016 - current.<br />
Ms Sarah Ralph is a partner of global<br />
law firm, Norton Rose Fulbright. Ms<br />
Ralph has practiced in employment<br />
and labour law for over 20 years and<br />
leads the firm’s national government<br />
practice. Ms Ralph regularly acts for<br />
public and private sector employers<br />
in complex employment matters<br />
including in the health sector. Ms<br />
Ralph’s experience includes working<br />
in government and the private sector<br />
in strategic and legal roles. Ms Ralph<br />
is a volunteer member of the Youth<br />
Support and Advocacy Service (YSAS)<br />
Risk and Audit Committee. Ms Ralph<br />
brings her experience in people<br />
management, corporate governance,<br />
and risk management to the Board.<br />
Emeritus Professor Hatem<br />
Salem AM<br />
MB, ChB (Mosul, Iraq), FRACP,<br />
FRCPA, MRCP (UK) MD (<strong>Monash</strong>),<br />
LRCP, MRCS.<br />
• Chair, Quality Committee<br />
Term of appointment:<br />
1 August <strong>2017</strong> - current.<br />
Hatem Salem is an Emeritus Professor<br />
at <strong>Monash</strong> University. Prior to this,<br />
Professor Salem was the Head of the<br />
Academic Department of Clinical<br />
Haematology at <strong>Monash</strong> University<br />
and the Head of Clinical Haematology<br />
at the Alfred Hospital. He served as<br />
President of Asia Pacific Society of<br />
Thrombosis and Haemostasis and past<br />
president and Executive Director of the<br />
Australasian Society of Thrombosis<br />
and Hemostasis. He is a senior<br />
Counsellor of the International Society<br />
of Thrombosis and Haemostasis.<br />
In 2005, his vision and ability to<br />
develop leading clinical and research<br />
programs was recognised by the<br />
Victorian Government’s Public<br />
<strong>Health</strong>care Award, where he<br />
was the recipient of the <strong>Health</strong><br />
Minister’s Award for Outstanding<br />
Individual Achievement.<br />
In 2010, Professor Hatem Salem was<br />
awarded the Member of the Order of<br />
Australia (AM) for service to medicine<br />
in the field of haematology as a<br />
clinician, educator and researcher and<br />
also through the establishment of the<br />
Australian Centre for Blood Diseases.<br />
47
Statutory<br />
compliance<br />
Carers Recognition Act 2012<br />
<strong>Monash</strong> <strong>Health</strong> is committed to<br />
partnering with and empowering<br />
our consumers.<br />
We understand that our consumers,<br />
their families and carers need to play<br />
an active role in their own healthcare<br />
and in helping us improve the quality<br />
and safety of our services.<br />
We take all practicable measures to<br />
ensure our employees and agents<br />
reflect the care relationship principles<br />
in developing, providing or evaluating<br />
support and assistance for persons in<br />
care relationships.<br />
The <strong>Monash</strong> <strong>Health</strong> Consumer and<br />
Community Participation Policy<br />
provides an organisation-wide<br />
framework describing our approach<br />
to embedding relationship centred<br />
care and partnerships in our culture,<br />
recognising that everyone in the<br />
organisation has an impact on patient,<br />
family, carer and consumer experience.<br />
Partnering with Consumers for an<br />
Exceptional Patient Experience<br />
education is mandatory for all new<br />
<strong>Monash</strong> <strong>Health</strong> staff both clinical and<br />
non-clinical. Our learning tools draw<br />
particular attention to the needs of<br />
carers and families.<br />
<strong>Monash</strong> <strong>Health</strong> reports on how we<br />
engage with our consumers, their<br />
families and carers in the annual<br />
Quality of Care <strong>Report</strong>. That report is<br />
available on our website: http://www.<br />
monashhealth.org/page/monash_<br />
health_quality_account<br />
There are no disclosures required to<br />
be made under the Carers Recognition<br />
Act 2012.<br />
Compliance with the<br />
Building Act 1993<br />
<strong>Monash</strong> <strong>Health</strong> facilities are managed<br />
through site inspections, risk<br />
assessments and audits. Contracts are<br />
in place to maintain Essential Safety<br />
Measures and annual compliance<br />
audited by independent Registered<br />
Building Surveyors.<br />
Building standards and<br />
condition assessments<br />
The condition of our buildings is<br />
assessed through site inspections<br />
and condition audits by architects<br />
and consultant engineers on an ‘as<br />
needed’ basis. Fire audits and risk<br />
assessments are undertaken by<br />
consultant fire engineers to comply<br />
with the Department of <strong>Health</strong> and<br />
Human Services Fire Risk Management<br />
Guidelines Series 7.<br />
Recommendations from fire audits are<br />
actioned through a series of projects<br />
developed in conjunction with the<br />
Department of <strong>Health</strong> and Human<br />
Services to maintain a high degree of<br />
fire safety. All bed-based facilities are<br />
audited on a five-yearly cycle.<br />
Fire safety audits<br />
The five-yearly fire safety audit of<br />
<strong>Monash</strong> <strong>Health</strong>’s 12 bed based facilities<br />
was completed in June 20<strong>18</strong>.<br />
Essential safety measures<br />
maintenance<br />
Contracts are in place to maintain all<br />
Essential Safety Measures elements at<br />
sites owned by <strong>Monash</strong> <strong>Health</strong>. Audits<br />
were performed at these sites by<br />
registered Building Surveyors to ensure<br />
compliance with Essential Safety<br />
Measures Maintenance regulations.<br />
Action plans to rectify defects<br />
identified during the audits<br />
are currently in place. In accordance<br />
with regulatory requirements, service<br />
and maintenance records are kept<br />
to enable completion of an annual<br />
Essential Safety Measures <strong>Report</strong> for<br />
all properties owned by <strong>Monash</strong><br />
<strong>Health</strong>. This provides confirmation<br />
that all Essential Safety Measures<br />
are operational at the required<br />
level of performance for the safety<br />
of these facilities.<br />
Risk assessment<br />
Victorian Managed Insurance Authority<br />
(VMIA) conducts site risk assessments<br />
(SRS) at <strong>Monash</strong> Medical Centre,<br />
Moorabbin Hospital, Kingston Centre,<br />
and Dandenong Hospital.<br />
Risk treatment options generated from<br />
the SRS are monitored through action<br />
plans until they are completed.<br />
Freedom of Information<br />
Act 1982<br />
Summary of requests received under<br />
the Act from 1 July <strong>2017</strong> to 30 June<br />
20<strong>18</strong>.<br />
Other (no documents found) 15<br />
Other (not proceeded with) 25<br />
Application fee not paid 0<br />
Not yet finalised 90<br />
Exemptions cited – total 230<br />
Clause:<br />
25 1<br />
25A(5) 3<br />
30(1) <strong>18</strong><br />
32(1) 6<br />
33(1) 119<br />
33(2)(A) 3<br />
33(4) 1<br />
33(4)(a) 0<br />
35(1)(a) 0<br />
35(1)(b) 56<br />
38 24<br />
48 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Fees and charges<br />
Application fees collected<br />
Application fees waived<br />
Copy charges collected<br />
$40,271.20<br />
$12,439.20<br />
$66,987.00<br />
Copy charges waived $7,640.30<br />
Initial decision makers<br />
Rachael Gillies, Release of Information<br />
Manager; Maija Dimits, <strong>Health</strong><br />
Information Manager; Elaine Elliott,<br />
<strong>Health</strong> Information Manager; Monika<br />
Bosnich, <strong>Health</strong> Information Manager;<br />
Tammy O’Connor, Senior Corporate<br />
Counsel; and Elle Bethune, Corporate<br />
Counsel.<br />
National Competition Policy<br />
<strong>Monash</strong> <strong>Health</strong> continued to comply<br />
with the Victorian Government’s<br />
Competitive Neutrality Policy. In<br />
addition, the Victorian Government’s<br />
Neutrality Pricing Principles for all<br />
relevant business activities have<br />
been applied by <strong>Monash</strong> <strong>Health</strong><br />
since 1 July 1988.<br />
Protected Disclosures<br />
Act 2012<br />
<strong>Monash</strong> <strong>Health</strong> has a procedure for<br />
protected disclosures and matters<br />
of this nature are referred to the<br />
Independent Broad-based Anti-<br />
Corruption Commission. Information<br />
is included in the ‘Patients & Visitors/<br />
Concerns and compliments’ section<br />
of the <strong>Monash</strong> <strong>Health</strong> Internet site<br />
for external parties and internally our<br />
staff policies and procedures provide<br />
direction for staff.<br />
Safe Patient Care Act 2015<br />
<strong>Monash</strong> <strong>Health</strong> has no matters to<br />
report in relation to its obligations<br />
under section 40 of the Safe Patient<br />
Care Act 2015.<br />
Victorian Industry<br />
Participation Policy Act 2003<br />
The following information for contracts<br />
commenced and/or completed in the<br />
financial year must be disclosed under<br />
the Victorian Industry Participation<br />
Policy (VIPP) Act 2003 (Refer to FRD<br />
25C Local Jobs First-Victorian Industry<br />
Participation Policy Disclosures in the<br />
<strong>Report</strong> of Operations):<br />
• Two contracts valued at $22M were<br />
commenced but not completed in<br />
the financial year for which a VIPP<br />
Plan was required;<br />
• Six contracts valued at $22.1M were<br />
commenced but not completed<br />
where a VIPP Plan was not required<br />
(due to nil to limited contestability)<br />
1. Four are local by nature; and<br />
2. Two are international by nature;<br />
• Eight conversations were held with<br />
the Industry Capability Network that<br />
correspond with the registration and<br />
issue of an Interaction Reference<br />
Number.<br />
Additional information<br />
available on request<br />
In accordance with FRD 22H, <strong>Monash</strong><br />
<strong>Health</strong> confirms the items listed below<br />
have been retained by <strong>Monash</strong> <strong>Health</strong><br />
and are available to the relevant<br />
Ministers, Members of Parliament and<br />
the public on request (subject to the<br />
freedom of information requirements,<br />
if applicable):<br />
a. Declarations of pecuniary interests<br />
have been duly completed by all<br />
relevant officers;<br />
b. Details of shares held by senior<br />
officers as nominee or held<br />
beneficially;<br />
c. Details of publications produced by<br />
the entity about itself, and how these<br />
can be obtained;<br />
d. Details of changes in prices, fees,<br />
charges, rates and levies charged by<br />
the <strong>Health</strong> Service;<br />
e. Details of any major external reviews<br />
carried out on the <strong>Health</strong> Service;<br />
f. Details of major research and<br />
development activities undertaken<br />
by the <strong>Health</strong> Service that are<br />
not otherwise covered either in<br />
the report of operations or in a<br />
document that contains the financial<br />
statements and report of operations;<br />
g. Details of overseas visits undertaken<br />
including a summary of the<br />
objectives and outcomes of each<br />
visit;<br />
h. Details of major promotional, public<br />
relations and marketing activities<br />
undertaken by the <strong>Health</strong> Service to<br />
develop community awareness of<br />
the <strong>Health</strong> Service and its services;<br />
i. Details of assessments and<br />
measures undertaken to improve the<br />
occupational health and safety of<br />
employees;<br />
j. A general statement on industrial<br />
relations within the <strong>Health</strong> Service<br />
and details of time lost through<br />
industrial accidents and disputes,<br />
which is not otherwise detailed in<br />
the report of operations;<br />
k. A list of major committees<br />
sponsored by the <strong>Health</strong> Service, the<br />
purposes of each committee and the<br />
extent to which those purposes have<br />
been achieved;<br />
l. Details of all consultancies and<br />
contractors including consultants/<br />
contractors engaged, services<br />
provided, and expenditure<br />
committed for each engagement.<br />
49
Disclosure index<br />
The <strong>Annual</strong> <strong>Report</strong> of <strong>Monash</strong> <strong>Health</strong> is prepared in accordance<br />
with all relevant Victorian legislation. This index has been prepared<br />
to facilitate identification of the Department’s compliance with<br />
statutory disclosure requirements.<br />
Legislation Requirement Page reference<br />
Charter and purpose<br />
FRD 22H Manner of establishment & relevant Ministers 39, 40<br />
FRD 22H Purpose, functions, powers and duties 2 & 5<br />
FRD 22H Initiatives and key achievements 6 & 7<br />
FRD 22H Nature and range of services provided 28<br />
Management and structure<br />
FRD 22H Organisational structure 34 & 35<br />
Financials and other information<br />
FRD 10A Disclosure index 50 & 51<br />
FRD 11A Disclosure of ex-gratia expenses 131<br />
FRD 21C Responsible person and executive officer disclosures 52<br />
FRD 22H Application and operation of Protected Disclosure 2012 49<br />
FRD 22H Application and operation of Carers Recognition Act 2012 48<br />
FRD 22H Application and operation of Freedom of Information Act 1982 48, 49<br />
FRD 22H<br />
Compliance with building and maintenance provisions of<br />
Building Act 1993<br />
48<br />
FRD 22H Details of consultancies over $10,000 63<br />
FRD 22H Details of consultancies under $10,000 63<br />
FRD 22H Employment and conduct principles 38<br />
FRD 22H Information and Communications Technology Expenditure 63<br />
FRD 22H Major changes or factors affecting performance 67<br />
FRD 22H Occupational violence 38<br />
FRD 22H<br />
Operational and budgetary objectives and performance<br />
against objectives<br />
56-57<br />
FRD 22H Summary of the entity’s environmental performance 40, 41<br />
FRD 22H Significant changes in financial position during the year 62<br />
50 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Legislation Requirement Page reference<br />
FRD 22H Statement on National Competition Policy 49<br />
FRD 22H Subsequent events 130<br />
FRD 22H Summary of the financial results for the year 62<br />
FRD 22H Additional information available on request 49<br />
FRD 22H<br />
Workforce Data Disclosures including a statement on the<br />
application of employment and conduct principles<br />
38<br />
FRD 25C Victorian Industry Participation Policy disclosures 49<br />
FRD 103F Non-Financial Physical Assets 94<br />
FRD 110A Cash flow statements 74<br />
FRD 112D Defined Benefit Superannuation Obligations 91<br />
SD 5.2.3 Declaration in report of operations 52<br />
SD 5.1.4 Financial Management Compliance Attestation 52<br />
Other requirements under Standing Directions 5.2<br />
SD 5.2.2 Declaration in financial statements 68<br />
SD 5.2.1(a)<br />
Compliance with Australian accounting standards and other<br />
authoritative pronouncements<br />
69-70<br />
SD 5.2.1(a) Compliance with Ministerial Directions 68<br />
Legislation<br />
Freedom of Information Act 1982 48 & 49<br />
Protected Disclosure Act 2012 49<br />
Carers Recognition Act 2012 48<br />
Victorian Industry Participation Policy Act 2003 49<br />
Building Act 1993 48<br />
Financial Management Act 1994 52<br />
Safe Patient Care Act 2015 49<br />
51
Attestations<br />
Data Integrity<br />
I, Andrew Stripp certify that <strong>Monash</strong><br />
<strong>Health</strong> has put in place appropriate<br />
internal controls and processes to<br />
ensure that reported data accurately<br />
reflects actual performance. <strong>Monash</strong><br />
<strong>Health</strong> has critically reviewed these<br />
controls and processes during the year.<br />
Andrew Stripp<br />
Chief Executive<br />
<strong>Monash</strong> <strong>Health</strong><br />
17 August 20<strong>18</strong><br />
Conflict of Interest<br />
I, Andrew Stripp, certify that <strong>Monash</strong><br />
<strong>Health</strong> has put in place appropriate<br />
internal controls and processes to<br />
ensure that it has complied with the<br />
requirements of hospital circular<br />
07/<strong>2017</strong> Compliance reporting in health<br />
portfolio entities (Revised) and has<br />
implemented a ‘Conflict of Interest’<br />
policy consistent with the minimum<br />
accountabilities required by the VPSC.<br />
Declaration of private interest forms<br />
have been completed by all executive<br />
staff within <strong>Monash</strong> <strong>Health</strong> and<br />
members of the board, and all declared<br />
conflicts have been addressed and are<br />
being managed. Conflict of interest is<br />
a standard agenda item for declaration<br />
and documenting at each executive<br />
board meeting.<br />
Compliance with <strong>Health</strong><br />
Purchasing Victoria (HPV)<br />
<strong>Health</strong> Purchasing Policies<br />
I, Andrew Stripp certify that <strong>Monash</strong><br />
<strong>Health</strong> has put in place appropriate<br />
internal controls and processes to<br />
ensure that it has complied with<br />
all requirements set out in the HPV<br />
<strong>Health</strong> Purchasing Policies including<br />
mandatory HPV collective agreements<br />
as required by the <strong>Health</strong> Services Act<br />
1988 (Vic) and has critically reviewed<br />
these controls and processes during<br />
the year.<br />
Andrew Stripp<br />
Chief Executive<br />
<strong>Monash</strong> <strong>Health</strong><br />
17 August 20<strong>18</strong><br />
Financial Management<br />
Compliance attestation<br />
I, Mr Dipak Sanghvi, on behalf of the<br />
Board certify that <strong>Monash</strong> <strong>Health</strong> has<br />
complied with the applicable Standing<br />
Directions of the Minister of Finance<br />
under the Financial Management Act<br />
1994 and Instructions.<br />
Mr Dipak Sanghvi<br />
Chair, Board of Directors<br />
Melbourne<br />
17 August 20<strong>18</strong><br />
Responsible bodies<br />
declarations<br />
In accordance with the Financial<br />
Management Act 1994, I am pleased<br />
to present the report of operations for<br />
<strong>Monash</strong> <strong>Health</strong> for the year ending 30<br />
June 20<strong>18</strong>.<br />
Mr Dipak Sanghvi<br />
Chair, Board of Directors<br />
Melbourne<br />
17 August 20<strong>18</strong><br />
Andrew Stripp<br />
Chief Executive<br />
<strong>Monash</strong> <strong>Health</strong><br />
17 August 20<strong>18</strong><br />
52 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Statement of<br />
Priorities - Part A<br />
<strong>Health</strong> Service Deliverables<br />
Help people stay healthy by completing the<br />
<strong>Monash</strong> <strong>Health</strong> Integrated <strong>Health</strong> Promotion<br />
Plan to improve alignment of health promotion<br />
activities, including our refugee health services<br />
and therefore health outcomes for disadvantaged<br />
population groups through improved collaboration<br />
of organisations across <strong>Monash</strong> <strong>Health</strong>’s<br />
catchment area.<br />
Build healthy neighbourhoods by establishing<br />
a regional Chronic Disease coalition with<br />
community partners including Primary <strong>Health</strong><br />
Networks, general practice, community health<br />
and consumers in line with the <strong>Monash</strong> <strong>Health</strong><br />
Chronic Disease Strategy.<br />
Target health gaps by continuing the<br />
implementation of <strong>Health</strong> Links – Chronic Care<br />
(<strong>Monash</strong> Watch) and evaluate to inform the future<br />
platform of service delivery.<br />
Reduce state-wide risks by implementing a Family<br />
Violence Education Plan in <strong>Monash</strong> <strong>Health</strong>’s<br />
emergency departments to improve support for<br />
victims of family violence; initially measured by<br />
the number of staff trained to respond.<br />
Ensure fair access by establishing a contemporary<br />
elective surgery model of care including<br />
implementing pre-procedural care that is<br />
standardised and transparent in delivery, reducing<br />
the number of consumers whom are: on the<br />
elective surgery waitlist; and, on the elective<br />
surgery waitlist longer than their clinically<br />
recommended time.<br />
Improve timely access to care by implementing a<br />
standardised model of care across <strong>Monash</strong> <strong>Health</strong><br />
emergency departments, focusing on upfront<br />
senior decision making and timely progression<br />
of care to improve the number of emergency<br />
consumers whom are: transferred from ambulance<br />
to emergency department within clinically<br />
recommended time; and, seen within the clinically<br />
recommended time.<br />
Status<br />
indicator<br />
Achieved<br />
Achieved<br />
Achieved<br />
Achieved<br />
In progress<br />
In progress<br />
Comment<br />
The Integrated <strong>Health</strong> Promotion Plan is<br />
complete and was submitted to the Department<br />
of <strong>Health</strong> and Human Services.<br />
In partnership with representatives of South<br />
Eastern Melbourne Primary Care Partnership and<br />
Southern <strong>Health</strong> Connect progress is underway<br />
against work plan milestones.<br />
The <strong>Health</strong> Links – Chronic Care (<strong>Monash</strong> Watch)<br />
evaluation report is complete.<br />
Development of a Victorian Integrated Care<br />
Model will be undertaken in consideration of the<br />
<strong>Health</strong> Care Home Trial in south east Melbourne,<br />
in partnership with the South Eastern Melbourne<br />
Primary <strong>Health</strong> Network.<br />
Family Violence Education Plan is implemented in<br />
<strong>Monash</strong> <strong>Health</strong>’s emergency departments.<br />
234 Emergency Department staff have received<br />
family violence education comprising 42<br />
registrars and 192 nurses. A comprehensive<br />
training program continues.<br />
The new peri-operative co-ordinator model<br />
practices consistently across all specialties<br />
and the Treatment in Turn and Prioritisation of<br />
Review work is complete. The time taken to treat<br />
consumers continues to decrease.<br />
The redesign program of work will continue in<br />
20<strong>18</strong>-19.<br />
The Prioritising Patient Care Pathway has<br />
been implemented and the Upfront Senior<br />
Decision Making model is in the process of<br />
implementation across all three emergency<br />
departments.<br />
Ambulance Victoria offload performance has<br />
progressively improved since the beginning of<br />
the year, as has the number of presentations seen<br />
within clinically recommended triage times.<br />
The redesign program of work will continue in<br />
20<strong>18</strong>-19.<br />
53
<strong>Health</strong> Service Deliverables<br />
Ensure fair access by developing and commencing<br />
implementation of a specialist consulting<br />
clinics redesign plan to ensure that clinics run<br />
efficiently and effectively, increasing the number<br />
of consumers who attend their first appointment<br />
within the recommended time.<br />
Improve access by enhancing partnerships with<br />
residential care facilities to provide optimal in<br />
home care with a view to provide better care and<br />
prevent unnecessary emergency department<br />
admissions.<br />
Plan and invest in the redesign of the <strong>Monash</strong><br />
Medical Centre emergency department to provide<br />
appropriate segregation for adult, paediatric and<br />
mental health patients.<br />
Plan and invest in commencing construction of<br />
the Casey Hospital expansion, in line with the<br />
construction program.<br />
Unlock innovation by implementing an emergency<br />
department interactive dashboard to increase<br />
visibility of patient flow across <strong>Monash</strong> <strong>Health</strong>.<br />
Unlock innovation by further developing the<br />
Mental <strong>Health</strong> Hospital In the Home service<br />
provided through Casey Hospital.<br />
Improve the traffic flows at Clayton through a<br />
redesign in collaboration with Vic Roads and local<br />
council.<br />
Unlock innovation by increasing access to care,<br />
teaching and research through the <strong>Monash</strong><br />
Children’s Telesurgery Service to regional<br />
operating theatres and emergency departments<br />
at Latrobe Regional Hospital, Central Gippsland<br />
<strong>Health</strong> Service and Bairnsdale Regional <strong>Health</strong><br />
Service.<br />
Strengthen the workforce by establishing<br />
interdisciplinary ward leadership teams to<br />
enhance local quality and safety improvement<br />
initiatives and the oversight of routine clinical<br />
practice.<br />
Status<br />
indicator<br />
In progress<br />
Achieved<br />
Achieved<br />
Achieved<br />
Achieved<br />
Achieved<br />
Achieved<br />
Achieved<br />
Achieved<br />
Comment<br />
Specialist Consulting redesign work is well<br />
underway, including: minimising risks associated<br />
with delays to care through redesigning e-referral<br />
management; clinic demand and capacity<br />
planning; improved data management and<br />
reporting; and, significant expansion of the<br />
telehealth specialist consulting program.<br />
The redesign program of work will continue in<br />
20<strong>18</strong>-19.<br />
In partnership with South Eastern Melbourne<br />
Primary <strong>Health</strong> Network a new model was<br />
implemented to coordinate aged care services<br />
between hospital and aged care facilities.<br />
<strong>Monash</strong> <strong>Health</strong> has increased its outreach<br />
services to residential aged care in alignment<br />
with Department of <strong>Health</strong> and Human Services<br />
mandatory reporting and HIP guidelines.<br />
The design is progressing on schedule for the<br />
construction work to be tendered in early 2019.<br />
Construction work is on track for the project<br />
to be completed in late 2019.<br />
The emergency department Power Business<br />
Intelligence interactive dashboard is operational<br />
across the three <strong>Monash</strong> <strong>Health</strong> emergency<br />
departments.<br />
Hospital in the Home activity for the Casey<br />
sector of <strong>Monash</strong> <strong>Health</strong> increased by greater<br />
than 25% in <strong>2017</strong>-<strong>18</strong>.<br />
The traffic redesign has been approved by<br />
VicRoads and the City of <strong>Monash</strong>. Design<br />
documentation is on schedule for tender in<br />
early 2019.<br />
The <strong>Monash</strong> Children’s telehealth service has<br />
increased access to care, teaching and research<br />
by increasing the number of telesurgery<br />
specialities, the number of consults, the number<br />
of calls to people’s homes, and the support<br />
provided in the Gippsland region by general<br />
practitioners, paediatricians, and allied health<br />
practitioners.<br />
The new ward governance model has<br />
commenced across <strong>Monash</strong> <strong>Health</strong> sites, with<br />
leadership teams formed, and program and ward<br />
quality and safety dashboards, available on both<br />
the quality boards in place in all wards and on<br />
the electronic quality and safety dashboards<br />
accessible via the intranet.<br />
54 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
<strong>Health</strong> Service Deliverables<br />
Strengthen the role and leadership of nurse<br />
managers through allocation of additional<br />
management time and education and training.<br />
Strengthen the workforce by developing a fivetier<br />
education strategy to address occupational<br />
violence and aggression incidents (and<br />
implement): online training for managers to<br />
address bullying and inappropriate behaviour;<br />
and, online training for all employees which<br />
includes processes for reporting patient and<br />
employee safety concerns and escalation.<br />
Prevent avoidable harm by developing and<br />
implementing a formal online training package to<br />
educate staff members that have patient contact<br />
on their obligations to report patient safety<br />
concerns, as measured by the number of staff<br />
trained and an increase in the number of reported<br />
incidents.<br />
Partner with consumers to put quality first by<br />
addressing priorities arising from the outcomes<br />
of the Victorian <strong>Health</strong>care Experience Survey:<br />
• Discharge planning:<br />
Transition hospital to home: Implement “My<br />
Passport” and Teach Back training across adult<br />
inpatient wards and paediatrics.<br />
• Environment: Implement redesigned ward<br />
upgrade and cleaning programs for adult<br />
inpatient wards at <strong>Monash</strong> Medical Centre.<br />
• Food services: Develop and implement a plan<br />
to address key drivers of the patient food<br />
experience, to commence implementation at<br />
<strong>Monash</strong> Medical Centre.<br />
Status<br />
indicator<br />
Achieved<br />
Achieved<br />
In progress<br />
In progress<br />
Achieved<br />
In progress<br />
Comment<br />
Nurse managers of 24 hour 7 day services have<br />
transitioned to full-time management positions.<br />
A new governance structure for all nurse<br />
managers is established and ongoing education<br />
and support is in place.<br />
The occupational violence and aggression<br />
strategy, work plan and training are developed<br />
and accessible to all employees.<br />
Implementation of the Department of <strong>Health</strong> and<br />
Human Services training is in progress, and will<br />
continue into 20<strong>18</strong>-19.<br />
The rollout of “My Passport” and Teach Back<br />
training was completed for 24 wards across<br />
<strong>Monash</strong> <strong>Health</strong>, and will continue into 20<strong>18</strong>-19.<br />
Redesigned ward upgrades and cleaning<br />
programs for adult inpatient wards at <strong>Monash</strong><br />
Medical Centre were completed.<br />
The plan is developed and implementation has<br />
commenced in accordance with the work plan.<br />
55
Statement of<br />
Priorities B<br />
High Quality and Safety indicator<br />
Target<br />
<strong>2017</strong>-20<strong>18</strong><br />
Result<br />
Accreditation<br />
Compliance with NSQHS Standard accreditation Full Compliance Achieved<br />
Infection prevention and control<br />
Compliance with Hand Hygiene Australia program >=80% 81%<br />
% of <strong>Health</strong> care worker immunised for influenza >=75% 78.0%<br />
Patient experience<br />
Victorian <strong>Health</strong>care Experience Survey - Percentage of positive patient<br />
experience reponses Quarter1<br />
Victorian <strong>Health</strong>care Experience Survey - Percentage of positive patient<br />
experience reponses Quarter2<br />
Victorian <strong>Health</strong>care Experience Survey - Percentage of positive patient<br />
experience reponses Quarter3<br />
Victorian <strong>Health</strong>care Experience Survey - Percentage of positive responses to<br />
questions on discharge care Quarter1<br />
Victorian <strong>Health</strong>care Experience Survey - Percentage of positive responses to<br />
questions on discharge care Quarter2<br />
Victorian <strong>Health</strong>care Experience Survey - Percentage of positive responses to<br />
questions on discharge care Quarter3<br />
Victorian <strong>Health</strong>care Experience Survey - Patients perception of cleanliness<br />
Quarter1<br />
Victorian <strong>Health</strong>care Experience Survey - Patients perception of cleanliness<br />
Quarter2<br />
Victorian <strong>Health</strong>care Experience Survey - Patients perception of cleanliness<br />
Quarter3<br />
>=95% 88.4%<br />
>=95% 89.6%<br />
>=95% 85.6%<br />
>= 75% 70.4%<br />
>= 75% 72.3%<br />
>= 75% 68.5%<br />
>= 70% 59.2%<br />
>= 70% 59.8%<br />
>= 70% 58.0%<br />
<strong>Health</strong>care associated infections<br />
Number of patients with surgical site infection No outliers Not Achieved<br />
ICU CLABSI (central line-associated blood stream infection) per 1000 line days -<br />
Clayton<br />
ICU CLABSI (central line-associated blood stream infection) per 1000 line days -<br />
Dandenong<br />
Nil 0.70<br />
Nil 0.00<br />
SAB rate (Occupied Bed days)
Target<br />
<strong>2017</strong>-20<strong>18</strong><br />
Result<br />
Adverse events<br />
Number of sentinel events Nil 10<br />
Mortality – number of deaths in low mortality DRGs2 Nil 0.02%<br />
Mental <strong>Health</strong><br />
Percentage of adult inpatients who are readmitted within 28 days of discharge =.65(Rehab) 0.79<br />
Governance, leadership and culture - % of Staff with positive response to questions<br />
Staff with an overall positive response to safety culture question >=80% 90%<br />
I am encouraged by my colleagues to report any patient safety concerns I may have >=80% 95%<br />
Patient care errors are handled appropriately in my work area >=80% 94%<br />
My suggestions about patient safety would be acted upon if I expressed them<br />
to my manager<br />
>=80% 91%<br />
The culture in my work area makes it easy to learn from the errors of others >=80% 87%<br />
Management is driving us to be a safety-centred organisation >=80% 93%<br />
This health service does a good job of training new and existing staff >=80% 82%<br />
Trainees in my discipline are adequately supervised >=80% 83%<br />
I would recommend a friend or relative to be treated as a patient here >=80% 91%<br />
57
Access and timelines<br />
Target<br />
<strong>2017</strong>-20<strong>18</strong><br />
Result<br />
Emergency Care<br />
Emergency - Casey Hospital<br />
Percentage of ambulance patients transferred within 40 minutes >=90% 76.0%<br />
Percentage of Triage Category 1 emergency patients seen immediately 100% 100.0%<br />
Percentage of Triage Categories 1-5 emergency patients seen within clinical<br />
recommended times<br />
>=80% 64.2%<br />
Percentage of emergency patients with length of stay less than 4 hours >=81% 70.8%<br />
Number of patients with a length of stay in the emergency department greater<br />
than 24 hours<br />
0 2<br />
Emergency - <strong>Monash</strong> Medical Centre<br />
Percentage of ambulance patients transferred within 40 minutes >=90% 72.0%<br />
Percentage of Triage Category 1 emergency patients seen immediately 100% 100.0%<br />
Percentage of Triage Categories 1-5 emergency patients seen within clinical<br />
recommended times<br />
>=80% 60.0%<br />
Percentage of emergency patients with length of stay less than 4 hours >=81% 58.1%<br />
Number of patients with a length of stay in the emergency department greater<br />
than 24 hours<br />
0 5<br />
Emergency - Dandenong Hospital<br />
Percentage of ambulance patients transferred within 40 minutes >=90% 72.5%<br />
Percentage of Triage Category 1 emergency patients seen immediately 100% 100.0%<br />
Percentage of Triage Categories 1-5 emergency patients seen within clinical<br />
recommended times<br />
>=80% 67.6%<br />
Percentage of emergency patients with length of stay less than 4 hours >=81% 64.2%<br />
Number of patients with a length of stay in the emergency department greater<br />
than 24 hours<br />
0 7<br />
Elective Surgery<br />
Percentage of Urgency Category 1 elective patients removed within 30 days 100% 100%<br />
Percentage of urgency category 1, 2 and 3 elective patients admitted within<br />
clinically recommended timeframes<br />
% patients on the waiting list who have waited longer than clinically<br />
recommended time for their respective triage category<br />
>=94% 86.4%<br />
Target<br />
<strong>2017</strong>-20<strong>18</strong><br />
Result<br />
Specialist Clinics<br />
Percentage of urgent patients referred by a GP or external specialist<br />
who attended a first appointment within 30 days<br />
Percentage of non-urgent patients referred by a GP or external specialist<br />
who attended a first appointment within 365 days<br />
100% 50.3%<br />
>=90% 96.5%<br />
Financial sustainability<br />
Target<br />
<strong>2017</strong>-20<strong>18</strong><br />
Result<br />
Finance<br />
YTD Operating Result ($m) $0.00 $0.04<br />
Trade creditors =14 days 11 days<br />
* GEM is Geriatric Evaluation and Management<br />
59
Statement of<br />
Priorities C<br />
Activity and Funding<br />
<strong>2017</strong>-<strong>18</strong> Activity<br />
Achievement<br />
Acute Admitted<br />
WIES Public 156,400<br />
WIES Private 15,975<br />
WIES (Public & Private) 172,375<br />
WIES DVA 579<br />
WIES TAC 740<br />
WIES TOTAL 173,694<br />
Acute Non-Admitted<br />
Home Enternal Nutrition 4,245<br />
Home Renal Dialysis - Home ABF 167<br />
Radiotherapy Non Admitted Shared Care 138<br />
Specialist Clinics - Public 223,703<br />
Home Perinatal Nutrition 157<br />
Subacute and Non-Acute Admitted<br />
Subacute WIES - Rehabilitation Public 2,678<br />
Subacute WIES - Rehabilitation Private/TAC/Workcover 442<br />
Subacute WIES - GEM Public 1,809<br />
Subacute WIES - GEM Private/TAC/Workcover 316<br />
Subacute WIES - Palliative Care Public 408<br />
Subacute WIES - Palliative Care Private 51<br />
Subacute WIES - DVA 60<br />
Transition Care - Occupied Bed days 17,331<br />
Transition Care - Home day 10,176<br />
60 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
<strong>2017</strong>-<strong>18</strong> Activity<br />
Achievement<br />
Subacute Non-Admited<br />
<strong>Health</strong> Independent Program - Public 194,152<br />
Aged Care<br />
Residential Aged Care 33,524<br />
HACC - Service Time Hours 51,594<br />
Mental <strong>Health</strong> ( Occupied Beddays) and Drug Services<br />
Mental <strong>Health</strong> Ambulatory 158,019<br />
Mental <strong>Health</strong> Inpatient - Available bed days 58,725<br />
Mental <strong>Health</strong> Inpatient - Secure Unit 16,384<br />
Mental <strong>Health</strong> Residential 44,984<br />
MH - Subacute 14,929<br />
Drug services 1,771<br />
Primary <strong>Health</strong><br />
Community <strong>Health</strong>/Primary Care Program -Service Time Hours 95,009<br />
Other<br />
NFC- Pancreas Transplants 14<br />
<strong>Health</strong> Workforce 562<br />
61
Summary of financial results<br />
20<strong>18</strong><br />
$’000<br />
<strong>2017</strong><br />
$’000<br />
2016<br />
$’000<br />
2015<br />
$’000<br />
2014<br />
$’000<br />
Total Revenue 1,882,391 1,850,870 1,751,695 1,512,402 1,450,332<br />
Total Expenses 1,877,401 1,754,104 1,647,800 1,528,277 1,428,992<br />
Net Result for the Year (inc. Capital<br />
and Specific Items)<br />
15 107,457 103,895 -15,875 21,340<br />
Retained Surplus/(Accumulate Deficit) 127,978 133,689 32,982 -67,073 -50,995<br />
Total Assets 1,813,045 1,715,387 1,591,476 1,420,199 1,405,432<br />
Total Liabilities 583,887 522,107 505,698 463,422 433,922<br />
Net Assets 1,229,158 1,193,280 1,085,778 956,777 971,510<br />
Total Equity 1,229,158 1,193,280 1,085,778 956,777 971,510<br />
Average collection days<br />
20<strong>18</strong> <strong>2017</strong> 2016 2015 2014<br />
Private 40 46 48 50 43<br />
Transport Accident Commission - - - - -<br />
Victorian WorkCover Authority (VWA) 67 98 96 127 117<br />
Nursing Home 41 38 37 28 26<br />
Inpatient debtors ageing<br />
90<br />
days<br />
<strong>2017</strong>-<br />
<strong>18</strong><br />
2016-<br />
17<br />
2015-<br />
16<br />
2014-<br />
15<br />
2013-<br />
14<br />
Private 1,839 675 67 238 2,8<strong>18</strong> 4,401 4,029 3,652 3,652<br />
Transport Accident<br />
Commission<br />
Victorian WorkCover<br />
Authority (VWA)<br />
- - - - - - - - -<br />
211 46 60 134 452 352 530 160 160<br />
Nursing Home 346 63 33 121 563 642 801 650 538<br />
Total 2,574 1,544 440 835 3,833 5,394 5,361 4,930 4,350<br />
62 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Disclosure<br />
Details of Information and Communication Technology (ICT) expenditure<br />
The total ICT expenditure incurred during <strong>2017</strong>-<strong>18</strong> is $54.6 million (excluding GST) with the details shown below:<br />
BAU ICT<br />
Expenditure<br />
Total (excluding<br />
GST)<br />
($’000)<br />
Non-BAU ICT<br />
Expenditure<br />
Total = A+B<br />
(Excluding GST)<br />
($’000)<br />
Operational<br />
Expenditure<br />
A (Excluding GST)<br />
($’000)<br />
Capital Expenditure<br />
B (Excluding GST)<br />
($’000)<br />
$30,135 $24,479 $241 $24,238<br />
<strong>2017</strong>-<strong>18</strong> Disclosure of Consultancy Expenditure<br />
Details of consultancies (under $10,000)<br />
In <strong>2017</strong>-<strong>18</strong>, there were 28 consultancies where the total fees payable to the consultants were less than $10,000.<br />
The total expenditure incurred during <strong>2017</strong>-<strong>18</strong> in relation to these consultancies is $117,288 (excluding GST).<br />
Details of consultancies (valued at $10,000 or greater)<br />
In <strong>2017</strong>-<strong>18</strong>, there were 23 consultancies where the total fees payable to the consultants were $10,000 or greater.<br />
The total expenditure incurred during <strong>2017</strong>-<strong>18</strong> in relation to these consultancies is $1,587,973 (excluding GST).<br />
Details of these consultancies are listed below.<br />
Consultants 20<strong>18</strong> <strong>2017</strong> 2016 2015 2014<br />
Consultants’ cost ($) 1,587,973 1,228,225 996,437 1,265,500 2,051,811<br />
Total number of consultants 51 107 140 80 115<br />
63
Consultant<br />
Purpose of<br />
Consultancy<br />
Start<br />
date<br />
End<br />
date<br />
Total<br />
approved<br />
project fee<br />
($’000)<br />
Expenditure<br />
<strong>2017</strong>-20<strong>18</strong><br />
($’000)<br />
Ernst & Young<br />
Internal Audit and FBT<br />
Services<br />
1/07/17 30/06/<strong>18</strong> 669 669<br />
Press Ganey Associates<br />
Pty Ltd<br />
Inpatient Surveying Consulting 1/07/17 30/06/<strong>18</strong> <strong>18</strong>7 <strong>18</strong>7<br />
Senateshj<br />
Information technology<br />
consulting<br />
1/07/17 30/06/<strong>18</strong> 88 88<br />
Pharmconsult Pty Ltd Consulting on Pharmacy 1/07/17 30/06/<strong>18</strong> 68 68<br />
Madison Cross Australia<br />
Pty Ltd<br />
<strong>Health</strong> Connexion<br />
Innovative Thinking It Unit<br />
Trust<br />
Consulting for Organisational<br />
Growth and Development<br />
Consulting for Transition<br />
Support Unit<br />
Information technology<br />
consulting<br />
1/07/17 30/06/<strong>18</strong> 58 58<br />
1/07/17 30/06/<strong>18</strong> 54 54<br />
1/07/17 30/06/<strong>18</strong> 52 52<br />
The Ideal Consultancy<br />
Pty Ltd<br />
Marketing Consulting 1/07/17 30/06/<strong>18</strong> 47 47<br />
Mkm <strong>Health</strong> Pty Limited<br />
Information technology<br />
consulting<br />
1/07/17 30/06/<strong>18</strong> 45 45<br />
Cetec Pty Ltd Workplace safety review 1/07/17 30/06/<strong>18</strong> 45 45<br />
Francis Group Consultants<br />
Aust Pty Ltd<br />
Project consulting 1/07/17 30/06/<strong>18</strong> 44 44<br />
Carney Associates Strategic Planning consulting 1/07/17 30/06/<strong>18</strong> 36 36<br />
Opturion Pty Ltd<br />
Pitcher Partners<br />
Information technology<br />
consulting<br />
Information technology<br />
consulting<br />
1/07/17 30/06/<strong>18</strong> 34 34<br />
1/07/17 30/06/<strong>18</strong> 30 30<br />
Aquaklar Analytical<br />
Supplies<br />
Workplace safety review 1/07/17 30/06/<strong>18</strong> 23 23<br />
Alison Evans Consulting Strategic Planning consulting 1/07/17 30/06/<strong>18</strong> <strong>18</strong> <strong>18</strong><br />
Simpply<br />
Information technology<br />
consulting<br />
1/07/17 30/06/<strong>18</strong> 16 16<br />
64 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Consultant<br />
Purpose of<br />
Consultancy<br />
Start<br />
date<br />
End<br />
date<br />
Total<br />
approved<br />
project fee<br />
($’000)<br />
Expenditure<br />
<strong>2017</strong>-20<strong>18</strong><br />
($’000)<br />
Hardes And Associates<br />
Consulting for Organisational<br />
Growth and Development<br />
1/07/17 30/06/<strong>18</strong> 15 15<br />
Novoture Pty Ltd Workplace Culture Review 1/07/17 30/06/<strong>18</strong> 14 14<br />
Margaret Charlton<br />
Consulting for Organisational<br />
Growth and Development<br />
1/07/17 30/06/<strong>18</strong> 13 13<br />
Disability Services<br />
Consulting<br />
Cwh Mediation<br />
& Workplace<br />
Insurance Scheme Review 1/07/17 30/06/<strong>18</strong> 13 13<br />
Workplace Review 1/07/17 30/06/<strong>18</strong> 10 10<br />
Hambleton Family Trust Workplace Review 1/07/17 30/06/<strong>18</strong> 10 10<br />
Advertising<br />
<strong>Monash</strong> <strong>Health</strong> made no expenditure in Government advertising.<br />
Car parking<br />
<strong>Monash</strong> <strong>Health</strong> complies with the Department of <strong>Health</strong> and Human Services hospital circular on car parking fees and details<br />
of car parking fees and concession benefits can be viewed at: https://www2.health.vic.gov.au/about/news-and-events/<br />
hospitalcirculars/circ0515<br />
<strong>Monash</strong> <strong>Health</strong>’s car parking fees and concession benefits can be found at: www.monashhealth.org<br />
65
Financial<br />
statements<br />
and explanatory<br />
notes<br />
66 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
67
68 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Independent Auditor’s <strong>Report</strong><br />
To the Board of <strong>Monash</strong> <strong>Health</strong><br />
Opinion<br />
I have audited the consolidated financial report of <strong>Monash</strong> <strong>Health</strong> (the health service) and its<br />
controlled entities (together the consolidated entity), which comprises the:<br />
• consolidated entity and health service balance sheet as at 30 June 20<strong>18</strong><br />
• consolidated entity and health service comprehensive operating statement for the year then<br />
ended<br />
• consolidated entity and health service statement of changes in equity for the year then ended<br />
• consolidated entity and health service cash flow statement for the year then ended<br />
• notes to the financial statements, including significant accounting policies<br />
• board member's, chief executive's and chief financial officer's declaration.<br />
In my opinion, the financial report presents fairly, in all material respects, the financial position of<br />
the consolidated entity and the health service as at 30 June 20<strong>18</strong> and their financial performance<br />
and cash flows for the year then ended in accordance with the financial reporting requirements of<br />
Part 7 of the Financial Management Act 1994 and applicable Australian Accounting Standards.<br />
Basis for<br />
Opinion<br />
I have conducted my audit in accordance with the Audit Act 1994 which incorporates the Australian<br />
Auditing Standards. I further describe my responsibilities under that Act and those standards in the<br />
Auditor’s Responsibilities for the Audit of the Financial <strong>Report</strong> section of my report.<br />
My independence is established by the Constitution Act 1975. My staff and I are independent of the<br />
health service and the consolidated entity in accordance with the ethical requirements of the<br />
Accounting Professional and Ethical Standards Board’s APES 110 Code of Ethics for Professional<br />
Accountants (the Code) that are relevant to my audit of the financial report in Victoria. My staff and<br />
I have also fulfilled our other ethical responsibilities in accordance with the Code.<br />
I believe that the audit evidence I have obtained is sufficient and appropriate to provide a basis for<br />
my opinion.<br />
Board’s<br />
responsibilities<br />
for the<br />
financial<br />
report<br />
The Board of the health service is responsible for the preparation and fair presentation of the<br />
financial report in accordance with Australian Accounting Standards and the Financial Management<br />
Act 1994, and for such internal control as the Board determines is necessary to enable the<br />
preparation and fair presentation of a financial report that is free from material misstatement,<br />
whether due to fraud or error.<br />
In preparing the financial report, the Board is responsible for assessing the health service and the<br />
consolidated entity’s ability to continue as a going concern, disclosing, as applicable, matters related<br />
to going concern and using the going concern basis of accounting unless it is inappropriate to do so.<br />
69
Auditor’s<br />
responsibilities<br />
for the audit<br />
of the financial<br />
report<br />
As required by the Audit Act 1994, my responsibility is to express an opinion on the financial report<br />
based on the audit. My objectives for the audit are to obtain reasonable assurance about whether<br />
the financial report as a whole is free from material misstatement, whether due to fraud or error,<br />
and to issue an auditor’s report that includes my opinion. Reasonable assurance is a high level of<br />
assurance, but is not a guarantee that an audit conducted in accordance with the Australian Auditing<br />
Standards will always detect a material misstatement when it exists. Misstatements can arise from<br />
fraud or error and are considered material if, individually or in the aggregate, they could reasonably<br />
be expected to influence the economic decisions of users taken on the basis of this financial report.<br />
As part of an audit in accordance with the Australian Auditing Standards, I exercise professional<br />
judgement and maintain professional scepticism throughout the audit. I also:<br />
• identify and assess the risks of material misstatement of the financial report, whether due to<br />
fraud or error, design and perform audit procedures responsive to those risks, and obtain<br />
audit evidence that is sufficient and appropriate to provide a basis for my opinion. The risk of<br />
not detecting a material misstatement resulting from fraud is higher than for one resulting<br />
from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations,<br />
or the override of internal control.<br />
• obtain an understanding of internal control relevant to the audit in order to design audit<br />
procedures that are appropriate in the circumstances, but not for the purpose of expressing<br />
an opinion on the effectiveness of the health service and the consolidated entity’s internal<br />
control<br />
• evaluate the appropriateness of accounting policies used and the reasonableness of<br />
accounting estimates and related disclosures made by the Board<br />
• conclude on the appropriateness of the Board's use of the going concern basis of accounting<br />
and, based on the audit evidence obtained, whether a material uncertainty exists related to<br />
events or conditions that may cast significant doubt on the health service and the<br />
consolidated entity’s ability to continue as a going concern. If I conclude that a material<br />
uncertainty exists, I am required to draw attention in my auditor’s report to the related<br />
disclosures in the financial report or, if such disclosures are inadequate, to modify my<br />
opinion. My conclusions are based on the audit evidence obtained up to the date of my<br />
auditor’s report. However, future events or conditions may cause the health service and the<br />
consolidated entity to cease to continue as a going concern.<br />
• evaluate the overall presentation, structure and content of the financial report, including the<br />
disclosures, and whether the financial report represents the underlying transactions and<br />
events in a manner that achieves fair presentation<br />
• obtain sufficient appropriate audit evidence regarding the financial information of the entities<br />
or business activities within the health service and consolidated entity to express an opinion<br />
on the financial report. I remain responsible for the direction, supervision and performance of<br />
the audit of the health service and the consolidated entity. I remain solely responsible for my<br />
audit opinion.<br />
I communicate with the Board regarding, among other matters, the planned scope and timing of the<br />
audit and significant audit findings, including any significant deficiencies in internal control that I<br />
identify during my audit.<br />
MELBOURNE<br />
20 August 20<strong>18</strong><br />
Ron Mak<br />
as delegate for the Auditor-General of Victoria<br />
70 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong><br />
2
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
<strong>Monash</strong> <strong>Health</strong><br />
Comprehensive Operating Statement<br />
For the Financial Year Ended 30 June 20<strong>18</strong><br />
Note Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Revenue from operating activities 2.1 1,776,667 1,667,804<br />
Revenue from non-operating activities 2.1 3,709 2,759<br />
Employee expenses 3.1 (1,299,663) (1,210,884)<br />
Non salary labour costs 3.1 (19,151) (16,447)<br />
Supplies and consumables 3.1 (262,011) (268,549)<br />
Commercial activities 3.1 (62,215) (54,898)<br />
Other expenses 3.1 (137,384) (119,897)<br />
Share of net result of associates and joint ventures accounted for<br />
using the equity method 87 147<br />
Net result before capital and specific items 39 35<br />
Capital purpose income 2.1 101,928 <strong>18</strong>0,160<br />
Depreciation and amortisation 4.3 (77,310) (67,063)<br />
Specific expenses 3.3 (372) (667)<br />
Finance costs 3.4 (3,547) (3,739)<br />
Finance costs - self funded activity 3.4 (1,670) (1,734)<br />
Bad and doubtful debts expense 3.1 (2,762) -<br />
Expenditure using capital purpose income 3.1 (11,316) (10,226)<br />
4,951 96,731<br />
Net result after capital and specific items 4,990 96,766<br />
Other economic flows included in net result<br />
Revaluation of long service leave (4,975) 10,691<br />
Total other economic flows included in net result (4,975) 10,691<br />
Net result for the year 15 107,457<br />
Other comprehensive income<br />
Items that will not be reclassified to net result<br />
Changes in property, plant and equipment revaluation surplus 8.1a 35,000 -<br />
Total other comprehensive income 35,000 -<br />
Comprehensive result 35,015 107,457<br />
This Statement should be read in conjunction with the accompanying notes.<br />
71
<strong>Monash</strong> <strong>Health</strong><br />
Balance Sheet<br />
For the Financial Year Ended 30 June 20<strong>18</strong><br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Current assets<br />
Cash and cash equivalents 6.2 160,932 116,009<br />
Receivables 5.1 42,771 47,582<br />
Inventories 5.2 17,320 15,742<br />
Prepayments 2,087 2,893<br />
Total current assets 223,110 <strong>18</strong>2,226<br />
Non-current assets<br />
Receivables 5.1 90,917 81,717<br />
Investments accounted for using the equity method 4.1 4,099 4,012<br />
Property, plant and equipment 4.2 1,490,954 1,443,956<br />
Intangible assets 4.4 3,965 3,476<br />
Total non-current assets 1,589,935 1,533,161<br />
TOTAL ASSETS 1,813,045 1,715,387<br />
Current liabilities<br />
Payables 5.4 90,222 81,217<br />
Borrowings 6.1 7,781 6,161<br />
Provisions 3.5 320,839 279,912<br />
Other current liabilities 5.3 15,044 12,619<br />
Total current liabilities 433,887 379,909<br />
Non-current liabilities<br />
Borrowings 6.1 85,797 83,4<strong>18</strong><br />
Provisions 3.5 64,204 58,780<br />
Total non-current liabilities 150,001 142,198<br />
TOTAL LIABILITIES 583,887 522,107<br />
NET ASSETS 1,229,158 1,193,280<br />
EQUITY<br />
Property, plant and equipment revaluation surplus 8.1a 676,545 641,545<br />
Restricted specific purpose surplus 8.1a 20,715 14,953<br />
Contributed capital 8.1b 403,920 403,093<br />
Accumulated surpluses 8.1c 127,978 133,689<br />
TOTAL EQUITY 1,229,158 1,193,280<br />
This Statement should be read in conjunction with the accompanying notes.<br />
72 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
<strong>Monash</strong> <strong>Health</strong><br />
Statement of Changes in Equity<br />
For the Financial Year Ended 30 June 20<strong>18</strong><br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Consolidated Property, Plant<br />
& Equipment<br />
Revaluation<br />
Surplus<br />
Restricted<br />
Specific<br />
Purpose<br />
Surplus<br />
Contributed<br />
Capital<br />
Accumulated<br />
Surpluses<br />
Total<br />
Note $'000 $'000 $'000 $'000 $'000<br />
Balance at 1 July 2016 641,545 8,203 403,048 32,982 1,085,778<br />
Net result for the year 8.1c - - - 107,457 107,457<br />
Transfer (from)/to accumulated surpluses 8.1a,c - 6,750 - (6,750) -<br />
Contributed capital from the Victorian Government 8.1b - - 45 - 45<br />
Balance at 30 June <strong>2017</strong> 641,545 14,953 403,093 133,689 1,193,280<br />
Net result for the year 8.1c - - - 15 15<br />
Other comprehensive income for the year 8.1a 35,000 - - - 35,000<br />
Transfer (from)/to accumulated surpluses 8.1a,c - 5,762 - (5,762) -<br />
Prior year reclassification from subsidiary - - - 36 36<br />
Contributed capital from the Victorian Government - - 827 - 827<br />
Balance at 30 June 20<strong>18</strong> 676,545 20,715 403,920 127,978 1,229,158<br />
This Statement should be read in conjunction with the accompanying notes.<br />
73
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
<strong>Monash</strong> <strong>Health</strong><br />
Cash Flow Statement<br />
For the Financial Year Ended 30 June 20<strong>18</strong><br />
Note Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
CASH FLOWS FROM OPERATING ACTIVITIES<br />
Operating grants from Government 1,528,862 1,441,631<br />
Capital grants from Government 52,966 1<strong>18</strong>,650<br />
Patient fees received 139,195 115,194<br />
Private hospital fees received 47,517 47,929<br />
Donations and bequests received 7,407 1,791<br />
GST received from ATO 35,101 38,016<br />
Recoupment from private practice for use of hospital facilities 12,987 11,696<br />
Interest and Investment income received 3,710 2,759<br />
Other receipts 36,178 53,102<br />
Total receipts 1,863,923 1,830,768<br />
Employee expenses paid (1,268,805) (1,213,970)<br />
Payments for supplies and consumables (282,833) (292,088)<br />
Finance costs (1,670) (1,734)<br />
Other payments (231,562) (211,354)<br />
Total payments (1,784,870) (1,719,146)<br />
NET CASH FLOW FROM OPERATING ACTIVITIES 8.2 79,053 111,622<br />
CASH FLOWS FROM INVESTING ACTIVITIES<br />
Purchase of intangibles, property, plant and equipment (44,908) (72,109)<br />
NET CASH FLOW USED IN INVESTING ACTIVITIES (44,908) (72,109)<br />
CASH FLOWS FROM FINANCING ACTIVITIES<br />
Repayment of car park loan (1,647) (1,048)<br />
Loan from government 10,000 -<br />
NET CASH FLOW USED IN FINANCING ACTIVITIES 8,353 (1,048)<br />
NET INCREASE IN CASH AND CASH EQUIVALENTS HELD 42,498 38,466<br />
Cash and cash equivalents at beginning of year 103,390 64,925<br />
CASH AND CASH EQUIVALENTS AT END OF FINANCIAL YEAR<br />
6.2 145,888 103,390<br />
This Statement should be read in conjunction with the accompanying notes.<br />
74 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 1: Summary of Significant Accounting Policies<br />
These annual financial statements represent the audited general purpose financial statements<br />
for <strong>Monash</strong> <strong>Health</strong> and its controlled entities for the year ended 30 June 20<strong>18</strong>. The report<br />
provides users with information about <strong>Monash</strong> <strong>Health</strong>’s stewardship of resources entrusted to it.<br />
(a) Statement of Compliance<br />
These financial statements are general purpose financial statements which have been prepared<br />
in accordance with the Financial Management Act 1994 and applicable AAS, which include<br />
interpretations issued by the Australian Accounting Standards Board (AASB). They are<br />
presented in a manner consistent with the requirements of AASB 101 Presentation of Financial<br />
Statements .<br />
The financial statements also comply with relevant Financial <strong>Report</strong>ing Directions (FRDs) issued<br />
by the Department of Treasury and Finance, and relevant Standing Directions (SDs) authorised<br />
by the Minister for Finance.<br />
<strong>Monash</strong> <strong>Health</strong> is a not-for-profit entity and therefore applies the additional paragraphs<br />
applicable to "not-for-profit" <strong>Health</strong> Services under the AASBs.<br />
The annual financial statements were authorised for issue by the Board of <strong>Monash</strong> <strong>Health</strong> on 17<br />
August 20<strong>18</strong>.<br />
(b) <strong>Report</strong>ing Entity<br />
The financial statements include all the controlled activities of <strong>Monash</strong> <strong>Health</strong>.<br />
Its principal address is:<br />
246 Clayton Road<br />
Clayton, Victoria 3168<br />
A description of the nature of <strong>Monash</strong> <strong>Health</strong>’s operations and its principal activities is included<br />
in the report of operations, which does not form part of these financial statements.<br />
Objectives and Funding<br />
<strong>Monash</strong> <strong>Health</strong>’s overall objective is to provide quality, patient-centred health care that meets<br />
the needs of the community through a vision of exceptional care, outstanding outcomes, key<br />
strategic goals of putting patients first, driving innovation, partnering strategically, leading in<br />
sustainable healthcare as well as to improve the quality of life for Victorians.<br />
<strong>Monash</strong> <strong>Health</strong> is predominantly funded by accrual based grant funding for the provision of<br />
services.<br />
(c) Basis of Accounting Preparation and Measurement<br />
These financial statements are presented in Australian dollars and the historical cost<br />
convention is used unless a different measurement basis is specifically disclosed in the note<br />
associated with the item measured on a different basis.<br />
The accounting policies have been applied in preparing the financial statements for the year<br />
ended 30 June 20<strong>18</strong>, and the comparative information presented in these financial statements<br />
for the year ended 30 June <strong>2017</strong>.<br />
Accounting policies are selected and applied in a manner which ensures that the resulting<br />
financial information satisfies the concepts of relevance and reliability, thereby ensuring that<br />
the substance of the underlying transactions or other events is reported.<br />
The financial statements are prepared on a going concern basis (refer to Note 8.11 Economic<br />
Dependency).<br />
All amounts shown in the financial statements have been rounded to the nearest thousand<br />
dollars, unless otherwise stated. Minor discrepancies in tables between totals and sum of<br />
components are due to rounding.<br />
75
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 1: Summary of Significant Accounting Policies (continued)<br />
(c) Basis of Accounting Preparation and Measurement (continued)<br />
Consistent with the requirements of AASB 1004 Contributions contributed capital and its<br />
repayment are treated as equity transactions and, therefore, do not form part of the income and<br />
expenses of <strong>Monash</strong> <strong>Health</strong>.<br />
Additions to net assets which have been designated as contributions by owners are recognised as<br />
contributed capital. Other transfers that are in the nature of contributions to or distributions by<br />
owners have also been designated as contributions by owners.<br />
<strong>Monash</strong> <strong>Health</strong> operates on a fund accounting basis and maintains three funds: Operating, Specific<br />
Purpose and Capital Funds. <strong>Monash</strong> <strong>Health</strong>'s Capital and Specific Purpose Funds include unspent<br />
donations and receipts from fund-raising activities conducted solely in respect of these funds.<br />
The financial statements, except for the cash flow statement, have been prepared using the accrual<br />
basis of accounting. Under the accrual basis, items are recognised as assets, liabilities, equity,<br />
income or expenses when they satisfy the definitions and recognition criteria for those items, that<br />
is, they are recognised in the reporting period to which they relate, regardless of when cash is<br />
received or paid.<br />
The financial statements are prepared in accordance with the historical cost convention, except for:<br />
● Non-current physical assets which, subsequent to acquisition, are measured at a revalued<br />
amount being their fair value at the date of the revaluation less any subsequent accumulated<br />
depreciation and subsequent impairment losses. Revaluations are made and are reassessed when<br />
the indices are published by the Valuer-General Victoria to ensure that the carrying amounts do not<br />
materially differ from their fair values;<br />
● The fair value of assets other than land is generally based on their depreciated replacement<br />
value.<br />
Judgements, estimates and assumptions are required to be made about the carrying values of<br />
assets and liabilities that are not readily apparent from other sources. The estimates and<br />
underlying assumptions are reviewed on an ongoing basis. The estimates and associated<br />
assumptions are based on professional judgements derived from historical experience and various<br />
other factors that are believed to be reasonable under the circumstances. Actual results may differ<br />
from these estimates.<br />
Revisions to accounting estimates are recognised in the period in which the estimate is revised and<br />
also in future periods that are affected by the revision. Judgements and assumptions made by<br />
management in the application of AAS that have significant effects on the financial statements and<br />
estimates relate to:<br />
● The fair value of land, buildings and plant and equipment (refer to Note 4.2 Property, Plant and<br />
Equipment);<br />
● Superannuation expense (refer to Note 3.6 Superannuation);<br />
● Employee benefit provisions are based on likely tenure of existing staff, patterns of leave claims,<br />
future salary movements and future discount rates (refer to Note 3.5 Employee Benefits in the<br />
Balance Sheet).<br />
Goods and Services Tax (GST)<br />
Income, expenses and assets are recognised net of the amount of associated GST, unless the GST<br />
incurred is not recoverable from the Australian Taxation Office (ATO). In this case the GST payable<br />
is recognised as part of the cost of acquisition of the asset or as part of the expense.<br />
Receivables and payables are stated inclusive of the amount of GST receivable or payable. The net<br />
amount of GST recoverable from, or payable to, the ATO is included with other receivables or<br />
payables in the Balance Sheet.<br />
Cash flows are presented on a gross basis. The GST components of cash flows arising from<br />
investing or financing activities which are recoverable from, or payable to the ATO, are presented<br />
as operating cash flow.<br />
Commitments and contingent assets and liabilities are presented on a gross basis.<br />
76 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 1: Summary of Significant Accounting Policies (continued)<br />
(d) Principles of Consolidation<br />
These statements are presented on a consolidated basis in accordance with AASB 10 Consolidated<br />
Financial Statements :<br />
• The consolidated financial statements of <strong>Monash</strong> <strong>Health</strong> includes all reporting entities controlled<br />
by <strong>Monash</strong> <strong>Health</strong> as at 30 June 20<strong>18</strong>.<br />
• Control exists when <strong>Monash</strong> <strong>Health</strong> has the power to govern the financial and operating policies of<br />
an organisation so as to obtain benefits from its activities. In assessing control, potential voting<br />
rights that presently are exercisable are taken into account. The consolidated financial statements<br />
include the audited financial statements of the controlled entities listed in Note 8.10 Controlled<br />
Entities.<br />
• The parent entity is not shown separately in the notes.<br />
Where control of an entity is obtained during the financial period, its results are included in the<br />
Comprehensive Operating Statement from the date on which control commenced. Where control<br />
ceases during a financial period, the entity’s results are included for that part of the period in which<br />
control existed. Where entities adopt dissimilar accounting policies and their effect is considered<br />
material, adjustments are made to ensure consistent policies are adopted in these financial<br />
statements.<br />
Entities consolidated into <strong>Monash</strong> <strong>Health</strong> reporting entity by virtue of the existence of congruent<br />
objectives, exposure to variable returns and significant management control include:<br />
● Kitaya Holdings Pty Ltd.<br />
Intersegment Transactions<br />
Transactions between segments within <strong>Monash</strong> <strong>Health</strong> have been eliminated to reflect the extent of<br />
<strong>Monash</strong> <strong>Health</strong>'s operations as a group.<br />
77
Note 2: Funding delivery of our services<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
<strong>Monash</strong> <strong>Health</strong>'s overall objective is to deliver programs and services that support and enhance<br />
the wellbeing of all Victorians.<br />
To enable <strong>Monash</strong> <strong>Health</strong> to fulfil its objective it receives income based on parliamentary<br />
appropriations. <strong>Monash</strong> <strong>Health</strong> also receives income from the supply of services.<br />
Structure<br />
2.1 Analysis of revenue by source<br />
2.2 Assets received free of charge or for nominal consideration<br />
78 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 2.1: Analysis of revenue by source<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Admitted<br />
Patients<br />
Non-<br />
Admitted EDs<br />
Aged Care Other i Total<br />
20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong><br />
Consolidated $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />
Mental<br />
<strong>Health</strong><br />
RAC (incl<br />
Mental<br />
<strong>Health</strong>)<br />
Primary<br />
<strong>Health</strong><br />
Government Grants 890,223 205,401 102,617 136,609 134,122 29,665 29,497 - 1,528,134<br />
Indirect Contributions by the Department of <strong>Health</strong> and<br />
Human Services 5,723 1,<strong>18</strong>9 803 906 414 179 <strong>18</strong>0 - 9,394<br />
Patient Fees 25,276 9,781 116 2,440 4,798 196 53 - 42,662<br />
Commercial Activities and Special Purpose Funds - - - - - - - 126,849 126,849<br />
Other Revenue from Operating Activities 69,628 69,628<br />
Total Revenue from Operating Activities 921,222 216,371 103,536 139,955 139,334 30,040 29,730 196,477 1,776,667<br />
Interest 3,709 3,709<br />
Total Revenue from Non-Operating Activities - - - - - - - 3,709 3,709<br />
Government Grants - - - - - - - 81,886 81,886<br />
Capital Purpose Income (excluding Interest) - - - - - - - 20,042 20,042<br />
Total Capital Purpose Income - - - - - - - 101,928 101,928<br />
Share of Net Result in Associates Accounted for using the<br />
Equity Method - - - - - - - 87 87<br />
Total Revenue 921,222 216,371 103,536 139,955 139,334 30,040 29,730 302,201 1,882,391<br />
Admitted<br />
Patients<br />
Non-<br />
Admitted EDs<br />
Aged Care Other i Total<br />
<strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong><br />
Consolidated $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />
Mental<br />
<strong>Health</strong><br />
RAC (incl<br />
Mental<br />
<strong>Health</strong>)<br />
Primary<br />
<strong>Health</strong><br />
Government Grants 879,938 200,794 101,079 104,070 99,847 21,957 22,466 - 1,430,150<br />
Indirect Contributions by the Department of <strong>Health</strong> and<br />
Human Services 6,996 1,453 981 1,108 506 2<strong>18</strong> 220 11,482<br />
Patient Fees 14,277 10,903 3,012 5,363 259 33 33,847<br />
Commercial Activities and Special Purpose Funds - - - - - - 125,342 125,342<br />
Other Revenue from Operating Activities 66,984 66,984<br />
Total Revenue from Operating Activities 901,211 213,149 102,060 108,190 105,716 22,434 22,719 192,326 1,667,804<br />
Interest - - - - - - - 2,759 2,759<br />
Total Revenue from Non-Operating Activities - - - - - - - 2,759 2,759<br />
Government Grants - - - - - - - 145,471 145,471<br />
Capital Purpose Income (excluding Interest) i - - - - - - - 34,689 34,689<br />
Total Capital Purpose Income - - - - - - - <strong>18</strong>0,160 <strong>18</strong>0,160<br />
Share of Net Result in Associates Accounted for using the<br />
Equity Method - - - - - - - 147 147<br />
Total Revenue 901,211 213,149 102,060 108,190 105,716 22,434 22,719 375,392 1,850,870<br />
i Other Programs include Commercial Activities, Special Purpose Funds and Capital.<br />
Revenue has been classified across programs as defined in the Agency Information Management System (AIMS) guidelines. For clinical support, infrastructure and corporate and diagnostic laboratory<br />
and medical services, Full Time Equivalent (FTE) has been used to allocate revenue across the programs.<br />
The Department of <strong>Health</strong> and Human Services makes certain payments on behalf of <strong>Monash</strong> <strong>Health</strong>. These amounts have been brought to account in determining the operating result for the year by<br />
recording them as revenue and expenses.<br />
79
Note 2.1: Analysis of revenue by source (continued)<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Revenue recognition<br />
Income is recognised in accordance with AASB 1<strong>18</strong> Revenue and is recognised as to the extent that it is probable<br />
that the economic benefits will flow to <strong>Monash</strong> <strong>Health</strong> and the income can be reliably measured at fair value.<br />
Unearned income at reporting date is reported as income received in advance. Amounts disclosed as revenue are<br />
where applicable, net of returns, allowances and duties and taxes.<br />
Government Grants and other transfers of income (other than contributions by owners)<br />
In accordance with AASB 1004 Contributions , government grants and other transfers of income (other than<br />
contributions by owners) are recognised as income when <strong>Monash</strong> <strong>Health</strong> gains control of the underlying assets<br />
irrespective of whether conditions are imposed on <strong>Monash</strong> <strong>Health</strong>’s use of the contributions. Contributions are<br />
deferred as income in advance when <strong>Monash</strong> <strong>Health</strong> has a present obligation to repay them and the present<br />
obligation can be reliably measured.<br />
Indirect contributions from the Department of <strong>Health</strong> and Human Services<br />
• Insurance is recognised as revenue following advice from the Department of <strong>Health</strong> and Human Services.<br />
• Long Service Leave (LSL) – Revenue is recognised upon finalisation of movements in LSL liability in line with<br />
the arrangements set out in the Department of <strong>Health</strong> and Human Services Hospital Circular 04/<strong>2017</strong>.<br />
Patient fees<br />
Patient fees are recognised as revenue on an accrual basis.<br />
Private practice fees<br />
Private practice fees are recognised as revenue at the time invoices are raised.<br />
Revenue from commercial activities<br />
Revenue from commercial activities such as car park and property rental income are recognised on an accrual<br />
basis and commercial laboratory medicine is recognised at the time invoices are raised.<br />
Donations and other bequests<br />
Donations and bequests are recognised as revenue when received. If donations are for a special purpose, they<br />
may be appropriated to a surplus, such as the specific restricted purpose surplus.<br />
Dividend revenue<br />
Dividend revenue is recognised when the right to receive payment is established. Dividends represents the<br />
income arising from <strong>Monash</strong> <strong>Health</strong>'s and its controlled entities' investments in financial assets.<br />
Interest revenue<br />
Interest revenue is recognised on a time proportionate basis that takes in account the effective yield of the<br />
financial asset, which allocates interest over the relevant period.<br />
Other income<br />
Other income includes recoveries for salaries and wages, non-property rental and external services provided.<br />
80 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 2.1: Analysis of revenue by source (continued)<br />
Category Groups<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
<strong>Monash</strong> <strong>Health</strong> has used the following category groups for reporting purposes for the current and previous<br />
financial years.<br />
Admitted Patient Services (Admitted Patients) comprises all acute and subacute admitted patient services,<br />
where services are delivered in public hospitals.<br />
Mental <strong>Health</strong> Services (Mental <strong>Health</strong>) comprises all specialised mental health services providing a range of<br />
inpatient, community based, residential, rehabilitation and ambulatory services which treat and support people<br />
with a mental illness and their families and carers. These services aim to identify mental illness early and seek to<br />
reduce its impact through providing timely acute care services and appropriate longer-term accommodation and<br />
support for those living with a mental illness.<br />
Non Admitted Services comprises acute and subacute non admitted services, where services are delivered in<br />
public hospital clinics and provide models of integrated community care, which significantly reduces the demand<br />
for hospital beds and supports the transition from hospital to home in a safe and timely manner.<br />
Emergency Department Services (EDs) comprises all emergency department services.<br />
Aged Care comprises a range of in home, specialist geriatric, residential care and community based programs<br />
and support services, such as Home and Community Care (HACC) that are targeted to older people, people with<br />
a disability, and their carers.<br />
Primary and Community <strong>Health</strong> comprises a range of home based, community based, primary health and<br />
dental services including health promotion and counselling, physiotherapy, speech therapy, podiatry and<br />
occupational therapy services.<br />
Residential Aged Care including Mental <strong>Health</strong> (RAC incl. Mental <strong>Health</strong>) referred to in the past as<br />
psychogeriatric residential services, comprises those Commonwealth-licensed residential aged care services in<br />
receipt of supplementary funding from the department under the mental health program. It excludes all other<br />
residential services funded under the mental health program, such as mental health funded community care units<br />
and secure extended care units.<br />
Other Services excluded from National <strong>Health</strong> Care Agreement (NHCA) (Other) comprises services not<br />
separately classified above, including: public health services such as laboratory testing, blood borne viruses /<br />
sexually transmitted infections clinical services, Kooris liaison officers, immunisation and screening services,<br />
drugs services including drug withdrawal, counselling and the needle and syringe program, disability services<br />
including aids and equipment and flexible support packages to people with a disability, community care programs<br />
including sexual assault support, early parenting services, parenting assessment and skills development, and<br />
various support services. <strong>Health</strong> and community initiatives also fall in this category group.<br />
81
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 2.2: Assets received free of charge or for nominal<br />
consideration<br />
During the reporting period, the fair value of assets<br />
received free of charge, was as follows:<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000<br />
Medical Equipment 136 713<br />
TOTAL 136 713<br />
Medical Equipment was gifted from various donors.<br />
The revenues and assets recognised as a result of such transactions shall be measured at the<br />
fair value of resources received.<br />
Fair value of assets and services received free of charge or for nominal consideration<br />
Resources received free of charge or for nominal consideration are recognised at their fair<br />
value when the transferee obtains control over them, irrespective of whether restrictions or<br />
conditions are imposed over the use of the contributions, unless received from another <strong>Health</strong><br />
Service or agency as a consequence of a restructuring of administrative arrangements. In the<br />
latter case, such transfer will be recognised at carrying amount. Contributions in the form of<br />
services are only recognised when a fair value can be reliably determined and the services<br />
would have been purchased if not received as a donation.<br />
82 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 3: The cost of delivering our services<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
This section provides an account of the expenses incurred by the hospital in delivering services and<br />
outputs. In Note 2, the funds that enable the provision of services were disclosed and in this note the<br />
cost associated with provision of services are recorded.<br />
Structure<br />
3.1 Analysis of expenses by source<br />
3.2 Analysis of expense and revenue by internally managed and restricted specific purpose funds<br />
3.3 Specific expenses<br />
3.4 Finance costs<br />
3.5 Employee benefits in the balance sheet<br />
3.6 Superannuation<br />
83
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 3.1: Analysis of Expenses by Source<br />
Admitted<br />
Patients<br />
Non-<br />
Admitted EDs<br />
RAC (incl<br />
Mental <strong>Health</strong> Mental<br />
<strong>Health</strong>) Aged Care<br />
Primary<br />
<strong>Health</strong> Other i Total<br />
20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong><br />
Consolidated $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />
Employee Expenses 783,491 159,495 119,889 144,431 43,107 22,035 27,215 - 1,299,663<br />
Other Operating Expenses<br />
Non Salary Labour Costs 10,091 2,372 2,619 3,201 768 53 47 - 19,151<br />
Supplies and Consumables 168,699 34,334 <strong>18</strong>,728 22,510 7,943 6,490 3,307 - 262,011<br />
Medical Indemnity Insurance 15,833 3,287 2,220 2,507 1,145 494 497 - 25,983<br />
Fuel, Light, Power and Water 9,837 1,986 1,330 1,694 1,010 473 449 - 16,779<br />
Repairs and Maintenance 12,382 2,057 1,301 1,820 1,110 462 321 - 19,453<br />
Other Expenses 3,668 7,582 3,938 4,797 (129) 1,893 259 115,376 137,384<br />
Total Expenditure from Operating Activities 1,004,001 211,113 150,025 <strong>18</strong>0,960 54,954 31,900 32,095 115,376 1,780,424<br />
Finance Costs (refer Note 3.4) - - - - - - - 3,547 3,547<br />
Finance Costs - Self Funded Activity (refer Note 3.4) - - - - - - - 1,670 1,670<br />
Other Non-Operating Expenses<br />
Specific Expenses (refer Note 3.3) - - - - - - - 372 372<br />
Bad and Doubtful Debts Expense - - - - - - - 2,762 2,762<br />
Expenditure for Capital Purposes - - - - - - 11,316 11,316<br />
Depreciation (refer Note 4.3) 47,104 9,781 6,608 7,460 3,407 1,470 1,481 - 77,310<br />
Total Other Expenses 47,104 9,781 6,608 7,460 3,407 1,470 1,481 19,667 96,977<br />
Total Expenses 1,051,105 220,894 156,633 <strong>18</strong>8,420 58,361 33,370 33,576 135,043 1,877,401<br />
Admitted<br />
Patients<br />
Non-<br />
Admitted EDs<br />
RAC (incl<br />
Mental <strong>Health</strong> Mental<br />
<strong>Health</strong>) Aged Care<br />
Primary<br />
<strong>Health</strong> Other i Total<br />
<strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong><br />
Consolidated $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />
Employee Expenses 727,953 151,473 108,477 136,312 41,141 19,823 25,705 - 1,210,884<br />
Other Operating Expenses<br />
Non Salary Labour Costs 8,964 2,680 1,887 2,095 558 135 128 - 16,447<br />
Supplies and Consumables 174,780 34,211 <strong>18</strong>,766 22,919 8,<strong>18</strong>4 6,211 3,478 - 268,549<br />
Medical Indemnity Insurance 25,322 105 70 79 36 16 16 - 25,644<br />
Fuel, Light, Power and Water 6,089 1,230 821 1,092 640 277 284 - 10,433<br />
Repairs and Maintenance 11,949 1,965 1,<strong>18</strong>9 2,055 905 438 320 - <strong>18</strong>,821<br />
Other Expenses 1,871 7,037 3,024 4,673 61 2,969 160 100,102 119,897<br />
Total Expenditure from Operating Activities 956,928 198,701 134,234 169,225 51,525 29,869 30,091 100,102 1,670,675<br />
Finance Costs (refer Note 3.4) - - - - - - - 3,739 3,739<br />
Finance Costs - Self Funded Activity (refer Note 3.4) - - - - - - - 1,734 1,734<br />
Other Non-Operating Expenses<br />
Specific Expenses (refer Note 3.3) - - - - - - - 667 667<br />
Expenditure for Capital Purposes - - - - - - - 10,226 10,226<br />
Depreciation (refer Note 4.3) 40,861 8,485 5,732 6,471 2,955 1,275 1,285 - 67,063<br />
Total Other Expenses 40,861 8,485 5,732 6,471 2,955 1,275 1,285 16,365 83,429<br />
Total Expenses 997,789 207,<strong>18</strong>6 139,966 175,696 54,480 31,144 31,376 116,467 1,754,104<br />
Other Programs include Commercial Activities, Special Purpose Funds and Capital.<br />
Expenditure has been classified across programs as defined in the Agency Information Management System (AIMS) guidelines. For clinical support, infrastructure and corporate and diagnostic<br />
laboratory and medical services, FTE has been used to allocate expenditure across the programs.<br />
i<br />
84 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 3.1: Analysis of expenses by source<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Expenses are recognised as they are incurred and reported in the financial year to which they<br />
relate.<br />
Employee expenses<br />
Employee expenses include:<br />
• Wages and salaries;<br />
• Fringe benefits tax;<br />
• Leave entitlements;<br />
• Termination payments;<br />
• Workcover premiums; and<br />
• Superannuation expenses.<br />
Grants and other transfers<br />
These include transactions such as grants, subsidies and personal benefit payments made in cash<br />
to individuals.<br />
Other operating expenses<br />
Other operating expenses generally represent the day-to-day running costs incurred in normal<br />
operations and include:<br />
a) Supplies and consumables<br />
Supplies and services costs are recognised as an expense in the reporting period in which they are<br />
incurred. The carrying amounts of any inventories held for distribution are expensed when<br />
distributed.<br />
b) Fair value of assets, services and resources provided free of charge or for nominal<br />
consideration<br />
Contributions of resources provided free of charge or for nominal consideration are recognised at<br />
their fair value when the transferee obtains control over them.<br />
c) Borrowing costs of qualifying assets<br />
In accordance with the paragraphs of AASB 123 Borrowing Costs applicable to not-for-profit public<br />
sector entities, <strong>Monash</strong> <strong>Health</strong> continues to recognise borrowing costs immediately as an expense,<br />
to the extent that they are directly attributable to the acquisition, construction or production of a<br />
qualifying asset.<br />
Net gain/(loss) on non-financial assets<br />
Net gain/(loss) on non-financial assets and liabilities includes realised and unrealised gains and<br />
losses as follows:<br />
a) revaluation gains/(losses) of non-financial physical assets. (Refer to Note 4.2 Property,<br />
plant and equipment; and<br />
b) net gain/(loss) on disposal of non-financial assets.<br />
Any gain or loss on the disposal of non-financial assets is recognised in the period of disposal.<br />
85
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 3.1: Analysis of expenses by source (continued)<br />
Net gain/(loss) on financial instruments<br />
Net gain/(loss) on financial instruments includes:<br />
a) realised and unrealised gains and losses from revaluations of financial instruments at fair value;<br />
b) disposals of financial assets and derecognition of financial liabilities.<br />
Amortisation of non-produced intangible assets<br />
Intangible non-produced assets with finite lives are amortised as an ‘other economic flow’ on a<br />
systematic basis over the asset’s useful life. Amortisation begins when the asset is available for<br />
use that is when it is in the location and condition necessary for it to be capable of operating in the<br />
manner intended by management.<br />
Other gains/(losses) from other economic flows<br />
Other gains/(losses) include:<br />
a) the revaluation of the present value of the long service leave liability due to changes in the<br />
bond rate movements, inflation rate movements and the impact of changes in probability factors;<br />
and<br />
b) transfer of amounts from the reserves to accumulated surplus or net result due to disposal or<br />
derecognition or reclassification.<br />
De-recognition of financial liabilities<br />
A financial liability is derecognised when the obligation under the liability is discharged, cancelled<br />
or expires.<br />
86 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 3.2: Analysis of expense and revenue by internally managed and<br />
restricted specific purpose funds<br />
Expense<br />
Revenue<br />
Consolidated Consolidated Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000 $'000 $'000<br />
Commercial Activities<br />
Private Practice and Other Patient Activities 19,954 20,324 23,522 23,349<br />
Laboratory Medicine 2,289 2,195 2,289 2,300<br />
Diagnostic Imaging 12,149 12,159 12,227 12,163<br />
Property - - 119 116<br />
Other:<br />
-Bequests and Donations 1,478 1,014 2,530 1,789<br />
-Breastscreen service 4,466 4,<strong>18</strong>4 4,169 4,234<br />
-Cardiology 8,359 8,043 9,987 10,144<br />
-Special Purpose Funds 8,980 8,744 13,444 12,239<br />
Other Activities<br />
Fundraising and Community Support 217 768 107 470<br />
Research and Scholarship 8,425 5,766 8,720 7,452<br />
Other 3,344 1,701 3,248 3,145<br />
TOTAL 69,661 64,898 80,362 77,401<br />
87
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 3.3: Specific expenses<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Specific Expenses<br />
Voluntary Departure Packages 372 667<br />
Total Specific Expenses 372 667<br />
Note 3.4: Finance costs<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Finance Costs - Self Funded Activity 1,670 1,734<br />
Finance Charges - Finance Leases i 3,547 3,739<br />
Total Finance Costs 5,217 5,473<br />
i Construction and fit out of Casey Hospital was funded as a Public Private Partnership under a Project<br />
Agreement between the State of Victoria and Progress <strong>Health</strong> Pty Ltd. This amount represents the<br />
interest payments made during the financial year.<br />
Finance costs include:<br />
• interest on bank overdrafts and short-term and long-term borrowings (interest expense is<br />
recognised in the period in which it is incurred);<br />
• amortisation of discounts or premiums relating to borrowings;<br />
• amortisation of ancillary costs incurred in connection with the arrangement of borrowings; and<br />
• finance charges in respect of finance leases recognised in accordance with AASB 117 Leases .<br />
88 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 3.5: Employee benefits in the balance sheet<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000<br />
Current Provisions<br />
Employee Benefits i<br />
Accrued Days Off<br />
- unconditional and expected to be settled wholly within 12 months ii 4,326 3,895<br />
<strong>Annual</strong> Leave<br />
- unconditional and expected to be settled wholly within 12 months ii 77,929 69,393<br />
- unconditional and expected to be settled wholly after 12 months iii 13,154 11,527<br />
Long Service Leave<br />
- unconditional and expected to be settled wholly within 12 months ii 19,886 <strong>18</strong>,413<br />
- unconditional and expected to be settled wholly after 12 months iii 136,833 122,527<br />
Accrued wages and salaries 41,664 30,041<br />
293,792 255,796<br />
Provisions related to Employee Benefit On-Costs<br />
Unconditional and expected to be settled within 12 months ii 10,733 10,890<br />
Unconditional and expected to be settled after 12 months iii 16,314 13,226<br />
27,047 24,116<br />
Total Current Provisions 320,839 279,912<br />
Non-Current Provisions<br />
Employee benefits i 57,912 53,053<br />
Provisions related to employee benefit on-costs 6,292 5,727<br />
Total Non-Current Provisions 64,204 58,780<br />
Total Provisions 385,043 338,692<br />
(a) Employee Benefits and Related On-Costs<br />
Current Employee Benefits and related on-costs<br />
Unconditional long service leave entitlements 173,747 156,155<br />
<strong>Annual</strong> leave entitlements 101,102 89,821<br />
Accrued wages and salaries 41,664 30,041<br />
Accrued days off 4,326 3,895<br />
Non-Current Employee Benefits and related on-costs<br />
Conditional long service leave entitlements iii 64,204 58,780<br />
Total Employee Benefits and Related On-Costs 385,043 338,692<br />
Notes:<br />
i Employee benefits consist of amounts for accrued days off, annual leave and long service leave accrued by employees, not including oncosts.<br />
ii The amounts disclosed are nominal amounts.<br />
iii The amounts disclosed are discounted to present values.<br />
89
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 3.5: Employee benefits in the balance sheet (continued)<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
Movements in provisions $'000 $'000<br />
Movement in Long Service Leave:<br />
Balance at start of year 214,935 206,012<br />
Provision made during the year<br />
- Expense recognising employee service 41,379 25,204<br />
Settlement made during the year (<strong>18</strong>,363) (16,281)<br />
Balance at end of year 237,951 214,935<br />
Employee Benefit Recognition<br />
Provision is made for benefits accruing to employees in respect of wages and salaries, annual leave and long<br />
service leave for services rendered to the reporting date as expense during the period of the services are<br />
delivered.<br />
Provisions<br />
Provisions are recognised when <strong>Monash</strong> <strong>Health</strong> has a present obligation, the future sacrifice of economic<br />
benefits is probable, and the amount of the provision can be measured reliably.<br />
The amount recognised as a liability is the best estimate of the consideration required to settle the present<br />
obligation at reporting date, taking into account the risks and uncertainties surrounding the obligation.<br />
Salaries and Wages, <strong>Annual</strong> Leave and Accrued Days Off<br />
Liabilities for salaries and wages, annual leave and accrued days off are all recognised in the provision for<br />
employee benefits as ‘current liabilities’, because <strong>Monash</strong> <strong>Health</strong> does not have an unconditional right to defer<br />
settlements of these liabilities.<br />
Long Service Leave<br />
The liability for LSL is recognised in the provision for employee benefits.<br />
Unconditional LSL is disclosed in the notes to the financial statements as a current liability, even where the<br />
<strong>Monash</strong> <strong>Health</strong> Service does not expect to settle the liability within 12 months because it will not have the<br />
unconditional right to defer the settlement of the entitlement should an employee take leave within 12 months.<br />
An unconditional right arises after a qualifying period.<br />
The components of this current LSL liability are measured at:<br />
Undiscounted value – if the health service expects to wholly settle within 12 months; and<br />
Present value – where the health service does not expect to settle a component of this current liability<br />
within 12 months.<br />
Conditional LSL is disclosed as a non-current liability. Any gain or loss following revaluation of the present<br />
value of non-current LSL liability is recognised as a transaction, except to the extent that a gain or loss arises<br />
due to changes in estimations e.g. bond rate movements, inflation rate movements and changes in probability<br />
factors which are then recognised as other economic flows.<br />
Termination Benefits<br />
Termination benefits are payable when employment is terminated before the normal retirement date or when<br />
an employee decides to accept an offer of benefits in exchange for the termination of employment.<br />
On-Costs Related to Employee Expense<br />
Provision for on-costs, such as workers compensation and superannuation are recognised together with<br />
provisions for employee benefits.<br />
90 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 3.6: Superannuation<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Paid Contribution for the<br />
Year<br />
Contribution Outstanding<br />
at Year End<br />
Consolidated Consolidated Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000 $'000 $'000<br />
Defined benefit plans:<br />
State Superannuation Fund 550 539 39 60<br />
First State 3,417 3,290 237 365<br />
Unisuper 369 298 29 24<br />
Defined contribution plans:<br />
First State 54,447 46,453 4,266 5,246<br />
Hesta 48,348 36,963 3,763 4,734<br />
VicSuper and Other 2,087 1,606 335 198<br />
Total 109,2<strong>18</strong> 89,149 8,669 10,627<br />
Employees of <strong>Monash</strong> <strong>Health</strong> are entitled to receive superannuation benefits and <strong>Monash</strong> <strong>Health</strong><br />
contributes to both defined benefit and defined contribution plans. The defined benefit plans provides<br />
benefits based on years of service and final average salary.<br />
Defined contribution superannuation plans<br />
In relation to defined contribution (i.e. accumulation) superannuation plans, the associated expense is<br />
simply the employer contributions that are paid or payable in respect of employees who are members of<br />
these plans during the reporting period. Contributions to defined contribution superannuation plans are<br />
expensed when incurred.<br />
Defined benefit superannuation plans<br />
The amount charged to the Comprehensive Operating Statement in respect of defined benefit<br />
superannuation plans represents the contributions made by <strong>Monash</strong> <strong>Health</strong> to the superannuation plans<br />
in respect of the services of current <strong>Monash</strong> <strong>Health</strong> staff during the reporting period. Superannuation<br />
contributions are made to the plans based on the relevant rules of each plan, and are based upon<br />
actuarial advice.<br />
<strong>Monash</strong> <strong>Health</strong> Services does not recognise any unfunded defined benefit liability in respect of the plans<br />
because the hospital has no legal or constructive obligation to pay future benefits relating to its<br />
employees; its only obligation is to pay superannuation contributions as they fall due. The Department of<br />
Treasury and Finance discloses the State's defined benefits liabilities in its disclosure for administered<br />
items.<br />
Superannuation contributions paid or payable for the reporting period are included as part of employee<br />
benefits in the Comprehensive Operating Statement of <strong>Monash</strong> <strong>Health</strong>.<br />
The name, details and amounts expensed in relation to the major employee superannuation funds and<br />
contributions made by <strong>Monash</strong> <strong>Health</strong> are disclosed above.<br />
91
Note 4: Key Assets to support service delivery<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
The hospital controls infrastructure and other investments that are utilised in fulfilling its<br />
objectives and conducting its activities. They represent the key resources that have been<br />
entrusted to the hospital to be utilised for delivery of those outputs.<br />
Structure<br />
4.1 Investments accounted for using the equity method<br />
4.2 Property, plant and equipment<br />
4.3 Depreciation and amortisation<br />
4.4 Intangible assets<br />
92 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 4.1: Investments accounted for using the equity method<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Ownership Interest Published Fair Value<br />
Principal Country of 20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong> <strong>2017</strong><br />
Name of Entity Activity Incorporation % % $'000 $'000<br />
Associates<br />
<strong>Monash</strong> <strong>Health</strong> Research Precinct Pty Ltd<br />
Property<br />
Investment Australia 20.33 20.33 4,099 4,012<br />
(a) As at 30 June 20<strong>18</strong>, the fair value of <strong>Monash</strong> <strong>Health</strong>'s interest in <strong>Monash</strong> <strong>Health</strong> Research Precinct Pty Ltd was based on its<br />
share of the company's net assets which is a level 3 input in terms of AASB 13 Fair Value Measurement.<br />
(b) The financial year end date of <strong>Monash</strong> <strong>Health</strong> Research Precinct Pty Ltd is 31 December. This was the reporting date established<br />
when that company was incorporated. For the purpose of applying the equity method of accounting, the financial statements of<br />
<strong>Monash</strong> <strong>Health</strong> Research Precinct Pty Ltd have been used, and appropriate adjustments have been made for the effects of<br />
significant transactions between that date and 30 June 20<strong>18</strong>.<br />
93
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.2: Property, plant and equipment<br />
(a) Gross carrying amount and accumulated depreciation<br />
Consolidated<br />
Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Land<br />
- Land at Fair Value 222,022 <strong>18</strong>7,022<br />
Total Land 222,022 <strong>18</strong>7,022<br />
Buildings<br />
- Buildings at Fair Value 676,088 676,088<br />
Less Accumulated Depreciation (120,453) (94,463)<br />
555,635 581,625<br />
- Buildings at Cost 461,591 429,989<br />
Less Accumulated Depreciation (49,291) (30,350)<br />
412,300 399,639<br />
Total Buildings 967,935 981,264<br />
Plant and Equipment<br />
- Plant and Equipment at Fair Value 57,559 43,092<br />
Less Accumulated Depreciation (23,814) (<strong>18</strong>,440)<br />
Total Plant and Equipment 33,745 24,652<br />
Medical Equipment<br />
- Medical Equipment at Fair Value 160,752 146,511<br />
Less Accumulated Depreciation (94,766) (82,683)<br />
Total Medical Equipment 65,987 63,828<br />
Computers and Communication Equipment<br />
- Computers and Communication Equipment at Fair Value 20,089 16,746<br />
Less Accumulated Depreciation (16,681) (13,685)<br />
Total Computers and Communication Equipment 3,408 3,061<br />
Furniture and Fittings<br />
- Furniture and Fittings at Fair Value 11,766 3,619<br />
Less Accumulated Depreciation (2,750) (1,402)<br />
Total Furniture and Fittings 9,016 2,217<br />
Motor Vehicles<br />
- Motor Vehicles at Fair Value 2,219 2,366<br />
Less Accumulated Depreciation (2,213) (2,353)<br />
Total Motor Vehicles 6 13<br />
Cultural Assets<br />
- Cultural Assets at Fair Value 2,792 2,792<br />
Total Cultural Assets 2,792 2,792<br />
94 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
(a) Gross carrying amount and accumulated depreciation (continued)<br />
Consolidated<br />
Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Assets Under Construction<br />
Assets Under Construction at Cost 55,820 60,379<br />
Software Under Construction at Cost 31,217 12,364<br />
Total Assets Under Construction 87,037 72,743<br />
Leased Assets Contracted under PPP Agreement<br />
- Leased Buildings at Fair Value 154,011 154,011<br />
Less Accumulated Depreciation (58,632) (52,136)<br />
95,379 101,875<br />
- Leasehold Improvements at Cost 1,448 1,448<br />
Less Accumulated Depreciation (547) (511)<br />
901 937<br />
- Leased Motor Vehicles 6,583 5,799<br />
Less Accumulated Depreciation (3,858) (2,248)<br />
2,725 3,551<br />
- Plant and Equipment at Fair Value 164 164<br />
Less Accumulated Depreciation (164) (164)<br />
- -<br />
- Medical Equipment at Fair Value 6,495 6,555<br />
Less Accumulated Depreciation (6,495) (6,555)<br />
- -<br />
- Computers and Communication Equipment at Fair Value 305 305<br />
Less Accumulated Depreciation (305) (305)<br />
- -<br />
- Furniture and Fittings at Fair Value 12 12<br />
Less Accumulated Depreciation (12) (12)<br />
- -<br />
Total Leased Assets 99,005 106,363<br />
TOTAL PROPERTY, PLANT AND EQUIPMENT 1,490,954 1,443,956<br />
(i) Casey Hospital commenced operation during the year of 30 June 2005. Construction and fit out of Casey Hospital was<br />
funded as a Public Private Partnership under a Project Agreement between the State of Victoria and Progress <strong>Health</strong> Pty Ltd.<br />
<strong>Monash</strong> <strong>Health</strong> is responsible for operating Casey Hospital and has recognised the leased asset and associated interest<br />
bearing liabilities (Note 6.1). The State of Victoria is obligated to fund quarterly service payments due to the Project<br />
Agreement for the life of that agreement, a period of up to 25 years.<br />
95
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.2: (b) Reconciliations of the carrying amounts of each class of asset<br />
Land Buildings Plant & Medical Computers and Furniture Motor Cultural Assets Under Leased Total<br />
Equipment Equipment Communication and Vehicles Assets Construction Assets<br />
Fittings<br />
$'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />
Balance at 1 July 2016 <strong>18</strong>7,022 797,490 <strong>18</strong>,121 47,458 2,408 2,004 21 2,793 206,272 112,207 1,375,797<br />
Additions - 1,200 9,227 27,644 1,884 514 - - 91,128 2,035 133,632<br />
Disposals - - (77) (609) - (16) - (1) - (38) (741)<br />
Net Transfers between Classes - 222,467 948 654 588 - - - (224,657) - -<br />
Depreciation (Note 4.3) - (39,893) (3,567) (11,319) (1,819) (285) (8) - - (7,841) (64,732)<br />
Balance at 1 July <strong>2017</strong> <strong>18</strong>7,022 981,264 24,652 63,828 3,061 2,217 13 2,792 72,743 106,363 1,443,956<br />
Additions - 212 2,602 14,814 1,067 278 - - 66,335 817 86,126<br />
Disposals - (<strong>18</strong>9) (11) (16) - - - - - (14) (229)<br />
Revaluation Increments 35,000 - - - - - - - - - 35,000<br />
Net Transfers between Classes - 29,720 11,962 192 2,296 7,872 - - (52,042) - 0<br />
Depreciation (Note 4.3) - (43,072) (5,460) (12,831) (3,017) (1,351) (7) - - (8,161) (73,899)<br />
Balance at 30 June 20<strong>18</strong> 222,022 967,935 33,745 65,987 3,408 9,017 6 2,792 87,037 99,005 1,490,954<br />
Land and buildings carried at valuation<br />
The Valuer-General Victoria undertook to re-value all of <strong>Monash</strong> <strong>Health</strong>'s owned and leased land and buildings to determine their fair value. The valuation, which conforms to Australian Valuation<br />
Standards, was determined by reference to the amounts for which assets could be exchanged between knowledgeable willing parties in an arm's length transaction. The valuation was based on<br />
independent assessments. The effective date of the valuation is 30 June 2014.<br />
In compliance with FRD 103F, in the year ended 30 June 20<strong>18</strong>, <strong>Monash</strong> <strong>Health</strong>'s management conducted an annual assessment of the fair value of land and buildings and leased buildings. To facilitate<br />
this, management obtained from the Department of Treasury and Finance the Valuer General Victoria indices for the financial year ended 30 June 20<strong>18</strong>.<br />
The fair value of the land had been adjusted by a managerial revaluation in 2016. The indexed value was then compared to individual assets written down book value as at 30 June 20<strong>18</strong> to determine<br />
the change in their fair values. The latest indices required a further managerial revaluation in 20<strong>18</strong>. The Department of <strong>Health</strong> and Human Services approved a managerial revaluation of the land asset<br />
class of $35m ($0 in <strong>2017</strong>).<br />
There was no material financial impact on change in fair value of buildings and leased buildings.<br />
96 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.2: (c) Fair value measurement hierarchy for assets<br />
Carrying Fair value measurement at end<br />
amount as of reporting period using:<br />
at 30 June<br />
Balance at 30 June 20<strong>18</strong> 20<strong>18</strong> Level 1 (i) Level 2 (i) Level 3 (i)<br />
Land at fair value<br />
- Non-Specialised Land 47,085 47,085<br />
- Specialised Land 174,937 174,937<br />
Total Land at Fair Value 222,022 47,085 174,937<br />
Buildings at fair value<br />
- Specialised Buildings 555,635 - 555,635<br />
Total Buildings at Fair Value 555,635 - 555,635<br />
Plant and Equipment at Fair Value 33,745 - 33,745<br />
Medical Equipment at Fair Value 65,987 - 65,987<br />
Computers and Communication Equipment at<br />
Fair Value 3,408 - 3,408<br />
Furniture and Fittings at Fair Value 9,016 - 9,016<br />
Cultural Assets at Fair Value 2,792 2,792 -<br />
Motor Vehicles at Fair Value 6 - 6<br />
Total Property, Plant and Equipment 892,611 - 49,877 842,734<br />
Fair value measurement at end<br />
Carrying of reporting period using:<br />
amount as<br />
at 30 June<br />
Balance at 30 June <strong>2017</strong> <strong>2017</strong> Level 1 (i) Level 2 (i) Level 3 (i)<br />
Land at fair value<br />
- Non-Specialised Land 39,514 39,514 -<br />
- Specialised Land 147,508 147,508<br />
Total Land at Fair Value <strong>18</strong>7,022 39,514 147,508<br />
Buildings at fair value<br />
- Specialised Buildings 581,625 - 581,625<br />
Total Building at Fair Value 581,625 - 581,625<br />
Plant and Equipment at Fair Value 24,652 - 24,652<br />
Medical Equipment at Fair Value 63,828 - 63,828<br />
Computers and Communication Equipment at<br />
Fair Value 3,061 - 3,061<br />
Furniture and Fittings at Fair Value 2,217 - 2,217<br />
Cultural Assets at Fair Value 2,792 2,792<br />
Motor Vehicles at Fair Value 13 13<br />
Total Property, Plant and Equipment 865,211 - 42,306 822,905<br />
Note<br />
i Classified in accordance with the fair value hierarchy<br />
97
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.2: (d) Reconciliation of level 3 Fair Value<br />
Plant and<br />
equipment<br />
Medical<br />
equipment<br />
Computers<br />
and<br />
Communic<br />
ations<br />
Furniture &<br />
Fittings<br />
Motor<br />
Vehicles<br />
Land Buildings<br />
$'000 $'000 $'000 $'000 $'000 $'000 $'000<br />
Consolidated<br />
Balance at 1 July <strong>2017</strong> 147,509 581,625 24,652 63,828 3,061 2,217 13<br />
Additions/(Disposals) - - 14,553 14,990 3,363 8,150 -<br />
Gains/(Losses) recognised in net result<br />
- Depreciation and amortisation - (25,990) (5,460) (12,831) (3,017) (1,351) (7)<br />
Items recognised in other comprehensive income<br />
- Revaluation 27,428 - - - - - -<br />
Balance at 30 June 20<strong>18</strong> 174,937 555,635 33,745 65,987 3,408 9,016 6<br />
98 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.2: (d) Reconciliation of level 3 Fair Value (continued)<br />
Plant and<br />
equipment<br />
Medical<br />
equipment<br />
Computers<br />
and<br />
Communica<br />
tions<br />
Furniture &<br />
Fittings<br />
Motor<br />
Vehicles<br />
Land Buildings<br />
$'000 $'000 $'000 $'000 $'000 $'000 $'000<br />
Consolidated<br />
Balance at 1 July 2016 147,509 609,271 <strong>18</strong>,142 47,458 2,408 2,004 21<br />
Additions - - 10,098 27,689 2,472 498 -<br />
Gains/(Losses) recognised in Net Result<br />
- Depreciation and Amortisation - (27,646) (3,575) (11,319) (1,819) (285) (8)<br />
Balance at 30 June <strong>2017</strong> 147,509 581,625 24,665 63,828 3,061 2,217 13<br />
99
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.2 (e): Fair value determination<br />
Asset class<br />
Types of assets<br />
In areas where there is an active<br />
market:<br />
Expected fair<br />
value level<br />
Likely valuation<br />
approach<br />
Non-specialised Land<br />
- Vacant Land<br />
Level 2 Market approach n.a.<br />
- Land not subject to restrictions as to<br />
use or sale<br />
Specialised Land<br />
Land subject to restriction as to use<br />
Level 3<br />
Specialised buildings (a)<br />
Vehicles<br />
Plant and equipment (a)<br />
Specialised buildings with limited<br />
alternative uses and/or substantial<br />
customisation<br />
Active resale market available Level 2 Market approach n.a.<br />
No active resale market available Level 3<br />
Specialised items with limited<br />
alternative uses and/or substantial<br />
customisation<br />
Level 3<br />
Level 3<br />
Specialised items with limited<br />
Medical equipment (a) alternative uses and/or substantial Level 3<br />
customisation<br />
Computers and<br />
Communication Equipment Any type Level 3<br />
(a)<br />
Furniture and Fittings Any type Level 3<br />
Market approach<br />
Depreciated<br />
replacement cost<br />
approach<br />
Depreciated<br />
replacement cost<br />
approach<br />
Depreciated<br />
replacement cost<br />
approach<br />
Depreciated<br />
replacement cost<br />
approach<br />
Depreciated<br />
replacement cost<br />
approach<br />
Depreciated<br />
replacement cost<br />
approach<br />
Significant inputs (Level 3<br />
only) (c)<br />
Community Service<br />
Obligations Adjustments<br />
- Cost per square metre<br />
- Useful life<br />
- Cost per square metre<br />
- Useful life<br />
- Cost per square metre<br />
- Useful life<br />
- Cost per unit<br />
- Useful life<br />
- Cost per square metre<br />
- Useful life<br />
- Cost per unit<br />
- Useful life<br />
(a) Newly built/acquired assets could be categorised as Level 2 assets as depreciation would not be a significant unobservable input (based on the 10 per cent<br />
materiality threshold).<br />
(b) AASB 13 Fair Value Measurement provides an exemption for not for profit public sector entities from disclosing the sensitivity analysis relating to ‘unrealised<br />
gains/(losses) on non-financial assets’ if the assets are held primarily for their current service potential rather than to generate net cash inflows.<br />
There were no changes in valuation techniques throughout the period to 30 June 20<strong>18</strong>.<br />
Initial Recognition<br />
Items of property, plant and equipment are measured initially at cost and subsequently revalued at fair value less accumulated depreciation and<br />
impairment loss. Where an asset is acquired for no or nominal cost, the cost is its fair value at the date of acquisition. Assets transferred as part of<br />
a merger are transferred at their carrying amounts.<br />
The cost of a leasehold improvement is capitalised as an asset and depreciated over the shorter of the remaining term of the lease or the estimated<br />
useful life of the improvements.<br />
Theoretical opportunities that may be available in relation to assets are not taken into account until it is virtually certain that any restrictions will no<br />
longer apply. Therefore, unless otherwise disclosed, the current use of these non-financial physical assets will be their highest and best uses.<br />
Land and buildings are recognised initially at cost and subsequently measured at fair value less accumulated depreciation and accumulated<br />
impairment loss.<br />
Subsequent Measurement<br />
Consistent with AASB 13 Fair Value Measurement , <strong>Monash</strong> <strong>Health</strong> determines the policies and procedures for recurring property, plant and<br />
equipment fair value measurements, in accordance with the requirements of AASB 13 and the relevant FRDs.<br />
All property, plant and equipment for which fair value is measured or disclosed in the financial statements are categorised within the fair value<br />
hierarchy.<br />
For the purpose of fair value disclosures, <strong>Monash</strong> <strong>Health</strong> has determined classes of assets on the basis of the nature, characteristics and risks of the<br />
asset and the level of the fair value hierarchy as explained above.<br />
In addition, <strong>Monash</strong> <strong>Health</strong> determines whether transfers have occurred between levels in the hierarchy by reassessing categorisation (based on the<br />
lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period.<br />
For the purpose of fair value disclosures, <strong>Monash</strong> <strong>Health</strong> has determined classes of assets and liabilities on the basis of the nature, characteristics<br />
and risks of the asset or liability and the level of the fair value hierarchy as explained above.<br />
The Valuer-General Victoria (VGV) is <strong>Monash</strong> <strong>Health</strong>’s independent valuation agency.<br />
The estimates and underlying assumptions are reviewed on an ongoing basis.<br />
100 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.2 (e): Fair value determination (continued)<br />
Fair value measurement<br />
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market<br />
participants at the measurement date.<br />
Consideration of highest and best use (HBU) for non‐financial physical assets<br />
Judgements about highest and best use must take into account the characteristics of the assets concerned, including restrictions on the<br />
use and disposal of assets arising from the asset’s physical nature and any applicable legislative/contractual arrangements.<br />
In accordance with paragraph AASB 13.29, <strong>Monash</strong> <strong>Health</strong> assumes the current use of a non-financial physical asset is its HBU unless<br />
market or other factors suggest that a different use by market participants would maximise the value of the asset.<br />
Therefore, an assessment of the HBU will be required when the indicators are triggered within a reporting period which suggest the<br />
market participants would have perceived an alternative use of an asset that can generate maximum value. Once identified, <strong>Monash</strong><br />
<strong>Health</strong> engages with VGV or other independent valuers for formal HBU assessment.<br />
These indicators, as a minimum, include:<br />
External factors:<br />
• Changed acts, regulations, local law or such instrument which affects or may affect the use or development of the asset;<br />
• Changes in planning scheme, including zones, reservations, overlays that would affect or remove the restrictions imposed on the asset’s<br />
use from its past use;<br />
• Evidence that suggests the current use of an asset is no longer core to requirements to deliver <strong>Monash</strong> <strong>Health</strong>’s service obligation; and<br />
• Evidence that suggests that the asset might be sold or demolished at reaching the late stage of an asset’s life cycle.<br />
Valuation hierarchy<br />
<strong>Monash</strong> <strong>Health</strong> uses valuation techniques that are appropriate for the circumstances and where there is sufficient data available to<br />
measure fair value, maximising the use of relevant observable inputs and minimising the use of unobservable inputs.<br />
All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorised within the fair value<br />
hierarchy.<br />
Identifying unobservable inputs (level 3) fair value measurements<br />
Level 3 fair value inputs are unobservable valuation inputs for an asset or liability. These inputs require significant judgement and<br />
assumptions in deriving fair value for both financial and non-financial assets.<br />
Unobservable inputs are used to measure fair value to the extent that relevant observable inputs are not available, thereby allowing for<br />
situations in which there is little, if any, market activity for the asset or liability at the measurement date. However, the fair value<br />
measurement objective remains the same, i.e., an exit price at the measurement date from the perspective of a market participant that<br />
holds the asset or owes the liability. Therefore, unobservable inputs shall reflect the assumptions that market participants would use<br />
when pricing the asset or liability, including assumptions about risk.<br />
Assumptions about risk include the inherent risk in a particular valuation technique used to measure fair value (such as a pricing risk<br />
model) and the risk inherent in the inputs to the valuation technique. A measurement that does not include an adjustment for risk<br />
would not represent a fair value measurement if market participants would include one when pricing the asset or liability i.e., it might<br />
be necessary to include a risk adjustment when there is significant measurement uncertainty. For example, when there has been a<br />
significant decrease in the volume or level of activity when compared with normal market activity for the asset or liability or similar<br />
assets or liabilities, and <strong>Monash</strong> <strong>Health</strong> has determined that the transaction price or quoted price does not represent fair value.<br />
<strong>Monash</strong> <strong>Health</strong> develops unobservable inputs using the best information available in the circumstances which includes its own data. In<br />
developing unobservable inputs, <strong>Monash</strong> <strong>Health</strong> begins with its own data and makes adjustments to this data if reasonably available<br />
information indicates that other market participants would use different data or data unique to <strong>Monash</strong> <strong>Health</strong> exists that is not available<br />
to other market participants.<br />
Non‐Specialised Land, Non‐Specialised Buildings and Cultural Assets<br />
Non-specialised land, non-specialised buildings and cultural assets are valued using the market approach. Under this valuation method,<br />
the assets are compared to recent comparable sales or sales of comparable assets which are considered to have nominal or no added<br />
improvement value.<br />
For non-specialised land and non-specialised buildings, an independent valuation was performed by the Valuer-General Victoria to<br />
determine the fair value using the market approach. Valuation of the assets was determined by analysing comparable sales and allowing<br />
for share, size, topography, location and other relevant factors specific to the asset being valued. An appropriate rate per square metre<br />
has been applied to the subject asset. The effective date of the valuation is 30 June 2014.<br />
101
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.2 (e): Fair value determination (continued)<br />
Specialised Land and Specialised Buildings<br />
Specialised land includes Crown Land which is measured at fair value with regard to the property’s highest and best use<br />
after due consideration is made for any legal or physical restrictions imposed on the asset, public announcements or<br />
commitments made in relation to the intended use of the asset. Theoretical opportunities that may be available in relation<br />
to the assets are not taken into account until it is virtually certain that any restrictions will no longer apply. Therefore,<br />
unless otherwise disclosed, the current use of these non-financial physical assets will be their highest and best use.<br />
The market approach is used for specialised land and specialised buildings although it is adjusted for the community<br />
service obligation (CSO) to reflect the specialised nature of the assets being valued. Specialised assets contain significant,<br />
unobservable adjustments; therefore these assets are classified as Level 3 under the market based direct comparison<br />
approach.<br />
The CSO adjustment is a reflection of the valuer’s assessment of the impact of restrictions associated with an asset to the<br />
extent that is also equally applicable to market participants. This approach is in light of the highest and best use<br />
consideration required for fair value measurement, and takes into account the use of the asset that is physically possible,<br />
legally permissible and financially feasible. As adjustments of CSO are considered as significant unobservable inputs,<br />
specialised land would be classified as Level 3 assets.<br />
For <strong>Monash</strong> <strong>Health</strong>, the depreciated replacement cost method is used for the majority of specialised buildings, adjusting for<br />
the associated depreciation. As depreciation adjustments are considered as significant and unobservable inputs in nature,<br />
specialised buildings are classified as Level 3 for fair value measurements.<br />
An independent valuation of <strong>Monash</strong> <strong>Health</strong> ’s specialised land and specialised buildings was performed by the Valuer-<br />
General Victoria. The valuation was performed using the market approach adjusted for CSO. The effective date of the<br />
valuation is 30 June 2014.<br />
In June 20<strong>18</strong> a managerial valuation was carried out in accordance with FRD 103F to revalue the land to its fair value.<br />
Plant and Equipment<br />
Plant and equipment (including medical equipment, computers and communication equipment and furniture and fittings are<br />
held at carrying amount (depreciated cost). When plant and equipment is specialised in use, such that it is rarely sold other<br />
than as part of a going concern, the depreciated replacement cost is used to estimate the fair value. Unless there is market<br />
evidence that current replacement costs are significantly different from the original acquisition cost, it is considered<br />
unlikely that depreciated replacement cost will be materially different from the existing carrying amount.<br />
There were no changes in valuation techniques throughout the period to 30 June 20<strong>18</strong>.<br />
For all assets measured at fair value, the current use is considered the highest and best use.<br />
Revaluations of Non‐Current Physical Assets<br />
Non-current physical assets are measured at fair value and are revalued in accordance with FRD 103F Non-Current<br />
Physical Assets . This revaluation process normally occurs every five years, based upon the asset's Government<br />
Purpose Classification, but may occur more frequently if fair value assessments indicate material changes in<br />
values. Independent valuers are used to conduct these scheduled revaluations and any interim revaluations are<br />
determined in accordance with the requirements of the FRDs. Revaluation increments or decrements arise from<br />
differences between an asset’s carrying value and fair value.<br />
Revaluation increments are recognised in ‘Other Comprehensive Income’ and are credited directly to the asset revaluation<br />
surplus, except that, to the extent that an increment reverses a revaluation decrement in respect of that same class of<br />
asset previously recognised as an expense in net result, the increment is recognised as income in the net result.<br />
Revaluation decrements are recognised in ‘Other Comprehensive Income’ to the extent that a credit balance exists in the<br />
asset revaluation surplus in respect of the same class of property, plant and equipment.<br />
Revaluation increases and revaluation decreases relating to individual assets within an asset class are offset against one<br />
another within that class but are not offset in respect of assets in different classes.<br />
Revaluation surplus is not transferred to accumulated funds on de-recognition of the relevant asset, except where an asset<br />
is transferred via contributed capital.<br />
In accordance with FRD 103F, <strong>Monash</strong> <strong>Health</strong>'s non-current physical assets were assessed to determine whether<br />
revaluation of the non-current physical assets was required.<br />
102 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 4.3: Depreciation and amortisation<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000<br />
Depreciation<br />
Buildings 43,072 39,893<br />
Plant & Equipment 5,460 3,567<br />
Medical Equipment 12,831 11,319<br />
Computers and Communication Equipment 3,017 1,819<br />
Furniture and Fittings 1,351 285<br />
Motor Vehicles 7 8<br />
Leased Assets i 8,161 7,841<br />
Total Depreciation 73,899 64,732<br />
Amortisation<br />
Intangible Assets 3,411 2,331<br />
Total Amortisation 3,411 2,331<br />
Total Depreciation and Amortisation 77,310 67,063<br />
(i) Of the balance disclosed under 'Depreciation Leased Assets', $6.5m ($6.5m <strong>2017</strong>) relates to leased buildings<br />
contracted under a PPP arrangement.<br />
All buildings, plant and equipment and intangible produced assets that have finite useful lives are<br />
depreciated. Depreciation begins when the asset is available for use, which is when it is in the location<br />
and condition necessary for it to be capable of operating in a manner intended by management.<br />
Depreciation is generally calculated on a straight line basis, at a rate that allocates the asset value, less<br />
any estimated residual value over its estimated useful life. Estimates of the remaining useful lives and<br />
depreciation method for all assets are reviewed at least annually, and adjustments made where<br />
appropriate. This depreciation charge is not funded by the Department of <strong>Health</strong> and Human Services.<br />
Assets with a cost in excess of $1,000 are capitalised and depreciation has been provided on<br />
depreciable assets so as to allocate their cost or valuation over their estimated useful lives.<br />
Intangible produced assets with finite lives are depreciated as an expense on a systematic basis over<br />
the asset’s useful life.<br />
The following table indicates the expected useful lives of non-current assets on which the depreciation<br />
charges are based.<br />
20<strong>18</strong> <strong>2017</strong><br />
Buildings<br />
– Structure Shell Building Fabric 45 to 70 45 to 70 years<br />
– Site Engineering Services and Central Plant 22 to 30 22 to 30 years<br />
– Fit Out 22 to 30 22 to 30 years<br />
– Trunk Reticulated Building Systems 22 to 30 22 to 30 years<br />
Plant & Equipment 3 to 10 years 3 to 10 years<br />
Medical Equipment 3 to 10 years 3 to 10 years<br />
Computers and Communication 3 years 3 years<br />
Furniture and Fitting Up to 10 Up to 10 years<br />
Motor Vehicles 4 years 4 years<br />
Leased Buildings 45 Years 45 Years<br />
Intangible Assets 5 years 5 years<br />
As part of the building valuation, building values were separated into components and each component<br />
assessed for its useful life which is represented above.<br />
103
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 4.4: Intangible assets<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Intangible Produced Assets - Software 34,088 30,<strong>18</strong>8<br />
Less Accumulated Amortisation (30,123) (26,712)<br />
Total Intangible Assets 3,965 3,476<br />
Reconciliation of the carrying amounts of intangible assets at the beginning and end of the previous<br />
and current financial year:<br />
Consolidated<br />
$'000<br />
Balance at 1 July 2016 4,912<br />
Additions 895<br />
Amortisation (refer Note 4.3) (2,331)<br />
Balance at 1 July <strong>2017</strong> 3,476<br />
Additions 3,900<br />
Amortisation (refer Note 4.3) (3,411)<br />
Balance at 30 June 20<strong>18</strong> 3,965<br />
Intangible assets represent identifiable non-monetary assets without physical substance such as<br />
computer software.<br />
Intangible assets are initially recognised at cost. Subsequently, intangible assets with finite useful<br />
lives are carried at cost less accumulated amortisation and accumulated impairment losses. Costs<br />
incurred subsequent to initial acquisition are capitalised when it is expected that additional future<br />
economic benefits will flow to <strong>Monash</strong> <strong>Health</strong>.<br />
Expenditure on research activities is recognised as an expense in the period in which it is incurred.<br />
104 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 5: Other assets and liabilities<br />
This section sets out those assets and liabilities that arose from the <strong>Monash</strong> <strong>Health</strong>'s operations.<br />
Structure<br />
5.1 Receivables<br />
5.2 Inventories<br />
5.3 Other liabilities<br />
5.4 Payables<br />
105
Note 5.1: Receivables<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000<br />
CURRENT<br />
Contractual<br />
Inter Hospital Debtors 1,799 1,698<br />
Trade Debtors 5,708 5,807<br />
Patient Fees <strong>18</strong>,914 22,259<br />
Accrued Revenue - Other 16,789 10,597<br />
Amounts Receivable from Governments and Agencies i - 6,394<br />
Less Allowance for Doubtful Debts<br />
Trade Debtors (2<strong>18</strong>) (308)<br />
Patient Fees (3,071) (2,448)<br />
39,921 43,999<br />
Statutory<br />
GST Receivable 2,850 3,583<br />
2,850 3,583<br />
TOTAL CURRENT RECEIVABLES 42,771 47,582<br />
NON CURRENT<br />
Statutory<br />
Long Service Leave - Department of <strong>Health</strong> and Human<br />
Services 90,917 81,717<br />
TOTAL NON-CURRENT RECEIVABLES 90,917 81,717<br />
TOTAL RECEIVABLES 133,688 129,299<br />
i Terms and conditions of amounts receivable from the Department of <strong>Health</strong> and Human Services vary according to the<br />
particular agreement with the Department.<br />
(a) Movement in the Allowance for doubtful debts<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000<br />
Balance at beginning of year 2,756 2,550<br />
Increase in allowance recognised in net result 533 206<br />
Balance at end of year 3,289 2,756<br />
(b) Nature and extent of risk arising from receivables<br />
Refer to Note 7.1(a) for the nature and extent of credit risk arising from contractual receivables.<br />
106 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 5.1: Receivables (continued)<br />
Receivables consist of:<br />
• Contractual receivables, which includes mainly debtors in relation to goods and services, loans to<br />
third parties, accrued investment income, and finance lease receivables; and<br />
• Statutory receivables, which includes predominantly amounts owing from the Victorian<br />
Government and Goods and Services Tax (GST) input tax credits recoverable.<br />
Receivables that are contractual are classified as financial instruments and categorised as loans and<br />
receivables. Statutory receivables are recognised and measured similarly to contractual receivables<br />
(except for impairment), but are not classified as financial instruments because they do not arise<br />
from a contract.<br />
Receivables are recognised initially at fair value and subsequently measured at amortised cost less<br />
any accumulated impairment. Trade debtors are carried at nominal amounts due and are due for<br />
settlement within 30 days from the date of recognition.<br />
In assessing impairment of statutory (non-contractual) financial assets, which are not financial<br />
instruments, professional judgement is applied in assessing materiality using estimates, averages<br />
and other computational methods in accordance with AASB 136 Impairment of Assets .<br />
Trade debtors are carried at nominal amounts due and are due for settlement within 30 days from<br />
the date of recognition. Collectability of debts is reviewed on an ongoing basis, and debts which are<br />
known to be uncollectible are written off. A provision for doubtful debts is recognised when there is<br />
objective evidence that the debts may not be collected and bad debts are written off when<br />
identified.<br />
107
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 5.2: Inventories<br />
At Cost:<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Pharmaceuticals 7,961 6,160<br />
Medical and Surgical Consumables 7,336 7,939<br />
General Stores 559 525<br />
Pathology 1,464 1,1<strong>18</strong><br />
TOTAL INVENTORIES 17,320 15,742<br />
Inventories include goods and other property held either for sale, consumption or for<br />
distribution at no or nominal cost in the ordinary course of business operations. It includes<br />
land held for sale and excludes depreciable assets.<br />
Inventories held for distribution are measured at weighted average cost, adjusted for any<br />
loss of service potential. All other inventories are measured at the lower of cost and net<br />
realisable value.<br />
Inventories acquired at no cost or for nominal consideration are measured at current<br />
replacement cost at the date of acquisition.<br />
The bases used in assessing loss of service potential for inventories held for distribution<br />
include current replacement cost and technical or functional obsolescence.<br />
Cost is assigned to high value, low volume inventory items on a specific identification of cost<br />
basis.<br />
108 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 5.3: Other liabilities<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
CURRENT<br />
Monies Held in Trust<br />
- Patient Monies Held in Trust 219 211<br />
- Accommodation Bonds (Refundable Entrance Fees) 14,825 12,408<br />
Total Other Liabilities 15,044 12,619<br />
Represented by the following assets:<br />
Cash Assets 15,044 12,619<br />
TOTAL 15,044 12,619<br />
109
Note 5.4: Payables<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000<br />
CURRENT<br />
Contractual<br />
Trade Creditors 30,323 29,604<br />
Accrued Expenses 31,562 24,311<br />
Amounts payable to doctors 544 544<br />
Superannuation Accrual 8,669 10,566<br />
Prepaid revenue - Department of <strong>Health</strong> and Human<br />
Services 5,608 -<br />
Other 13,516 16,192<br />
TOTAL PAYABLES 90,222 81,217<br />
Payables consist of:<br />
• Contractual payables which consist predominantly of accounts payable representing<br />
liabilities for goods and services provided to <strong>Monash</strong> <strong>Health</strong> prior to the end of the financial<br />
year that are unpaid, and arise when <strong>Monash</strong> <strong>Health</strong> becomes obliged to make future<br />
payments in respect of the purchase of those goods and services. The normal credit terms<br />
for accounts payable are usually nett 30 - 35 days.<br />
Contractual payables are classified as financial instruments and are initially recognised at<br />
fair value, and then subsequently carried at amortised cost. Statutory payables are<br />
recognised and measured similarly to contractual payables, but are not classified as<br />
financial instruments and not included in the category of financial liabilities at amortised<br />
cost, because they do not arise from a contract.<br />
110 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 5.4 (a): Payables and borrowings maturity analysis<br />
The following table discloses the contractual maturity analysis for <strong>Monash</strong> <strong>Health</strong>'s financial liabilities.<br />
Maturity analysis of Financial Liabilities as at 30 June<br />
Carrying<br />
Amount<br />
Nominal<br />
Amount<br />
Less than 1<br />
Month<br />
1-3 Months 3 months -<br />
1 Year<br />
1 - 5 Years Over 5<br />
Years<br />
20<strong>18</strong> $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />
Financial Liabilities<br />
Maturity Dates<br />
At amortised cost<br />
Payables 90,222 90,222 45,822 44,400<br />
Borrowings 93,578 93,578 1,648 858 8,544 36,499 46,030<br />
Other Financial Liabilities i<br />
- Accommodation Bonds 14,825 14,825 - 667 14,159 - -<br />
- Other 219 219 219 - - - -<br />
Total Financial Liabilities 198,844 198,844 47,689 45,925 22,703 36,499 46,030<br />
<strong>2017</strong><br />
Financial Liabilities<br />
At amortised cost<br />
Payables 81,217 81,217 56,757 24,460 - - -<br />
Borrowings 89,579 89,579 - 2,438 7,236 35,524 44,381<br />
Other Financial Liabilities i<br />
- Accommodation Bonds 12,408 12,408 - 1,625 10,783 - -<br />
- Other 211 211 211 - - - -<br />
Total Financial Liabilities <strong>18</strong>3,415 <strong>18</strong>3,415 56,968 28,523 <strong>18</strong>,019 35,524 44,381<br />
Ageing analysis of financial liabilities excludes the types of statutory financial liabilities (i.e. GST payable)<br />
i<br />
111
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 6: How we finance our operations<br />
This section provides information on the sources of finance utilised by <strong>Monash</strong> <strong>Health</strong> during its<br />
operations, along with interest expenses (the cost of borrowings) and other information related to<br />
financing activities of <strong>Monash</strong> <strong>Health</strong>.<br />
This section includes disclosures of balances that are financial instruments (such as borrowings and<br />
cash balances). Note: 7.1 provides additional, specific financial instrument disclosures.<br />
Structure<br />
6.1 Borrowings<br />
6.2 Cash and cash equivalents<br />
6.3 Commitments for expenditure<br />
112 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 6.1: Borrowings<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
CURRENT<br />
Australian Dollar Borrowings<br />
– Finance Lease Liability i 5,600 5,048<br />
– TCV Loan ii 1,<strong>18</strong>1 1,113<br />
– Advances from Government iii 1,000 -<br />
Total Australian Dollars Borrowings 7,781 6,161<br />
Total Current 7,781 6,161<br />
NON CURRENT<br />
Australian Dollar Borrowings<br />
– Finance Lease Liability i 51,945 56,229<br />
– TCV Loan ii 26,008 27,<strong>18</strong>9<br />
– Advances from Government iii 7,844 -<br />
Total Australian Dollars Borrowings 85,797 83,4<strong>18</strong><br />
Total Non-Current 85,797 83,4<strong>18</strong><br />
Total Borrowings 93,578 89,579<br />
i During the year ended 30 June 2005, Casey Hospital commenced operation. Construction and fit out of Casey Hospital was<br />
funded as Public Private Partnership under a Project Agreement between the State of Victoria and Progress <strong>Health</strong> Pty Ltd.<br />
<strong>Monash</strong> <strong>Health</strong> is responsible for operating Casey Hospital and has recognised the leased asset (Note 4.2) and associated<br />
interest bearing liabilities. The State of Victoria is obligated to fund quarterly service payments due under the Project<br />
Agreement for the life of that agreement, a period of up to 25 years.<br />
ii During the year ended 30 June 2010, <strong>Monash</strong> <strong>Health</strong> entered into a loan agreement with the Treasury Corporation of<br />
Victoria to fund $19.6m improvements required to the car park at the Clayton site. The loan is repayable over 22 years with<br />
repayments being made quarterly.<br />
During the year ended 30 June 2014, <strong>Monash</strong> <strong>Health</strong> made a further drawdown under the existing loan arrangement with the<br />
Treasury Corporation of Victoria to fund $13.5m improvements required to the car park at the Clayton site. The loan is<br />
repayable over 20 years with repayments being made quarterly.<br />
iii During the year ended 30 June 20<strong>18</strong>, the Department of <strong>Health</strong> and Human Services granted an interest free loan of $10m<br />
to <strong>Monash</strong> <strong>Health</strong>. The loan is repayable over 10 years with repayments being made annually.<br />
(a) Maturity analysis of borrowings<br />
Please refer to Note 5.4 for the ageing analysis of borrowings.<br />
(b) Defaults and breaches<br />
During the current and prior year, there were no defaults and breaches of any of the borrowings.<br />
113
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 6.1 Borrowings (continued)<br />
(c) Finance lease liabilities<br />
Minimum future lease<br />
payments (i)<br />
Present value of<br />
minimum future lease<br />
payments<br />
20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong> <strong>2017</strong><br />
Finance leases $'000 $'000 $'000 $'000<br />
Casey Hospital Public Private Partnership Lease<br />
Repayments in relation to finance leases are payable as follows:<br />
Not later than one year 6,592 6,592 3,399 3,199<br />
Later than one year but not later than 5 years 26,370 26,370 15,871 14,933<br />
Later than 5 years 41,752 48,345 34,553 38,891<br />
Other finance lease liabilities payable i<br />
Not later than one year 2,276 1,969 2,201 1,849<br />
Later than one year but not later than 5 years 1,555 2,475 1,521 2,405<br />
Minimum lease payments ii 78,546 85,751 57,545 61,277<br />
Less future finance charges (21,001) (24,474) - -<br />
TOTAL 57,545 61,277 57,545 61,277<br />
Included in the financial statements as:<br />
Current borrowings lease liabilities 5,600 5,048<br />
Non-current borrowing lease liabilities 51,945 56,229<br />
57,545 61,277<br />
The weighted average interest rate implicit in the finance lease is 6.07% (<strong>2017</strong>: 6.07%).<br />
i Other finance lease liabilities include obligations that are recognised on the Balance Sheet.<br />
ii Minimum future lease payments include the aggregate of all base payments and any guaranteed residual.<br />
A lease is a right to use an asset for an agreed period of time in exchange for payment. Leases are classified at their<br />
inception as either operating or finance leases based on the economic substance of the agreement so as to reflect the risks<br />
and rewards incidental to ownership.<br />
Leases of property, plant and equipment are classified as finance leases whenever the terms of the lease transfer<br />
substantially all the risks and rewards of ownership to the lessee. All other leases are classified as operating leases, in the<br />
manner described in Note 6.3 Commitments for expenditure.<br />
Finance Leases<br />
Entity as lessor<br />
<strong>Monash</strong> <strong>Health</strong> does not hold any finance lease arrangements with other parties.<br />
Entity as lessee<br />
Finance leases are recognised as assets and liabilities at amounts equal to the fair value of the lease property or, if lower, the<br />
present value of the minimum lease payment, each determined at the inception of the lease. The lease assets under the PPP<br />
arrangement are accounted for as a non-financial physical asset and is depreciated over the term of the lease. Minimum<br />
lease payments are apportioned between reduction of the outstanding lease liability, and the periodic finance expense which<br />
is calculated using the interest rate implicit in the lease, and charged directly to the Comprehensive Operating Statement.<br />
Contingent rentals associated with finance leases are recognised as an expense in the period in which they are incurred.<br />
Leasehold Improvement<br />
The cost of leasehold improvements are capitalised as an asset and depreciated over the remaining term of the lease or the<br />
estimated useful life of the improvements, whichever is the shorter.<br />
Borrowings<br />
All borrowings are initially recognised at fair value of the consideration received, less directly attributable transaction costs.<br />
Subsequent to initial recognition, borrowings are measured at amortised cost with any difference between the initial<br />
recognised amount and the redemption value being recognised in the net result over the period of the borrowing using the<br />
effective interest method. Fair value is determined in the manner described in Note 7.1.<br />
114 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 6.2: Cash and Cash Equivalents<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Cash on Hand 74 74<br />
Cash at Bank i 160,858 115,935<br />
Total Cash and Cash Equivalents 160,932 116,009<br />
Represented by:<br />
Cash as per Cash Flow Statement 145,888 103,390<br />
Cash for Monies Held in Trust (refer to Note 5.3)<br />
- Cash at Bank 15,044 12,619<br />
Total Cash and Cash Equivalents 160,932 116,009<br />
i<br />
$7.6m (<strong>2017</strong>: $7.9m) relates to funding from the Commonwealth Department of <strong>Health</strong> and Human Services for the <strong>Monash</strong><br />
<strong>Health</strong> Translation Precinct.<br />
Cash and cash equivalents recognised on the Balance Sheet comprise cash on hand and in banks,<br />
deposits at call and highly liquid investments (with an original maturity date of three months or less),<br />
which are held for the purpose of meeting short term cash commitments rather than for investment<br />
purposes, which are readily convertible to known amounts of cash and are subject to insignificant risk<br />
of changes in value.<br />
For cash flow statement presentation purposes, cash and cash equivalents include any bank overdrafts,<br />
which are included as liabilities on the Balance Sheet.<br />
115
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 6.3: Commitments for expenditure<br />
a) Commitments other than public private partnerships<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Capital Expenditure Commitments<br />
Payable:<br />
Plant and equipment 29,987 37,728<br />
Total Capital Expenditure Commitments 29,987 37,728<br />
Operating Commitments<br />
Payable:<br />
Contracted services 100,074 108,854<br />
Total Operating Commitments 100,074 108,854<br />
Lease Commitments<br />
Commitments in relation to leases contracted for at the<br />
reporting date - cancellable 33,814 36,<strong>18</strong>0<br />
Total Lease Commitments 33,814 36,<strong>18</strong>0<br />
Total Commitments other than Public Private<br />
Partnerships 163,875 <strong>18</strong>2,762<br />
All amounts shown in the commitments note are nominal amounts inclusive of GST.<br />
Commitments for future expenditure include operating and capital commitments arising from contracts. These<br />
commitments are disclosed by way of a note at their nominal value and are inclusive of the GST payable. In<br />
addition, where it is considered appropriate and provides additional relevant information to users, the net<br />
present values of significant individual projects are stated. These future expenditures cease to be disclosed as<br />
commitments once the related liabilities are recognised on the balance sheet.<br />
Service concession arrangements<br />
<strong>Monash</strong> <strong>Health</strong> sometimes enters into certain arrangement with private sector participants to design and<br />
construct or upgrade assets used to provide public services. These arrangements are typically complex and<br />
usually include the provision of operational and maintenance services for a specified period of time. These<br />
arrangements are often referred to as either public private partnerships or service concession arrangements<br />
(SCAs). The State of Victoria is obliged to fund Quarterly Service Payments due under the Project Agreement<br />
for the life of that Agreement, a period of up to 25 years. <strong>Monash</strong> <strong>Health</strong> expects that it will continue to<br />
operate and control Casey Hospital at the expiry of the lease. The building has been componentised into 4<br />
major asset classes, of which their estimated useful lives are between 22 to 70 years.<br />
These SCAs usually take one of two main forms. In the more common form, <strong>Monash</strong> <strong>Health</strong> pays the operator<br />
over the period of the arrangement, subject to specified performance criteria being met. At the date of<br />
commitment to the principal provisions of the arrangement, these estimated periodic payments are allocated<br />
between a component related to the design and construction or upgrading of the asset and components<br />
related to the ongoing operation and maintenance of the asset. The former component is accounted for as a<br />
lease payment in accordance with the lease policy (See Note 6.1). The remaining components are accounted<br />
for as commitments for operating costs which are expensed in the comprehensive operating statement as<br />
they are incurred.<br />
116 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 6.3: Commitments for expenditure (continued)<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
(b) Public Private Partnerships i, ii $'000 $'000<br />
Commissioned Public Private Partnerships - Casey<br />
Hospital<br />
Nominal Value Nominal Value iii<br />
PPP operations and maintenance commitment<br />
Not later than one year 11,211 6,244<br />
Later than 1 year and not later than 5 years 21,597 27,734<br />
Later than 5 years 60,147 65,221<br />
Total PPP operations and maintenance commitment 92,954 99,199<br />
Capital commitments iv<br />
Not later than one year 9,<strong>18</strong>7 8,973<br />
Later than 1 year and not later than 5 years 39,101 38,147<br />
Later than 5 years 70,391 80,531<br />
Total capital commitments 1<strong>18</strong>,678 127,652<br />
TOTAL COMMITMENTS FOR PUBLIC PRIVATE PARTNERSHIPS 211,633 226,850<br />
Amounts shown are exempt from GST.<br />
i<br />
The present values of the minimum lease payments for commissioned Public Private Partnerships (PPP) are recognised on the Balance Sheet<br />
and are not disclosed as commitments.<br />
ii<br />
The year on year reduction in the nominal amounts of the other commitments reflects the payments made.<br />
iii<br />
The prior year amounts have been updated to reflect the Department of Treasury and Finance commitments and are now comparable to the<br />
current year disclosure.<br />
iv The capital commitments include both interest and principle repayments based on the Treasury Corporation of Victoria PPP model as<br />
provided by DHHS. The finance lease liability disclosed in Note 6.1 presents the principle component of the capital commitment, as minimum<br />
future lease payments.<br />
(c) Commitments payable<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Capital Expenditure Commitments<br />
Less than 1 year 23,570 23,175<br />
Longer than 1 year but not longer than 5 years 6,417 14,552<br />
Total Capital Expenditure Commitments 29,987 37,728<br />
Operating Commitments<br />
Less than 1 year 35,701 30,213<br />
Longer than 1 year but not longer than 5 years 64,370 61,766<br />
5 years or more 3 16,875<br />
Total Operating Commitments 100,074 108,854<br />
Lease Commitments<br />
Less than 1 year 7,588 7,612<br />
Longer than 1 year but not longer than 5 years 15,512 15,252<br />
5 years or more 10,714 13,316<br />
Total Lease Commitments 33,814 36,<strong>18</strong>0<br />
Public Private Partnership Commitments (commissioned) i<br />
Less than 1 year 20,398 15,2<strong>18</strong><br />
Longer than 1 year but not longer than 5 years 60,698 65,881<br />
5 years or more 130,537 145,751<br />
Total Public Private Partnership Commitments 211,633 226,850<br />
Total Commitments 375,508 409,612<br />
Less GST recoverable from Australian Tax Office (17,132) (15,562)<br />
Total Commitments 358,376 394,050<br />
117
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 7: Risks, contingencies and valuation uncertainties<br />
<strong>Monash</strong> <strong>Health</strong> is exposed to risk from its activities and outside factors. In addition, it is often<br />
necessary to make judgements and estimates associated with recognition and measurement of items in<br />
the financial statements. This section sets out financial instrument specific information, (including<br />
exposures to financial risks) as well as those items that are contingent in nature or require a higher<br />
level of judgement to be applied, which for <strong>Monash</strong> <strong>Health</strong> is related mainly to fair value determination.<br />
Structure<br />
7.1 Financial instruments<br />
7.2 Contingent assets and contingent liabilities<br />
1<strong>18</strong> <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 7.1: Financial instruments<br />
Financial instruments arise out of contractual agreements that give rise to a financial asset of one<br />
entity and a financial liability or equity instrument of another entity. Due to the nature of <strong>Monash</strong><br />
<strong>Health</strong>'s activities, certain financial assets and financial liabilities arise under statute rather than a<br />
contract. Such financial assets and financial liabilities do not meet the definition of financial<br />
instruments in AASB 132 Financial Instruments: Presentation .<br />
(a) Financial instruments: categorisation<br />
Contractual<br />
Financial<br />
Assets -<br />
Receivables<br />
Contractual<br />
Financial<br />
Liabilities at<br />
Amortised<br />
Cost<br />
Total<br />
Consolidated<br />
20<strong>18</strong> $'000 $'000 $'000<br />
Contractual Financial Assets<br />
Cash and cash equivalents 160,932 - 160,932<br />
Receivables<br />
- Trade debtors 5,490 - 5,490<br />
- Other receivables 34,431 - 34,431<br />
Total Financial Assets i 200,853 - 200,853<br />
Financial Liabilities<br />
Payables - 90,222 90,222<br />
Borrowings - 93,578 93,578<br />
Other financial liabilities<br />
- Accommodation bonds - 14,825 14,825<br />
- Other - 219 219<br />
Total Financial Liabilities i - 198,844 198,844<br />
Contractual<br />
Financial<br />
Assets -<br />
Receivables<br />
Contractual<br />
Financial<br />
Liabilities at<br />
Amortised<br />
Cost<br />
Total<br />
Consolidated<br />
<strong>2017</strong> $'000 $'000 $'000<br />
Contractual Financial Assets<br />
Cash and cash equivalents 116,009 - 116,009<br />
Receivables<br />
- Trade debtors 5,499 - 5,499<br />
- Other receivables 38,500 - 38,500<br />
Total Financial Assets i 160,008 - 160,008<br />
Financial Liabilities<br />
Payables - 81,217 81,217<br />
Borrowings - 89,579 89,579<br />
Other financial liabilities<br />
- Accommodation bonds - 12,408 12,408<br />
- Other - 211 211<br />
Total Financial Liabilities i - <strong>18</strong>3,415 <strong>18</strong>3,415<br />
i The carrying amount excludes statutory receivables (i.e. GST receivable and DHHS receivable) and<br />
statutory payables (i.e. Revenue in Advance and DHHS payable).<br />
119
Note 7.1: Financial instruments (continued)<br />
(b) Net holding gain/(loss) on financial instruments by category<br />
Notes To the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Net Holding<br />
Gain/(Loss) Total<br />
Consolidated<br />
20<strong>18</strong> $'000 $'000<br />
Financial Assets<br />
Cash and Cash Equivalents i 2,807 2,807<br />
Investment - Term Deposit 524 524<br />
Financial Assets - Receivables i (2,713) (2,713)<br />
Total Financial Assets 6<strong>18</strong> 6<strong>18</strong><br />
Financial Liabilities<br />
Financial Liabilities at Amortised Cost ii (54) (54)<br />
Total Financial Liabilities (54) (54)<br />
<strong>2017</strong><br />
Financial Assets<br />
Cash and Cash Equivalents i 1,867 1,867<br />
Investment - Term Deposit 1,038 1,038<br />
Receivables i (2,<strong>18</strong>9) (2,<strong>18</strong>9)<br />
Total Financial Assets 716 716<br />
Financial Liabilities<br />
Financial Liabilities at Amortised Cost ii (378) (378)<br />
Total Financial Liabilities (378) (378)<br />
i For cash and cash equivalents and receivables, the net gain or loss is calculated by taking the movement<br />
in the fair value of the asset, the interest revenue, plus or minus foreign exchange gains or losses arising<br />
from revaluation of the financial assets, and minus any impairment recognised in the net result.<br />
ii For financial liabilities measured at amortised cost, the net gain or loss is calculated by taking the<br />
interest expense measured at amortised cost.<br />
Categories of financial instruments<br />
Receivables and cash are financial instrument assets with fixed and determinable payments that are not<br />
quoted on an active market. These assets are initially recognised at fair value plus any directly attributable<br />
transaction costs. Subsequent to initial measurement, receivables are measured at amortised cost using the<br />
accrual method (and for assets, less any impairment). <strong>Monash</strong> <strong>Health</strong> recognises the following assets in this<br />
category:<br />
· cash and deposits<br />
· receivables (excluding statutory receivables); and<br />
· term deposits<br />
Financial liabilities at amortised cost are initially recognised on the date they are originated. They are<br />
initially measured at fair value plus any directly attributable transaction costs. Subsequent to initial<br />
recognition, these financial instruments are measured at amortised cost with any difference between the<br />
initial recognised amount and the redemption value being recognised in profit and loss over the period of the<br />
interest bearing liability, using the accrual method. <strong>Monash</strong> <strong>Health</strong> recognises the following liabilities in this<br />
category:<br />
· payables (excluding statutory payables); and<br />
· borrowings (including finance lease liabilities).<br />
Offsetting financial instruments: Financial instrument assets and liabilities are offset and the net amount<br />
presented in the consolidated balance sheet when, and only when, <strong>Monash</strong> <strong>Health</strong> has a legal right to offset<br />
the amounts and intends either to settle on a net basis or to realise the asset and settle the liability<br />
simultaneously.<br />
120 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 7.1: Financial instruments (continued)<br />
(b) Net holding gain/(loss) on financial instruments by category<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Some master netting arrangements do not result in an offset of balance sheet assets and<br />
liabilities. Where <strong>Monash</strong> <strong>Health</strong> does not have a legally enforceable right to offset recognised<br />
amounts, because the right to offset is enforceable only on the occurrence of future events<br />
such as default, insolvency or bankruptcy, they are reported on a gross basis.<br />
Derecognition of financial assets: A financial asset (or, where applicable, a part of a<br />
financial asset or part of a group of similar financial assets) is derecognised when:<br />
· the rights to receive cash flows from the asset have expired; or<br />
· <strong>Monash</strong> <strong>Health</strong> retains the right to receive cash flows from the asset, but has assumed an<br />
obligation to pay them in full without material delay to a third party under a ‘pass through’<br />
arrangement; or<br />
· <strong>Monash</strong> <strong>Health</strong> has transferred its rights to receive cash flows from the asset and either:<br />
· has transferred substantially all the risks and rewards of the asset; or<br />
· has neither transferred nor retained substantially all the risks and rewards of the asset,<br />
but has transferred control of the asset.<br />
Where <strong>Monash</strong> <strong>Health</strong> has neither transferred nor retained substantially all the risks and<br />
rewards or transferred control, the asset is recognised to the extent of <strong>Monash</strong> <strong>Health</strong>’s<br />
continuing involvement in the asset.<br />
Impairment of financial assets: At the end of each reporting period, <strong>Monash</strong> <strong>Health</strong><br />
assesses whether there is objective evidence that a financial asset or group of financial assets<br />
is impaired. All financial instrument assets, except those measured at fair value through profit<br />
or loss, are subject to annual review for impairment.<br />
The allowance is the difference between the financial asset’s carrying amount and the present<br />
value of estimated future cash flows, discounted at the effective interest rate. In assessing<br />
impairment of statutory (non-contractual) financial assets, which are not financial<br />
instruments, professional judgement is applied in assessing materiality using estimates,<br />
averages and other computational methods in accordance with AASB 136 Impairment of<br />
Assets .<br />
Reclassification of financial instruments: Subsequent to initial recognition and under rare<br />
circumstances, non-derivative financial instruments assets that have not been designated at<br />
fair value through profit or loss upon recognition, may be reclassified out of the fair value<br />
through profit or loss category, if they are no longer held for the purpose of selling or<br />
repurchasing in the near term.<br />
Derecognition of financial liabilities: A financial liability is derecognised when the<br />
obligation under the liability is discharged, cancelled or expires.<br />
When an existing financial liability is replaced by another from the same lender on<br />
substantially different terms, or the terms of an existing liability are substantially modified,<br />
such an exchange or modification is treated as a derecognition of the original liability and the<br />
recognition of a new liability. The difference in the respective carrying amounts is recognised<br />
as an ‘other economic flow’ in the Comprehensive Operating Statement.<br />
121
Notes To and Forming Part of the Financial Statements<br />
Monas <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/<strong>18</strong><br />
Note 7.2: Contingent assets and contingent liabilities<br />
At 30 June 20<strong>18</strong>, there were no contingent assets (<strong>2017</strong>: $0)<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Contingent Liabilities<br />
Quantifiable<br />
Backdated EBA Awards - 2,900<br />
Total Quantifiable Contingent Liabilities - 2,900<br />
All amounts shown in the contingents note are nominal amounts inclusive of GST.<br />
Contingent assets and contingent liabilities are not recognised in the Balance Sheet, but are disclosed<br />
by way of note and, if quantifiable, are measured at nominal value. Contingent assets and contingent<br />
liabilities are presented inclusive of GST receivable or payable respectively.<br />
122 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8: Other disclosures<br />
This section includes additional material disclosures required by accounting standards or otherwise, for<br />
the understanding of this annual report.<br />
Structure<br />
8.1 Equity<br />
8.2 Reconciliation of net result for the year to net cash flow from operating activities<br />
8.3 Responsible persons disclosures<br />
8.4 Remuneration of executives<br />
8.5 Related parties<br />
8.6 Remuneration of auditors<br />
8.7 Ex-gratia payments<br />
8.8 AASBs issued that are not yet effective<br />
8.9 Events occurring after the balance sheet date<br />
8.10 Controlled entities<br />
8.11 Economic dependency<br />
123
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.1: Equity<br />
(a) Surpluses<br />
Property, Plant and Equipment Revaluation Surplus<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000<br />
$'000<br />
Balance at the beginning of the reporting period 641,545 641,545<br />
Revaluation increment<br />
- Land 35,000 -<br />
Balance at the end of the reporting period* 676,545 641,545<br />
* Represented by:<br />
- Land 158,864 123,864<br />
- Buildings 516,917 516,917<br />
- Cultural assets 447 447<br />
- Motor vehicles 317 317<br />
676,545 641,545<br />
Restricted Specific Purpose Surplus<br />
Balance at the beginning of the reporting period 14,953 8,203<br />
Transfer from accumulated surplus 5,762 6,750<br />
Balance at the end of the reporting period 20,715 14,953<br />
Total Surpluses 697,260 656,498<br />
(b) Contributed Capital<br />
Balance at the beginning of the reporting period 403,093 403,048<br />
Capital contribution received from Victorian Government 827 45<br />
Balance at the end of the reporting period 403,920 403,093<br />
(c) Accumulated Surpluses<br />
Balance at the beginning of the reporting period 133,689 32,982<br />
Net result for the year 15 107,457<br />
Transfers to restricted specific purpose surplus (5,762) (6,750)<br />
Prior year adjustment 36 -<br />
Balance at the end of the reporting period 127,978 133,689<br />
Total equity at end of year 1,229,158 1,193,280<br />
Contributed Capital<br />
Consistent with Australian Accounting Interpretation 1038 Contributions by Owners Made to<br />
Wholly-Owned Public Sector Entities and FRD 119A Contributions by Owners , appropriations<br />
for additions to the net asset base have been designated as contributed capital. Other<br />
transfers that are in the nature of contributions to or distributions by owners that have been<br />
designated as contributed capital are also treated as contributed capital.<br />
Transfers of net assets arising from administrative restructurings are treated as contributions<br />
by owners. Transfers of net liabilities arising from administrative restructures are to go<br />
through the Comprehensive Operating Statement.<br />
Property, Plant and Equipment Revaluation Surplus<br />
The asset revaluation surplus is used to record increments and decrements on the revaluation<br />
of non-current physical assets.<br />
Specific Restricted Purpose Surplus<br />
A specific restricted purpose surplus is established where <strong>Monash</strong> <strong>Health</strong> has possession or<br />
title to the funds but has no discretion to amend or vary the restriction and/or condition<br />
underlying the funds received.<br />
124 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.2: Reconciliation of net result for the year to net cash<br />
Flow from operating activities<br />
Consolidated Consolidated<br />
20<strong>18</strong> <strong>2017</strong><br />
$'000 $'000<br />
Net result for the period 15 107,457<br />
Non-cash movements:<br />
Depreciation and amortisation 77,310 67,063<br />
Provision for doubtful debts 533 206<br />
Adjustment Prior year capital contribution 11 -<br />
Share of net results in associates (87) (147)<br />
Net movement in finance lease i (3,198) (2,172)<br />
Government non cash funding for hospital expansion (44,380) (61,905)<br />
Adjustment of non current portion of loan to present value (1,155) -<br />
Movements included in investing and financing activities<br />
Net gain from disposal of non-financial physical assets 342 271<br />
Movements in assets and liabilities:<br />
Change in operating assets and liabilities<br />
(Increase)/Decrease in Receivables 54 (6,963)<br />
(Increase)/Decrease in Prepayments 806 422<br />
Increase/(Decrease) in Payables 9,005 (14,158)<br />
Increase/(Decrease) in Provisions 41,375 24,165<br />
(Increase)/Decrease in Inventories (1,578) (2,617)<br />
NET CASH INFLOW FROM OPERATING ACTIVITIES 79,053 111,622<br />
i Funded by and payments made by the Department of <strong>Health</strong> and Human Services to <strong>Monash</strong><br />
<strong>Health</strong>.<br />
125
Note 8.3: Responsible persons disclosures<br />
Responsible Ministers:<br />
The Honourable Jill Hennessy, Minister for <strong>Health</strong>, Minister for Ambulance Services<br />
The Honourable Martin Foley, Minister for Housing, Disability and Ageing, Minister<br />
for Mental <strong>Health</strong><br />
Governing Boards<br />
Ms Barbara Yeoh (term expired 30 June 20<strong>18</strong>)<br />
Ms Debbie Williams (term expired 30 June 20<strong>18</strong>)<br />
Mr Charles Gillies<br />
Ms Heather Cleland<br />
Mr Dipak Sanghvi<br />
Ms Jorden Lam<br />
Dr Misty Jenkins<br />
Ms Sarah Ralph<br />
Prof. Hatem Salem<br />
Accountable Officers<br />
Mr Andrew Stripp<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
In accordance with the Ministerial Directions issued by the Minister for Finance under the Financial<br />
Management Act 1994 , the following disclosures are made regarding responsible persons for the reporting<br />
period.<br />
Period<br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />
Remuneration of Responsible Persons<br />
The number of Responsible Persons are shown in their relevant income bands.<br />
Parent<br />
20<strong>18</strong> <strong>2017</strong><br />
Income Band No. No.<br />
$0 - $19,999 - 3<br />
$20,000 - $29,999 - 2<br />
$30,000 - $39,999 8 5<br />
$70,000 - $79,999 1<br />
1<br />
$420,000 - $429,999 - 1<br />
$460,000 - $469,999 1 -<br />
Total numbers of Responsible Persons 10 12<br />
Total remuneration received or due and receivable by Responsible<br />
Persons from the reporting entity amounted to:<br />
$854,638 $770,504<br />
Amounts relating to the Governing Board Members and Accountable Officer are disclosed in the <strong>Monash</strong><br />
<strong>Health</strong>'s controlled entities financial Statement. Amounts relating to responsible Ministers are reported within<br />
the Department of Parliamentary Services' Financial <strong>Report</strong> as disclosed in Note 8.5 Related Parties.<br />
126 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.4: Remuneration of executives<br />
Executive Officers' Remuneration<br />
The number of executive officers, other than Ministers and Accountable Officers, and their total<br />
remuneration during the reporting period are shown in the table below. Total annualised employee<br />
equivalent provides a measure of full time equivalent executive officers over the reporting period.<br />
Remuneration comprises employee benefits in all forms of consideration paid, payable or provided in<br />
exchange for services rendered, and is disclosed in the following categories:<br />
Short-term Employee Benefits<br />
Salary and wages, annual leave or sick leave that are usually paid or payable on a regular basis, as well as<br />
non-monetary benefits such as allowances and free or subsidised goods or services.<br />
Post-employment Benefits<br />
Pensions and other retirement benefits paid or payable on a discrete basis when employment has ceased.<br />
Other Long-term Benefits<br />
Long service leave, other long-service benefit or deferred compensation.<br />
Remuneration of executive officers<br />
Parent<br />
Total Remuneration<br />
20<strong>18</strong> <strong>2017</strong><br />
$ '000 $ '000<br />
Short-term benefits 2,351 2,173<br />
Post-employment benefits 213 202<br />
Other Long-term benefits 74 45<br />
Total remuneration 2,638 2,420<br />
Total number of executives 9 12<br />
Total annualised employee equivalent i 9 8<br />
Remuneration of Kitaya Holding Pty Ltd's executive officers is disclosed in the company's financial<br />
statements.<br />
(i) <strong>Annual</strong>ised employee equivalent is based on working 38 ordinary hours per week over the reporting period.<br />
127
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.5: Related parties<br />
<strong>Monash</strong> <strong>Health</strong> is a wholly owned and controlled entity of the State of Victoria. Related parties of the<br />
hospital include:<br />
• All key management personnel (KMPs) and their close family members;<br />
• Cabinet ministers (where applicable) and their close family members; and<br />
• Controlled entities<br />
• All hospitals and public sector entities that are controlled and consolidated into the whole of state<br />
consolidated financial statements.<br />
KMPs are those people with the authority and responsibility for planning, directing and controlling the<br />
activities of <strong>Monash</strong> <strong>Health</strong> and its controlled entities, directly or indirectly.<br />
The Board of Directors and the Chief Executive of <strong>Monash</strong> <strong>Health</strong> and it's controlled entities are<br />
deemed to be KMPs.<br />
Key Management Personnel<br />
<strong>Monash</strong> <strong>Health</strong><br />
Ms Barbara Yeoh (term expired 30 June 20<strong>18</strong>)<br />
Ms Debbie Williams (term expired 30 June 20<strong>18</strong>)<br />
Mr Charles Gillies<br />
Ms Heather Cleland<br />
Mr Dipak Sanghvi<br />
Ms Jorden Lam<br />
Dr Misty Jenkins<br />
Ms Sarah Ralph<br />
Prof. Hatem Salem<br />
Mr Andrew Stripp<br />
Position Title<br />
Board Member<br />
Board Member<br />
Board Member<br />
Board Member<br />
Board Member<br />
Board Member<br />
Board Member<br />
Board Member<br />
Board Member<br />
Chief Executive<br />
Kitaya Holding Pty Ltd's KMPs are disclosed in the company's financial statements<br />
Significant transactions with government-related entities<br />
<strong>Monash</strong> <strong>Health</strong> received funding from the Department of <strong>Health</strong> and Human Services of $1,451<br />
million (<strong>2017</strong>: $1,384 million).<br />
The Department of <strong>Health</strong> and Human Services granted an interest free loan of $10m to <strong>Monash</strong><br />
<strong>Health</strong> during the year ended 30 June 20<strong>18</strong>. The loan is repayable over 10 years with repayments<br />
<strong>Monash</strong> <strong>Health</strong> has two loan agreements with Treasury Corporation of Victoria for $19.6m and<br />
$13.3m with amounts borrowed repayable over 22 and 20 years respectively. At 30 June 20<strong>18</strong>, the<br />
total amount due to the Treasury Corporatiion of Victoria in relation to these loans was $27.2m.<br />
Expenses incurred by <strong>Monash</strong> <strong>Health</strong> in delivering services and outputs are in accordance with <strong>Health</strong><br />
Purchasing Victoria requirements. Goods and services including procurement, diagnostics, patient<br />
meals and multi-site operational support are provided by other Victorian <strong>Health</strong> Service Providers on<br />
commercial terms.<br />
Professional medical indemnity insurance and other insurance products are obtained from a Victorian<br />
Public Financial Corporation.<br />
Treasury Risk Management Directions require <strong>Monash</strong> <strong>Health</strong> to hold cash (in excess of working<br />
capital) and investments, and source all borrowings from Victorian Public Financial Corporations.<br />
The compensation detailed below excludes the salaries and benefits the Portfolio Ministers receive.<br />
The Minister’s remuneration and allowances is set by the Parliamentary Salaries and Superannuation<br />
Act 1968 , and is reported within the Department of Parliamentary Services’ Financial <strong>Report</strong>.<br />
128 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.5: Related parties (continued)<br />
Parent Parent<br />
20<strong>18</strong> <strong>2017</strong><br />
$ '000 $ '000<br />
Compensation of Key Management Personnel<br />
Short-term Employee Benefits 779 701<br />
Post-employment benefits 62 59<br />
Other long-term benefits 14 11<br />
Total i 855 771<br />
i KMPs are also reported in Note 8.3 Responsible Persons<br />
Transactions with KMPs and Other Related Parties<br />
Given the breadth and depth of State government activities, related parties transact with the<br />
Victorian public sector in a manner consistent with other members of the public e.g. stamp duty and<br />
other government fees and charges. Further employment of processes within the Victorian public<br />
sector occur on terms and conditions consistent with the Public Administration Act 2004 and Codes<br />
of Conduct and Standards issued by the Victorian Public Sector Commission. Procurement processes<br />
occur on terms and conditions consistent with the Victorian Government Procurement Board<br />
requirements.<br />
Outside of normal citizen type transactions with the Department of <strong>Health</strong> and Human Services, all<br />
other related party transactions that involved KMPs and their close family members have been<br />
entered into on an arm's length basis. Transactions are disclosed when they are considered material<br />
to the users of the financial report in making and evaluation decisions about the allocation of scare<br />
resources.<br />
There were no related party transactions with Cabinet Ministers required to be disclosed in 20<strong>18</strong>.<br />
There were no related party transactions required to be disclosed for <strong>Monash</strong> <strong>Health</strong> Board Members<br />
and Chief Executive in 20<strong>18</strong>.<br />
Controlled Entities Related Party Transactions<br />
Kitaya Holdings Pty Ltd operates Jessie McPherson Private Hospital. <strong>Monash</strong> <strong>Health</strong> is reimbursed by<br />
its controlled entity, Kitaya Holdings Pty Ltd, for the provision of goods and services required to run<br />
the private hospital. The fee includes charges for labour, power, food, cleaning and other services.<br />
All transactions are conducted on normal commercial terms and conditions.<br />
The aggregate amounts brought to account in respect of the following types of transactions were:<br />
20<strong>18</strong> <strong>2017</strong><br />
$ '000 $ '000<br />
Rental income received from its controlled entity 1,149 1,132<br />
Contracted Goods and Services provided to its controlled entity 24,228 24,9<strong>18</strong><br />
Amounts owing at balance date<br />
Amount owing to controlled entity 13,<strong>18</strong>8 14,239<br />
129
Note 8.6: Remuneration of auditors<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
20<strong>18</strong> <strong>2017</strong><br />
$000 $000<br />
Victorian Auditor-General's Office<br />
Audit of financial statement 335 326<br />
TOTAL REMUNERATION OF AUDITORS 335 326<br />
130 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.7: Ex gratia payments<br />
There have been no ex gratia payments made during the financial year (<strong>2017</strong>: $0).<br />
131
Note 8.8: AASBs Issued that are not yet effective<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Certain new Australian accounting standards have been published that are not mandatory for the 30<br />
June 20<strong>18</strong> reporting period. The Department of Treasury and Finance assesses the impact of all these<br />
new standards and advises <strong>Monash</strong> <strong>Health</strong> of their applicability and early adoption where applicable.<br />
As at 30 June 20<strong>18</strong>, the following standards and interpretations had been issued by the AASB but were<br />
not yet effective. They become effective for the first financial statements for reporting periods<br />
commencing after the stated operative dates as detailed in the table below. <strong>Monash</strong> <strong>Health</strong> has not and<br />
does not intend to adopt these standards early.<br />
Applicable for<br />
annual<br />
reporting<br />
Standard<br />
Summary<br />
periods<br />
beginning on<br />
Impact on public sector entity<br />
financial statements<br />
AASB 9 Financial Instruments The key changes introduced by AASB 9 1 January 20<strong>18</strong> The assessment has identified that the<br />
include simplified requirements for the<br />
classification and measurement of<br />
financial assets, a new hedging<br />
accounting model and a revised<br />
impairment loss model to recognise<br />
impairment losses earlier, as opposed to<br />
the current approach that recognises<br />
impairment only when incurred.<br />
amendments are likely to result in<br />
earlier recognition of impairment<br />
losses and at more regular intervals.<br />
The initial application of AASB 9 is not<br />
expected to significantly impact the<br />
financial positon however there will be<br />
a change to the way financial<br />
instruments are classified and new<br />
disclosure requirements<br />
AASB 2014‐1 Amendments to Australian<br />
Accounting Standards [Part E Financial<br />
Instruments]<br />
AASB 2014‐7 Amendments to Australian<br />
Accounting Standards arising from<br />
AASB 9<br />
AASB 15 Revenue from Contracts with<br />
Customers<br />
AASB 2014‐5 Amendments to Australian<br />
Accounting Standards arising from<br />
AASB 15<br />
Amends various AASs to reflect the<br />
AASB’s decision to defer the mandatory<br />
application date of AASB 9 to annual<br />
reporting periods beginning on or after<br />
1 January 20<strong>18</strong>, and to amend reduced<br />
disclosure requirements<br />
Amends various AASs to incorporate the<br />
consequential amendments arising from<br />
the issuance of AASB 9.<br />
The core principle of AASB 15 requires<br />
an entity to recognise revenue when the<br />
entity satisfies a performance obligation<br />
by transferring a promised good or<br />
service to a customer. Note that<br />
amending standard AASB 2015‐8<br />
Amendments to Australian Accounting<br />
Standards – Effective Date of AASB 15 has<br />
deferred the effective date of AASB 15 to<br />
annual reporting periods beginning on or<br />
after 1 January 20<strong>18</strong>, instead of 1 January<br />
<strong>2017</strong><br />
Amends the measurement of trade<br />
receivables and the recognition of<br />
dividends as follow:<br />
Trade receivables, that do not<br />
have a significant financing<br />
component, are to be measured at<br />
their transaction price at initial<br />
recognition.<br />
Dividends are recognised in the<br />
profit and loss only when:<br />
o the entity’s right to<br />
receive payment of the<br />
dividend is established;<br />
o it is probable that the<br />
economic benefits<br />
associated with the dividend<br />
will flow to the entity; and<br />
1 January 20<strong>18</strong> This amending standard will defer the<br />
application period of AASB 9 to the<br />
20<strong>18</strong>‐19 reporting period in<br />
accordance with the transition<br />
requirements.<br />
1 January 20<strong>18</strong> The assessment has indicated that there<br />
will be no significant impact for the<br />
public sector.<br />
1 January 20<strong>18</strong> The changes in revenue recognition<br />
requirements in AASB 15 may result in<br />
changes to the timing and amount of<br />
revenue recorded in the financial<br />
statements. The Standard will also<br />
require additional disclosures on service<br />
revenue and contract modifications.<br />
1 January 20<strong>18</strong><br />
The assessment has indicated that there<br />
will be no significant impact for the<br />
public sector.<br />
AASB 2015‐8 Amendments to Australian<br />
Accounting Standards – Effective Date of<br />
AASB 15<br />
o the amount can be<br />
measured reliably.<br />
This standard defers the mandatory<br />
effective date of AASB 15 from 1 January<br />
<strong>2017</strong> to 1 January 20<strong>18</strong>.<br />
1 January 20<strong>18</strong> This amending standard will defer the<br />
application period of AASB 15 for forprofit<br />
entities to the 20<strong>18</strong>‐19 reporting<br />
period in accordance with the transition<br />
requirements.<br />
AASB 2016‐3 Amendments to Australian<br />
Accounting Standards – Clarifications to<br />
AASB 15<br />
This Standard amends AASB 15 to clarify<br />
requirements for identifying<br />
performance obligations, principal versus<br />
agent considerations and the timing of<br />
recognising revenue from granting a<br />
licence<br />
The amendments require:<br />
a promise to transfer to a customer<br />
a good or service that is ‘distinct’ to be<br />
recognised as a separate performance<br />
obligation;<br />
for items purchased online, the<br />
entity is a principal if it obtains control of<br />
the good or service prior to transferring<br />
to the customer; and<br />
for licences identified as being<br />
distinct from other goods or services in<br />
a contract, entities need to determine<br />
whether the licence transfers to the<br />
customer over time (right to use) or at a<br />
point in time (right to access).<br />
1 January 20<strong>18</strong><br />
The assessment has indicated that there<br />
will be no significant impact for the<br />
public sector, other than the impact<br />
identified for AASB 15 above.<br />
132 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.8: AASBs Issued that are not yet effective (continued)<br />
Standard<br />
AASB 2016‐7 Amendments to Australian<br />
Accounting Standards – Deferral of<br />
AASB 15 for Not‐for‐Profit Entities<br />
AASB 2016‐8 Amendments to Australian<br />
Accounting Standards – Australian<br />
Implementation Guidance for Not‐for‐<br />
Profit Entities<br />
Summary<br />
This standard defers the mandatory<br />
effective date of AASB 15 for not‐for‐profit<br />
entities from 1 January 20<strong>18</strong> to 1 January<br />
2019.<br />
Applicable for<br />
annual<br />
reporting<br />
periods<br />
beginning on<br />
AASB 2016‐8 inserts Australian<br />
1 January 2019<br />
requirements and authoritative<br />
implementation guidance for not‐for‐profitentities<br />
into AASB 9 and AASB 15.<br />
This Standard amends AASB 9 and AASB<br />
15 to include requirements to assist notfor‐profit<br />
entities in applying the<br />
respective standards to particular<br />
transactions and events.<br />
Impact on public sector entity<br />
financial statements<br />
1 January 2019 This amending standard will defer the<br />
application period of AASB 15 for not‐forprofit<br />
entities to the 2019‐20 reporting period.<br />
This standard clarifies the application of<br />
AASB 15 and AASB 9 in a not‐for‐profit<br />
context. The areas within these standards<br />
that are amended for not‐for‐profit<br />
application include:<br />
AASB 9 Statutory receivables are<br />
recognised and measured similarly to<br />
inancial assets<br />
AASB 15<br />
• The “customer” does not need to be the<br />
recipient of goods and/or services;<br />
• The “contract” could include an<br />
arrangement entered into under the<br />
direction of another party;<br />
• Contracts are enforceable if they are<br />
enforceable by legal or “equivalent means”;<br />
• Contracts do not have to have commercial<br />
substance, only economic substance; and<br />
• Performance obligations need to be<br />
“sufficiently specific” to be able to apply<br />
AASB 15 to these transactions<br />
AASB 16 Leases The key changes introduced by AASB 16<br />
include the recognition of most operating<br />
leases (which are currently not recognised) on<br />
balance sheet which has an impact on net<br />
debt.<br />
1 January 2019 The assessment has indicated that most<br />
operating leases, with the exception of short<br />
term and low value leases will come on to the<br />
balance sheet and will be recognised as right of<br />
use assets with a corresponding lease liability.<br />
In the operating statement, the operating lease<br />
expense will be replaced by depreciation<br />
expense of the asset and an interest charge.<br />
AASB 1058 Income of Not‐for‐Profit<br />
Entities<br />
AASB 1058 standard will replace the<br />
majority of income recognition in relation<br />
to government grants and other types of<br />
contributions requirements relating to<br />
public sector not‐for‐profit entities,<br />
previously in AASB 1004 Contributions.<br />
The restructure of administrative<br />
arrangement will remain under AASB<br />
1004 and will be restricted to government<br />
entities and contributions by owners in a<br />
public sector context,<br />
AASB 1058 establishes principles for<br />
transactions that are not within the scope<br />
of AASB 15, where the consideration to<br />
acquire an asset is significantly less than<br />
fair value to enable not‐for‐profit entities<br />
to further their objective<br />
1 January 2019 The current revenue recognition for grants<br />
is to recognise revenue up front upon<br />
receipt of the funds. This may change under<br />
AASB 1058, as capital grants for the<br />
construction of assets will need to be<br />
deferred. Income will be recognised over<br />
time, upon completion and satisfaction of<br />
performance obligations for assets being<br />
constructed, or income will be recognised at<br />
a point in time for acquisition of assets.<br />
The revenue recognition for operating<br />
grants will need to be analysed to establish<br />
whether the requirements under other<br />
applicable standards need to be considered<br />
for recognition of liabilities (which will have<br />
the effect of deferring the income associated<br />
with these grants). Only after that analysis<br />
would it be possible to conclude whether<br />
there are any changes to operating grants.<br />
The impact on current revenue recognition<br />
of the changes is the phasing and timing of<br />
revenue recorded in the profit and loss<br />
statement.<br />
133
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.8: AASBs Issued that are not yet effective (continued)<br />
Standard<br />
AASB 1059 Service Concession<br />
Arrangements: Grantor<br />
Summary<br />
This standard applies to arrangements that<br />
involve an operator providing a public<br />
service on behalf of a public sector grantor.<br />
It involves the use of a service concession<br />
asset and where the operator manages at<br />
least some of the public service at its own<br />
direction. An arrangement within the<br />
scope of this standard typically involves an<br />
operator constructing the asset used to<br />
provide the public service or upgrading<br />
the assets and operating and maintaining<br />
the assets for a specified period of time.<br />
The State has 2 types of PPPs:<br />
1. Social Infrastructure: A PPP that<br />
requires the government to make<br />
payments to the operator upon<br />
commencement of services:<br />
• Operator finances and constructs the<br />
infrastructure; and<br />
State pays unitary service payments over<br />
2. Economic Infrastructure: A PPP that is<br />
based on user pays model:<br />
• Operator finances and constructs the<br />
infrastructure;<br />
• State does not pay for the cost of the<br />
construction; and<br />
• Operator charges asset users and<br />
recovers the cost of construction and<br />
operation for the term of the contract.<br />
Applicable for<br />
annual<br />
reporting<br />
periods<br />
beginning on<br />
Impact on public sector entity<br />
financial statements<br />
1 January 2019 For an arrangement to be in scope of AASB<br />
1059 all of the following requirements are<br />
to be satisfied: be satisfied:<br />
• Operator is providing public services using<br />
a service concession asset;<br />
• Operator manages at ‘least some’ of public<br />
services under its own discretion;<br />
• The State controls / regulates:<br />
o What services are to be provided;<br />
o To whom; and<br />
o At what price<br />
• State controls any significant residual<br />
interest in the asset.<br />
If the arrangement does not satisfy all the<br />
above requirements the recognition will fall<br />
under the requirements of another<br />
applicable accounting standard.<br />
Currently the social infrastructure PPPs are<br />
only recognised on the balance sheet at<br />
commercial acceptance. The arrangement<br />
will need to be progressively recognised as<br />
and when the asset is being constructed.<br />
This will have the impact of progressively<br />
recognising the financial liability and<br />
corresponding asset as the asset is being<br />
constructed.<br />
For economic infrastructure PPP<br />
arrangements, that were previously not on<br />
balance sheet, the standard will require<br />
recognition of these arrangements on<br />
balance sheet. There will be no impact to<br />
net debt, as a deferred revenue liability will<br />
be recognised and amortised over the<br />
concession term.<br />
134 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.9: Events occurring after the balance sheet date<br />
Assets, liabilities, income or expenses arise from past transactions or other past events. Where<br />
the transactions result from an agreement between <strong>Monash</strong> <strong>Health</strong> and other parties, the<br />
transactions are only recognised when the agreement is irrevocable at or before the end of the<br />
reporting period.<br />
Adjustments are made to amounts recognised in the financial statements for events which occur<br />
between the end of the reporting period and the date when the financial statements are<br />
authorised for issue, where those events provide information about conditions which existed at<br />
the reporting date. Note disclosure is made about events between the end of the reporting period<br />
and the date the financial statements are authorised for issue where the events relate to<br />
conditions which arose after the end of the reporting period that are considered to be of material<br />
interest.<br />
There have been no significant events after reporting date.<br />
135
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
Note 8.10: Controlled entities<br />
Name of entity Country of incorporation Equity<br />
Holding<br />
Kitaya Holdings Pty Ltd Australia 100%<br />
(trading as Jessie McPherson Private Hospital)<br />
CONTROLLED ENITITES CONTRIBUTION TO THE CONSOLIDATED RESULTS<br />
20<strong>18</strong> <strong>2017</strong><br />
Kitaya Holdings Pty Ltd 100% 100%<br />
136 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>
Note 8.11: Economic dependency<br />
Notes to the Financial Statements<br />
<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />
<strong>Monash</strong> <strong>Health</strong> is wholly dependent on the continued financial support of the State<br />
Government and in particular, the Department of <strong>Health</strong> and Human Services.<br />
The Department of <strong>Health</strong> and Human Services has provided confirmation that it will<br />
continue to provide <strong>Monash</strong> <strong>Health</strong> adequate cash flow support to meet its current<br />
and future obligations as and when they fall due for a period up to September 2019.<br />
The hospital’s current asset ratio improved slightly but continues to be below an<br />
adequate short term position (20<strong>18</strong>: 0.51 and <strong>2017</strong>: 0.48) while cash generated<br />
from operations fell to a surplus of $79m from $112m in <strong>2017</strong>. Cash reserves<br />
increased to $160m from $116m in <strong>2017</strong>. A letter confirming adequate cash flow<br />
was also provided in the previous financial year.<br />
The financial statements have been prepared on a going concern basis.<br />
137
Corporate Office<br />
246 Clayton Road, Clayton<br />
t 03 9594 6666<br />
e info@monashhealth.org<br />
www.monashhealth.org<br />
ABN 82 142 080 338